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A. Introduction 
 
 
Each cell in a multicellular animal is programmed during development to respond to a 
specific set of signals that act in various combinations to regulate the behavior of the cell and 
to determine whether the cell lives or dies and whether it proliferates or stays quiescent.  
 
 
A.1. Stimulus-transcription coupling 
 
Cell signaling requires both extracellular signaling molecules and a complementary set of 
receptor proteins in each cell that enable it to bind and respond to extracellular stimuli in a 
programmed and characteristic way. Through cascades of highly regulated protein 
phosphorylations, elaborate sets of interacting proteins relay most signals from the cell 
surface to the nucleus, thereby altering the gene expression pattern of the cell and, as a 
consequence, its behavior. G-protein-coupled receptors (GPCR) are the largest family of cell-
surface receptors. Most G-protein-coupled receptors activate a chain of events that alter the 
concentration of one or more small intracellular signaling molecules. These small molecules, 
often referred to as second messengers, in turn pass the signal in by altering the behavior of 
selected cellular proteins. One of the most widely used intracellular mediators is cyclic AMP 
(cAMP), which is synthesized from ATP by the plasma-membrane-bound enzyme adenylyl 
cyclase, and it is rapidly and continuously destroyed by cAMP phosphodiesterases, which 
hydrolyze cAMP to adenosine 5’-monophosphate. cAMP exerts its effects by activating the 
enzyme cAMP-dependent protein kinase, also called protein kinase A (PKA), which catalyzes 
the transfer of the terminal phosphate group from ATP to specific serine or threonine residues 
of selected proteins. The proteins phosphorylated by PKA are marked by the presence of two 
or more basic amino acids on their amino-terminal side. Phosphorylation of the appropriate 
amino acids in turn regulates the activity of the target protein. In the inactive state PKA 
consists of a complex of two catalytic subunits and two regulatory subunits that bind cyclic 
AMP. The binding of cAMP alters the conformation of the regulatory subunits, causing them 
to dissociate from the complex. The released catalytic subunits are thereby activated to 
phosphorylate specific substrate protein molecule (Fig. 1). In some cells an increase in cAMP 
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activates the transcription of specific genes. In cells that secrete the peptide hormone 
somatostatin, for example, cAMP turns on the gene that encodes this hormone. The regulatory 
region of the somatostatin gene contains a short DNA consensus sequence (5`-TGACGTCA-
3`), called cAMP response element (CRE), that is also found in the regulatory region of other 
genes that are activated by cAMP. This sequence is recognized by a specific gene regulatory 
protein called CRE-binding (CREB) protein. CREB belongs to the family of basic region 
leucine zipper proteins and was first discovered through its ability to bind to the CRE in the 
promoter of the somatostatin (Gonzalez et al., 1989; Montminy and Bilezikjian, 1987; 
Montminy et al., 1986). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. cAMP and PKA signaling pathway. 
Activation of G-protein-coupled receptors leads to the activation of adenylyl cyclase which will 
synthesize cAMP from ATP. When cAMP binds to the regulatory subunits of PKA, the catalytic 
subunits will be released, will translocate to the nucleus, phosphorylating and subsequently activating 
the transcription factor CREB. 
 
 
Other well studied cell-surface receptors are the receptor tyrosine kinases (RTKs). All RTKs 
consist of a single transmembrane domain that separates the intracellular tyrosine kinase 
domain from the extracellular portion (Ullrich and Schlessinger, 1990). The intracellular 
catalytic domain includes the ATP-binding site that catalyzes receptor autophosphorylation 
and tyrosine phosphorylation of RTK substrates (Yarden and Ullrich, 1988). The 
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phosphotyrosyl residues are binding sites for adaptor proteins that interface with numerous 
downstream signaling pathways (Pawson, 1995). The mitogen-activated protein (MAP) 
kinases are components of the downstream signal transduction cascades initiated following 
binding of RTK cognate ligand. MAP kinases (MAPKs) are serine/threonine kinases that are 
activated by dual phosphorylation on threonine and tyrosine residues in response to a wide 
array of extracellular stimuli. Three distinct groups of MAPKs have been identified in 
mammalian cells; extracellular-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and 
p38 (Fig. 2). Although MAPKs regulate cytoplasmic targets, such as cytosolic phospholipase 
A2 (Lin et al., 1993), a major role for MAPKs is to transmit extracellular signals to the 
nucleus, where the transcription of specific genes is induced by phosphorylation and 
activation of transcription factors (Hill and Treismann, 1995; Karin and Hunter, 1995). The 
transcription factor complex activating protein-1 (AP-1), which belongs to the family of basic 
region leucine zipper proteins, has been identified as a target of MAPK signaling pathway 
(Karin, 1995). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. The MAPK signaling cascade. 
In response to extracellular stimuli, such as mitogen and stress, MAPKKK is activated, leading to the 
activation of MAPKK, which in turn activates the MAPK which will translocate to the nucleus to 
phosphorylate and subsequently activate specific transcription factors. 
 
 
A.2. Basic region leucine zipper (bZIP) transcription factors 
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The bZIP transcription factors are proteins that bind to sequence-specific double-stranded 
DNA as homodimers or heterodimers to either activate or repress gene transcription (Hurt, 
1995). The amino acid alignment of bZIP proteins allowed the identification of the bZIP 
motif, a long bipartite α-helix that is 60 to 80 amino acids long (Vinson et al., 1989). The N-
terminal half contains two clusters of basic amino acids responsible for sequence-specific 
DNA-binding, while the C-terminal half contains an amphipathic protein sequence of variable 
length with a leucine every seven amino acids (Vinson et al., 2002). The DNA-binding 
domain consists of a high concentration of basic residues (Lys or Arg) that can interact with 
the negatively charged phosphates of the DNA backbone. The amphipathic sequence termed 
“leucine zipper” mediates homo- and heterodimerization of bZIP proteins (Landschulz et al., 
1988). There are many types of leucine zipper proteins, and they cannot all form heterodimers 
with one another. Whether or not a particular heterodimer can be formed depends on how 
well the hydrophobic surfaces of the two leucine zippers α helices mesh with each other, 
which, in turn, depends on the exact amino acid sequences of the two zipper regions. Thus 
each leucine zipper protein in the cell can form dimers with only a small set of the other 
leucine zipper proteins (Vinson et al., 2002).  
 
 
Fig. 3. Leucine zippers. 
Leucine zipper of the yeast activator protein GCN4. Only the “zippered” α helices (white and light 
blue), derived from different subunits of the dimeric protein, are shown. The two helices wrap around 
each other in a gently coiled coil. The interacting leucine residues are shown in red. (Nelson and Cox, 
2000). 
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In the late 1980s, several mammalian bZIP proteins were purified and the cDNAs were 
cloned (Vinson et al., 2002). Among the first bZIP proteins identified were the AP-1 (c-FOS 
and c-JUN) heterodimer (Bohmann et al., 1987), the CREB homodimer (Montminy and 
Bilezikjian, 1987) and the C/EBP homodimer (Johnson et al., 1987; Landschulz et al., 1988).  
 
CREB 
The transcription factor CREB is the prototype of the bZIP family of transcription factors. 
CREB binds to a conserved cAMP response element present within the 5`-flanking region of 
many cAMP-responsive genes (Montminy et al., 1986; Roesler et al., 1988). CREB contains a 
bZIP domain and two glutamine rich domains, referred to as Q1 and Q2/CAD (constitutive 
active domain) that are separated by the kinase inducible domain (KID). Within the KID 
resides the critical residue Ser-133, which once phosphorylated in a stimulus-inducible 
manner, makes the KID a binding target for the transcriptional coactivator, CREB binding 
protein (CBP) (Chrivia et al., 1993; Kwok et al., 1994). CBP binds to the Ser-133-
phosphorylated KID domain via its KIX domain (Parker et al., 1996; Radhakrishnan et al., 
1997), and it is the stimulus-dependent interaction between these two domains that is believed 
to function as the trigger for inducible gene expression. Q2/CAD interacts with components 
of the basal transcriptional machinery and may be responsible for facilitating stimulus-
independent CRE-derived gene expression (Ferreri et al., 1994; Quinn, 1993; Xing et al., 
1995). The modular structure of CREB is shown in Fig. 5. CREB is inactive in the 
dephosphorylated state and turns into an activator upon phosphorylation. The key enzyme 
leading to CREB activation is the cAMP-dependent protein kinase (PKA), but CREB serves 
also as a substrate for calcium/calmodulin-dependent protein kinase IV and the mitogen and 
stress-activated protein kinases (SAPK) MSK1 and 2 (Sun et al., 1994; Wiggin et al., 2002). 
CREB has been shown to be important in long-lasting changes in synaptic strength in diverse 
organisms including Drosophila, Aplysia and mouse (Frank and Greenberg, 1994; Silva et al., 
1998). Several studies have revealed a role for the CREB family of activators in the control of 
cell survival and proliferation (Long et al., 2001; Ionescu et al., 2001). It has been 
demonstrated that CREB DNA-binding activity and phosphorylation are necessary for the 
nerve growth factor (NGF)-dependent survival of neurons (Riccio et al., 1999; Bedogni et al., 
2003). In addition, several cell cycle genes such as cyclin D1 and cyclin A are regulated by 
CREB via a functional CRE element (Desdouets et al., 1995; Lee et al., 1999; D’Amico et al., 
2000). Additionally, alteration of CRE binding proteins with loss of CREB expression were 
observed in the human adrenocortical cancer cell line H295R. Similar alterations were found 
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in human malignant adrenocortical tumors (Rosenberg et al., 2002a, b). Also the involvement 
of CREB in the control of tumor metastasis was demonstrated in cases of melanoma cells 
(Jean and Bar-Eli, 2000, 2001). Several evidences strongly support a role of CREB as a 
neuroprotectant (Hu et al., 1999; Walton et al., 1999; Tanaka et al., 2000; Mabuchi et al., 
2001). While the complete disruption of CREB is lethal in mice (Rudolph et al., 1998) and is 
therefore not likely to be compatible with human life, several pathological conditions exist in 
which CREB function may be disrupted subtly or incompletely. Some such conditions are 
genetic disorders in which CREB interactors are defective. A heterozygous mutation in CBP, 
for example, produces Rubenstein-Taybi Syndrome, which is characterized by multiple 
deficits including mental retardation (Petrij et al., 1995). In most cases, the mechanism by 
which the disruption of CREB function may produce disease is poorly understood. One 
notable exception is the group of polyglutamine repeat diseases, which includes Huntington’s 
Disease, a devastating neurodegenerative disorder (Lonze and Ginty, 2002). 
 
ATF2 
Activating transcription factor 2 (ATF2), also known as cAMP response element binding 
protein-1 CRE-BP-1 (Nomura et al., 1993), is a member of the activating protein-1 (AP-1) 
family of bZIP proteins. ATF2 binds to the classical CRE motif 5`-TGACGTCA-3` (Thiel et 
al., 2005a). Furthermore, the related DNA target sequence 5`-TTGCGTAA-3` has been 
reported as high affinity consensus binding site for ATF2 homodimers (Benbrook and Jones, 
1994). ATF2 is able to form homodimers and heterodimers through the leucine zipper and the 
preferred dimerization partner is c-Jun (Hai and Curran, 1991; Van Dam et al., 1993; 
Benbrook and Jones, 1994; Tsai et al., 1996). ATF2 is ubiquitously expressed with the highest 
level of expression being observed in the brain (Takeda et al., 1991). ATF2 contains at its N-
terminus a phosphorylation-dependent transcriptional activation domain (Livingstone et al., 
1995) and at its C-terminus a bZIP domain, responsible for DNA-binding and dimerization. In 
the absence of appropriate inducers, ATF2 remains transcriptionally inactive due to an 
inhibitory intramolecular interaction between the activation domain and the bZIP domain of 
ATF2 (Li and Green, 1996). The modular structure of ATF2 is shown in Fig. 19. The activity 
of the activation domain of ATF2 appears to be masked in the intact protein and is dependent 
upon two closely situated threonine residues, Thr 69 and Thr 71. These residues are 
phosphorylated in vivo and can be efficiently phosphorylated in vitro by the JNK/SAPK 
group of MAPK family (Livingstone et al., 1995). The replacement of these phosphorylation 
sites with alanine inhibited the transcriptional activity of ATF2. The phosphorylation of ATF2 
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N-terminus can also be mediated by ERK2 in vitro although in much less efficiently. It is 
doubtful, however, that ERK1/2 play any role in the regulation of ATF2 activity in vivo 
(Livingstone et al., 1995). ATF2 has been implicated in a wide variety of biological processes 
including skeletal and central nervous system (CNS) development (Reimold et al., 1996), 
proinflammatory cytokine stimulation (Gupta et al., 1995) and the cellular stress response 
(Clerk and Sugden, 1997; Gupta et al., 1995; Morooka et al., 1995; Wilhelm et al., 1995). 
Additionally, elevated ATF2 expression was found in Alzheimer’s Disease cortex (Yamada et 
al., 1997b). These studies raise the possibility that activation of ATF2 protein may have a role 
in neuronal programmed cell death (Walton et al., 1998). The inactivation of ATF2 gene in 
transgenic mice revealed an absolute requirement of ATF2 for skeletal and central nervous 
system development. Moreover, induction of genes regulated by CRE sites such as E-selectin 
were impaired (Reimold at al., 1996). In addition, mice lacking ATF2 display features of a 
severe form of meconium aspiration syndrome (Maekawa at al., 1999), a neonatal disease that 
results in acute and chronic respiratory morbidity. These ATF2 deficient mice die shortly after 
birth. 
 
c-Jun 
The transcription factor c-Jun is a bZIP protein, which is a central component of the 
transcriptional complex AP-1. Like all AP-1 family members c-Jun recognizes either 12-O-
tetradecanoylphorbol-13-acetate (TPA) response elements (TREs) (5`-TGAGCTCA-3`) or 
cAMP response elements (5`-TGACGTCA-3`) (Hirai and Yaniv, 1989; Sassone-Corsi et al., 
1990; Ryseck and Bravo, 1991). Studies of c-jun expression indicate that it belongs to the 
immediate-early class of genes, which are rapidly transient induced in response to mitogenic 
stimuli in quiescent cells (Curran and Franza, 1988). Although many cells contain low levels 
of c-Jun protein, the transcription of the c-jun gene is greatly stimulated both by hormones 
(e.g., epidermal growth factor) and by compounds that stimulate the activity of protein kinase 
C (e.g., Phorbol esters) (Dixit et al., 1989; Lamph et al., 1988). c-Jun contains at its C-
terminus a bZIP domain, responsible for DNA-binding and dimerization. The N-terminus of 
c-Jun contains a phosphorylation-dependent transcriptional activation domain (Pulverer et al., 
1991; Smeal et al., 1991). The modular structure of c-Jun is shown in Fig. 37. One crucial 
property of c-Jun is the formation of functional heterodimers with multiple transcription 
factors, and these partners alter the affinity of c-Jun for DNA-binding sites, and, 
subsequently, determine the downstream target genes controlled by c-Jun (Angel and Karin, 
1991; Hai and Curran, 1991). Furthermore, c-Jun and its heterodimer partners are targets for 
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phosphorylation by kinases linked to specific signaling pathways. c-Jun N-terminal kinases 
(JNK) phosphorylate the serine residues 63 and 73 within the N-terminus of c-Jun and this 
enables c-Jun to activate the mRNA polymerase complex resulting in transcription of effector 
genes (Derijard et al., 1994; Gupta et al., 1995). c-Jun plays a general role in the regulation of 
cell proliferation and apoptosis. It has been shown in fibroblasts isolated from E11.5 c-jun-/- 
and c-jun+/- embryos that the absence or diminished expression of c-Jun resulted in greatly 
reduced growth rates, and that this proliferation defect could not be compensated by addition 
of purified mitogens (Johnson et al., 1993; Schreiber et al., 1999). Evidences concerning the 
role of c-Jun and c-Jun phosphorylation in apoptosis was obtained in neuronal cells where 
transient overexpression of c-Jun induced apoptosis and expression of a dominant-negative c-
jun mutant inhibited apoptosis in vitro (Estus et al., 1994; Ham et al., 1995, Behrens et al., 
1999). In vitro experiments have demonstrated that expression of c-Jun can kill neonatal 
neurons (Schlingensiepen et al., 1993) but, in the adult nervous system, c-Jun might be 
involved in neuroprotection and regeneration (Aznar et al., 1995; Sommer et al., 1995). 
Furthermore, targeted disruption of c-jun is lethal (Hilberg et al., 1993; Johnson et al., 1993; 
Schorpp-Kistner et al., 1999), where lethality of c-jun-/- fetuses has been suggested to be due 
to defective liver development (Hilberg et al., 1993).  
 
c-Fos 
The transcription factor c-Fos is a nuclear phosphoprotein belonging to the AP-1 family of 
bZIP proteins. In most cell types c-fos mRNA and protein are present at low levels, however, 
they can be induced by a diverse array of agents in a variety of situations (Morgan and 
Curran, 1991). c-fos is not able to form homodimers and one way c-fos can mediate 
transcription is via heterodimerization with jun family members and binding TRE/AP-1 sites 
(Rauscher et al., 1988; McBride and Nemer, 1998). The c-Fos protein contains several 
transcriptionally active regions, including some autonomous transactivation domains 
(Sutherland et al., 1992; Wisdom and Verma, 1993; Deng and Karin, 1994; Jooss et al., 
1994), a carboxy-terminal transrepression domain (Sassone-Corsi et al., 1988a; Gius et al., 
1990; Ofir et al., 1990) and a region that interacts with the TATA box-binding protein (Metz 
et al., 1994). Like all other bZIP proteins, c-Fos contains on its C-terminus a bZIP domain, 
responsible for DNA-binding and dimerization (Landschulz et al., 1988). Fos protein has been 
implicated as playing a pivotal role during cell growth, differentiation and development 
(Muller and Wagner, 1984; Holt et al., 1986; Distel et al., 1987; Dony and Gruss, 1987; 
Nishikura and Murray, 1987; Ruther et al., 1987; Verma and Graham, 1987). It has been 
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shown that a c-fos null mutation leads to a number of tissue specific deficits of function, some 
of the most striking of them occurring in the bone and CNS (Johnson et al., 1992; Wang et al., 
1992). c-Fos is persistently induced in brain of mice treated with kainic acid, a potent 
activator of glutamate receptors that causes apoptosis of hippocampal neurons (Smeyne et al., 
1993). 
 
CREB2/ATF4 
cAMP response element binding protein 2, also called activating transcription factor 4 
(ATF4), is a ubiquitously expressed 351-amino acid protein (Karpinski et al., 1992). 
CREB2/ATF4 has been described to repress transcription (Karpinski et al., 1992; Jungling et 
al., 1994) but new data show that CREB2/ATF4 is a strong transcriptional activator (Liang 
and Hai, 1997; He et al., 2001; Schoch et al., 2001; Luo et al., 2003, Thiel et al., 2005a). 
CREB2/ATF4 can form dimers with other transcription factors including those in the 
CCAAT/enhancer binding protein family (Vallejo et al., 1993). CREB2 mRNA is expressed 
ubiquitously in human tumor cell lines and mouse organs suggesting that it is involved in 
regulating transcription in a wide variety of cell types (Karpinski et al., 1992). CREB2/ATF4 
contains in the C-terminal end a leucine-zipper motif and an adjacent basic domain that have 
been shown to be involved in dimerization and DNA binding, respectively. It also contains on 
the N-terminus a consensus MAPK phosphorylation sites but lacking protein kinase A and 
protein kinase C phosphorylation sites (Karpinski et al., 1992). The modular structure of 
CREB2 is shown in Fig. 5. Mammalian ATF4 has been implicated in various physiological 
processes including wound healing (Estes et al., 1995), eye development (Tanaka et al., 1998; 
Hettmann et al., 2000), stress responses (Fawcett et al., 1999), apoptosis (Kawai et al., 1998) 
and cancer (Mielnicki et al., 1996). It has been reported that targeted disruption of ATF4 in 
mice causes perinatal lethality, dwarfism and severe osteoporosis, which are abnormalities 
caused by a failure of osteoblasts to fully differentiate and to properly function (Yang and 
Karsenty, 2004).  
 
ATF5 
Activating transcription factor 5, also known as ATF7 and ATFx, is a bZIP transcription 
factor that forms homodimers, which, at least in vitro, bind the CRE (Peters et al., 2001). 
ATF5 displays 58% amino acid identity to CREB2/ATF4 in the carboxy-terminal bZIP region 
(Hansen et al., 2002). Like other bZIP proteins, ATF5 contains C-terminal basic leucine 
zipper DNA-binding domain and N-terminal transcriptional domain. In the leucine zipper 
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domain, ATF5 has only three leucines instead of the five that are present in CREB2/ATF4 
with the distal two leucines replaced by valines (Pati et al., 1999). It has been reported that the 
expression of ATFx is down-regulated in a variety of cells undergoing apoptosis following 
growth factors deprivation, indicating that ATFx has an anti-apoptotic function. The role of 
ATFx in cell survival appears to be purely anti-apoptotic, as overexpression of the gene did 
not affect the rate of cell growth or cell cycle progression (Persengiev et al., 2002). It has been 
shown that constitutive expression of ATF5 blocks neuronal differentiation of cultured 
embryonic neural progenitor cells and maintains them in a proliferating state. It has been also 
shown that loss of ATF5 function, or ATF5 expression, leads to neuronal differentiation of 
cultured neural progenitors (Angelastro et al., 2005). 
 
C/EBPα 
CCAAT/enhancer binding protein α is the prototype of the C/EBP family and belongs to the 
bZIP class of transcription factors (Johnson et al., 1987; Grayson et al., 1988; Landschulz et 
al., 1988). C/EBPα is expressed at high levels in the adipose tissue, liver, intestine, lung, 
adrenal gland, peripheral-blood mononuclear cells and placenta (Cao et al., 1991; Williams et 
al., 1991; Antonson and Xanthopoulos, 1995; Lekstrom-Himes and Xanthopoulos, 1998). The 
C/EBP proteins bind specifically to the dyad symmetrical sequence 5´-ATTGCGCAAT-3´ 
(Agre et al., 1989). However, it has been also reported that C/EBP proteins bind to ATF/CRE 
motifs (5´-TGACGTCA-3´) (Bakker and Parker, 1991). All members of the C/EBP family 
have a C-terminally located bZIP domain that is responsible for DNA binding and 
dimerization (Landschulz et al., 1988). The modular structure of C/EBPα is depicted in Fig. 
60. C/EBPα activates transcription of several liver and fat cell specific genes (MacDougald 
and Lane, 1995; Christy et al., 1989; Friedman et al., 1989; Friedman and McKnight, 1990). It 
has been demonstrated that C/EBPα can induce growth arrest in adipocytes suggesting that it 
may play a role in regulating the balance between proliferation and differentiation (Freytag 
and Geddes, 1992; Umek et al., 1991). When overexpressed in cultured cells, C/EBPα acts as 
a strong inhibitor of cell proliferation (Diehl et al., 1996; Timchenko et al., 1996; Hendricks-
Taylor and Darlington, 1995). It has been shown that C/EBPα is critical for the proper 
development of both the liver and the lung since animals deficient in C/EBPα display severe 
abnormalities in these organs and die within 10 h after birth (Flodby et al., 1996).  
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CHOP 
The C/EBP homologous protein (CHOP), also known as growth arrest and DNA damage 
protein 153 (GADD153), was first identified as a gene that was induced by DNA damage 
(Fornace et al., 1988; Ron and Habener, 1992). CHOP can form heterodimers with other 
members of the C/EBP family, regulating gene expression either as a dominant-negative 
factor preventing the binding of the C/EBPs to their canonical DNA targets (Ron and 
Habener, 1992) or as a transcriptional activator by directing CHOP-C/EBP heterodimers to 
other DNA sequences (Ubeda et al., 1996). Similar to the Fos proteins, CHOP does not form 
stable homodimers and thereby it depends on heterodimerization with other proteins to exert 
functions on the control of gene transcription (Ron and Habener, 1992). CHOP contains in its 
C-terminus a bZIP domain (Ramji and Foka, 2002), while the N-terminus of CHOP contains a 
transcriptional activation domain which is inducible by cellular stress (Ubeda et al., 1996). 
Several studies have reported a relationship between CHOP expression in cultured cells and 
various stress conditions such as the depletion of Ca2+ stores (Brewer et al., 1997), oxidative 
stress (Guyton at al., 1996) and glucose or amino acids deprivation (Carlson et al., 1993; 
Bruhat et al., 1997). The expression of CHOP appears to play a role in the control of the cell 
division cycle (Barone et al., 1994; Zhan et al., 1994). CHOP has also been implicated in the 
inhibition of adipocyte differentiation (Batchvarova et al., 1995) and seems to be involved in 
cell apoptosis induced by endoplasmic reticulum stress (Zinszner et al., 1998), alkylating 
agents (Wang and Ron, 1996), or by Fas and ceramides (Brenner et al., 1997). 
 
 
A.3. Problems and aim 
 
The bZIP transcription factor CREB is inactive in the dephosphorylated state and needs 
phosphorylation to be activated. To study CREB-mediated gene transcription, a signaling 
cascade leading to CREB phosphorylation and activation needs to be triggered. This can be 
accomplished either by adding cAMP analogues such as the cell permeable dibutyryl cAMP, 
or by adding forskolin, a direct activator of adenylyl cyclase. These experiments are 
problematic in that high levels of phosphodiesterase enzymes in the cells may immediately 
hydrolyze cAMP to 5`-AMP, resulting in that no cAMP-mediated gene transcription can be 
monitored (Klar et al., 2002). Additionally, high levels of cAMP may also activate the 
exchange proteins directly activated by cAMP/Rap1 (EPAC/Rap1) pathway, which is a PKA 
independent signaling pathway (Kawasaki at al., 1998; De Rooij et al., 1998). Thus, many 
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functions of cAMP previously attributed to PKA may be in fact the result of EPAC activation 
(Mai et al., 2002). Another way to study CREB-mediated gene transcription is to overexpress 
the catalytic subunit of PKA. This approach has the advantage that by excluding a parallel 
signaling cascade via the cAMP-induced EPAC, only the biological outcome of PKA 
activation is studied. However, the translocation of the catalytic subunit of PKA into the 
nucleus is not efficient and may rely solely on diffusion (Harootunian at al., 1993). Therefore, 
high amounts of expression vector in the range of 1-5 µg/plate are often used (Grewal et al., 
2000; Streeper et al., 2000, 2001) in order to observe an effect on gene transcription. The 
problem is that these high amounts of expressed catalytic subunit are far away from the 
physiological concentrations within the cells. The best way to study CREB-regulated gene 
transcription is to uncouple the investigation of transcriptional targets of CREB from the 
signaling pathways in the cell leading to CREB phosphorylation and activation. This was 
accomplished in this work by using the constitutively active mutant of CREB termed 
C2/CREB. Constitutively active mutants of ATF2 (C2/ATF2), c-Jun (C2/c-Jun) and C/EBPα 
(C2/CEBPα) were also used to study gene transcription mediated by ATF2, c-Jun and 
C/EBPα, respectively. 
The bZIP proteins dimerize to bind specific DNA sequences. Many conflicting results were 
published concerning the dimerization of bZIP proteins but the dimerization code is not yet 
completely understood. To analyze the specificity of dimerization between different bZIP 
domains and also to determine bZIP dimerization partners the dominant-negative bZIP 
mutants termed A-ZIP mutants were used (Fig. 4). The dominant-negative bZIP mutants A-
ZIPs are reagents that inhibit DNA-binding of the wild-type bZIP proteins in a leucine zipper-
dependent fashion. A-ZIP proteins are amphipathic molecules that contain an acidic region 
instead of the natural basic domain N-terminal to the leucine zipper domain. This acidic 
extension of the leucine zipper forms a heterodimeric coiled coil structure with the basic 
region of its target that is more stable than the bZIP dimer bound to DNA. The heterodimer 
complexes formed between an A-ZIP mutant and a wild-type bZIP protein are then defective 
for DNA-binding (Vinson et al., 2002). 
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Fig.4. Schematic representation of the dominant-negative bZIP mutants termed A-ZIP mutants. 
CREB homodimer and CREB/A-CREB heterodimer are shown. 
 
 
The aim of this work was to analyze and clarify genes regulated by different bZIP proteins by 
using either gain-of-function mutants (the constitutively active mutants, C2/bZIPs), or loss-of-
function mutants (the dominant-negative mutants, A-ZIPs). Furthermore, gain-of-function 
experiments allowed the identification of target genes where the bZIP proteins are involved 
and loss-of-function experiments allowed better understanding of the dimerization code of 
different bZIP proteins. 
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B. Materials and Methods 
 
 
B.1. Materials 
 
B.1.1. Chemicals and Reagents 
 
The chemicals used in this work were obtained from the following companies: 
 
Acros organics (Geel, Belgium) 
Biochrom (Berlin, Germany) 
Fisher Scientific (Nidderau, Germany) 
Fluka (Neu-Ulm, Germany) 
Calbiochem (Bistro, GB) 
Merck Biosciences (Schwalbach, Germany) 
Pierce (Rockford, USA) 
Roth (Karlsruhe, Germany) 
Sigma (Taufkirchen, Germany) 
Tocris (BIOTREND chemicals, Cologne, Germany) 
VWR (Darmstadt, Germany) 
 
The reagents were obtained from: 
 
Axxora platform (Alexis Biochemicals, Gruenberg, Germany) 
Biomol (Hamburg, Germany) 
GIBCO BRL (Invitrogen Life Technologies, Karlsruhe, Germany) 
MBI Fermentas (St. Leon-Rot, Germany) 
PAA (Coelbe, Germany) 
Promega (Mannheim, Germany) 
Roche (Mannheim, Germany) 
Stratagene Europe (Amsterdam, Holland) 
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The following substances and compounds used in this work were prepared as follows: 
 
BAPTA-AM [1,2-bis(o-Aminophenoxy)ethane-N-N-N´-N´-tetraacetic Acid Tetra 
(acetoxymethyl) Ester] 
Calbiochem # 196419 
Stock Solution: 10 mM in DMSO 
BAPTA-AM is a calcium chelator (Tsien, 1980, 1981). 
 
Buserelin 
Sigma # B-3303 
Stock Solution: 1 mg/ml (806 µM) in distilled water 
Amino acid sequence: Glu-His-Trp-Ser-Tyr-D-Ser-Leu-Arg-Pro-NHEt (Pinter et al., 1999). 
 
Carbachol (Carbamylcholine chloride) 
Sigma # C-4382 
Stock solution: 100 mM in distilled water 
Carbachol is an cholinergic receptor agonist (Yamada et al., 1997a; Pugh and Margiotta, 
2000). 
 
Chloroquine diphosphate salt 
Sigma # C-6628 
Stock solution: 10 mM in distilled water 
Chloroquine was used to increase transfection efficiency (Luthman and Magnusson, 1983). 
 
Complete 
Roche # 11 697 498 001 
Stock solution: 25x conc (one tablet Complete was dissolved in 2 ml redist water) 
Complete is a Protease Inhibitor Cocktail Tablets, that is used for the inhibition of serine, 
cysteine and metalloproteases in bacterial, mammalian, yeast and plant cell extracts in large 
volumes (North, 1969). 
 
G 418 sulfate 
Calbiochem # 345810 
Stock solution: 300 mg/ml in distilled water 
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JNK Inhibitor 1 (L-stereoisomer) [L-JNK1] 
Alexis # 159-600-R100 
Stock solution: 1 mM in PBS 
Amino acid sequence: GRKKRRQRRR-PP-RPKRPTTLNLFPQVPRSQD-amide (Bonny et 
al., 2001). 
 
KN-62 (1-[N,O-bis-(5-Isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine) 
Calbiochem # 422706 
Stock solution: 5 mM in DMSO 
KN-62 is known as a cell-permeable selective inhibitor of the calcium/calmodulin-dependent 
protein kinases (Tokumitsu et al., 1990). 
 
Lipopolysaccharide (LPS) from E.coli 
Sigma # L2630 
Stock solution: 1 µg/µl in distilled water 
LPS is the major component of the cell wall of Gram negative bacteria and is known to 
trigger a variety of inflammatory reactions in macrophages and other cells (Wright et al., 
1990; Downey et al., 1998). 
 
PD98059 (2´-amino-3´-methoxyflavon) 
Calbiochem # 513 
Stock solution: 75 mM in DMSO 
PD98059 is an inhibitor of the MAP kinase kinase MEK that acts by inhibiting the activation 
of MAP kinase and subsequent the phosphorylation of MAP kinase substrates (Pang et al., 
1995; Langlois et al., 1995). 
 
SB203580 [4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole] 
Alexis # 270-179-M001 
Stock solution: 13.2 mM in DMSO 
SB203580 is a specific inhibitor of p38 MAP kinase (Cuenda et al., 1995; Saklatvala et al., 
1996). 
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B.1.2. Filters and X-ray films 
 
The nitrocellulose filters and membranes were obtained from either Schleicher & Schuell 
(Dassel, Germany) or VWR (Darmstadt, Germany) and the X-ray films were obtained from 
Fuji. 
 
 
B.1.3. Vectors and Plasmids 
 
B.1.3.1. Vectors and expression plasmids 
 
Plasmids were kindly obtained from G. Thiel if nothing else is mentioned. 
 
pM1 
The pM1 expression plasmid was obtained from I. Sadowski (Department of Biochemistry 
and Molecular Biology, University of British Columbia, Vancouver, Canada). It encodes the 
DNA-binding domain of the transcription factor GAL4 (amino acids 1-147) of 
Saccharomyces cerevisiae (Sadowski et al., 1992). 
 
pGAL4-c-Jun 
The pGAL4-c-Jun expression plasmid was obtained from Michael Karin, University of 
California, San Diego (Groot et al., 2000). The GAL4 fusion protein encoded by this plasmid 
contains the transcriptional activation sequence from amino acids 1-246 of c-Jun fused to the 
DNA-binding domain of GAL4. The modular structure of GAL4-c-Jun is shown in Fig. 53A. 
 
pGAL4-ATF2 
The pGAL4-ATF2 expression plasmid was purchased from Stratagene (La Jolla, CA, USA). 
The GAL4 fusion protein encoded by this plasmid contains the transcriptional activation 
sequence from amino acids 1-96 of ATF2 fused to the DNA-binding domain of GAL4. The 
modular structure of GAL4-ATF2 is shown in Fig. 53A. 
 
pGAL4-CREB2/ATF4 
The GAL4 fusion protein encoded by this plasmid contains the transcriptional activation 
sequence from amino acids 6-181 of CREB2/ATF4 fused to the DNA-binding domain of 
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GAL4 (Schoch et al., 2001). The modular structure of GAL4-CREB2/ATF4 is shown in Fig. 
53A. 
 
pGAL4-CREB 
The pGAL4-CREB expression plasmid was purchased from Stratagene (La Jolla, CA, USA). 
The fusion protein encodes the transcriptional activation sequence of CREB (amino acids 1-
281) fused to the DNA-binding domain of GAL4. The modular structure of GAL4-CREB is 
shown in Fig. 16A. 
 
pGAL4-ATF5 
The pGAL4-ATF5 plasmid encodes the GAL4 fusion protein encompassing amino acids 14-
204 of ATF5 fused to the DNA-binding domain of GAL4. The modular structure of pGAL4-
ATF5 is shown in Fig. 53A.  
 
pEBGN 
The pEBGN expression vector encodes Schistosoma japanicum glutathione S-transferase 
GST under the control of elongation factor 1α gene promoter. In addition, pEBGN has a 
nuclear localization sequence (NLS) derived from the Simian Virus 40 large T antigen which 
was inserted to accomplish nuclear targeting of the GST fusion protein (Thiel and Cibelli, 
1999). 
 
pEBGN-CREB and pEBGN-KCREB 
The pEBGN-CREB and pEBGN-KCREB plasmids encode the GST fusion proteins GST-
CREB and GST-KCREB encompassing amino acids 235-326 of CREB or KCREB, 
respectively (Thiel et al., 2005a). The modular structure of GST-CREB and GST-KCREB is 
shown in Fig. 22A. 
 
CREB133A and K-CREB 
The CREB133A and K-CREB expression plasmids were a kind gift of Wilhart Knepel and 
Elke Oetjen, Department of Molecular Pharmacology, University of Göttingen, Germany. 
CREB133A contains a serine to alanine mutation at the position 133, while K-CREB is a 
CREB mutant containing a point mutation R236L within the basic DNA-binding domain, 
impairing DNA-binding (Thiel et al., 2005b). 
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pCMV5 
The pCMV5 is an expression vector, where gene expression is controlled by the 
cytomegalovirus gene IE promoter/enhancer (NCBI accession # AF239249). 
 
pCMV-FLAG-CREB 
The pCMV-FLAG-CREB expression plasmid encodes amino acids 1-326 of CREB. In 
addition, a triple FLAG tag (sequence MDYKDHDGDYKDHDIDYKDDDDK) is present on 
the N-terminus for immunodetection of the protein (Thiel et al., 2005a). The modular 
structure of pCMV-FLAG-CREB is shown in Fig. 5. 
 
pCMV-FLAG-CREB2 
The pCMV-FLAG-CREB2 expression plasmid encodes amino acids 1-351 of CREB2/ATF4. 
In addition, a triple FLAG tag is present on the N-terminus (Thiel et al., 2005a). The modular 
structure of pCMV-FLAG-CREB2 is shown in Fig. 5. 
 
pCMX-PL1-ATF2 
The pCMX-PL1-ATF2 expression plasmid consists of the cDNA of the transcription factor 
ATF2 and is controlled by the cytomegalovirus gene IE promoter enhancer. This plasmid was 
a kind gift of Jon D. Shuman (NIAID, Rockville, USA) (Steinmüller and Thiel, 2003). 
 
pCMV-FLAG-C2/CREB 
The pCMV-FLAG-C2/CREB plasmid encodes a constitutively active C2/CREB chimera. The 
C2/CREB fusion protein encodes amino acids 1-187 of CREB2 (the transcriptional activation 
domain of CREB2) fused to amino acids 182-326 of CREB (the C-terminal region of CREB 
encompassing the bZIP domain). In addition, a triple FLAG tag is present on the N-terminus 
(Thiel et al., 2005a, b). The modular structure of pCMV-FLAG-C2/CREB is shown in Fig. 5. 
 
pCMV-FLAG-C2/ATF2 
The pCMV-FLAG-C2/ATF2 expression plasmid encodes a constitutively active ATF2 
mutant. The encoded protein contains the transcriptional activation domain of CREB2 (amino 
acids 1 to 187) linked to the C-terminal region of ATF2 (amino acids 92-389), encompassing 
the bZIP domain of ATF2. In addition, a triple FLAG tag is present on the N-terminus 
(Steinmüller and Thiel, 2003). The modular structure of pCMV-FLAG-C2/ATF2 is shown in 
Fig. 19. 
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pCMV-FLAG-C2/c-Jun 
The pCMV-FLAG-C2/c-Jun expression plasmid encodes a constitutively active C2/c-Jun 
chimera. The encoded protein contains the transcriptional activation domain of CREB2 
(amino acids 1 to 187) linked to the C-terminal region of c-Jun (amino acids 188 to 331), 
encompassing the bZIP domain of c-Jun. In addition, a triple FLAG tag is present on the N-
terminus. The modular structure of pCMV-FLAG-C2/c-Jun is shown in Fig. 37. 
 
pCMV-FLAG-C/EBPα 
The pCMV-FLAG-C/EBPα expression plasmid encodes amino acids 1-358 of C/EBPα. In 
addition, a triple FLAG tag is present on the N-terminus (Thiel et al., 2005a). The modular 
structure of pCMV-FLAG-C/EBPα is shown in Fig. 60. 
 
pCMV-FLAG-C2/C/EBPα 
The pCMV-FLAG-C2/C/EBPα expression plasmid encodes the chimeric transcription factor 
C2/C/EBPα consisting of the N-terminal transcriptional activation domain of CREB2 (amino 
acids 1 to 187) and the C-terminal bZIP domain of C/EBPα (amino acids 245 to 358). In 
addition, a triple FLAG tag is present on the N-terminus The modular structure of pCMV-
FLAG-C2/C/EBPα is shown in Fig. 60. 
 
pCMV-FLAG-ATF5 
The pCMV-FLAG-ATF5 expression plasmid encodes amino acids 1-281 of ATF5. In 
addition, a triple FLAG tag is present on the N-terminus.  
 
pCMV-CHOP 
The pCMV-CHOP expression vector contains 170 amino acids of CHOP. Additionally, a 
triple FLAG tag is present on the N-terminus. 
 
pCMV-FLAG-ATF2∆N 
The pCMV-FLAG-ATF2∆N expression plasmid encodes a truncated form of ATF2, 
consisting of the C-terminus of the transcription factor ATF2 (Steinmüller and Thiel, 2003). 
The modular structure of pCMV-FLAG-ATF2∆N is shown in Fig. 41B. 
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pCMV-FLAG-c-Jun∆N 
The pCMV-FLAG-c-Jun∆N expression plasmid encodes a truncated form of c-Jun, consisting 
of the C-terminus of the transcription factor c-Jun (Steinmüller and Thiel, 2003). The modular 
structure of pCMV-FLAG-c-Jun∆N is shown in Fig. 41B. 
 
MEKK1∆ 
The MEKK1∆ expression plasmid was obtained from Michael Karin, University of 
California, San Diego. It encodes a truncated form of MEK kinase 1 lacking the amino acids 
sequence from 1 to 351 (Minden et al., 1994). 
 
pMKP-1 
The pMKP-1 plasmid was obtained from N. G. Tonks, Cold Spring Harbour Laboratory, New 
York, USA (Sun et al., 1993; Kaufmann et al., 2001). 
 
pcDNA3MKK6(E) 
The pcDNA3MKK6(E) expression plasmid contains a mutated MAP kinase kinase 6 
(MKK6)-cDNA inserted into the expression vector pcDNA3 (Invitrogen, San Diego, USA) 
with HA-Epitope Tag. This mutant was designed by a replacement of serine 151 and 
threonine 155 with glutamate. This plasmid was kindly obtained from J. Han, Department of 
Immunology, The Scripps Research Institute, La Jolla, USA (Han et al., 1996). 
 
pcDNA3p38 
The pcDNA3p38 plasmid that contains the p38-cDNA and a FLAG-epitope inserted into the 
pcDNA3 vector (Invitrogen, San Diego, USA) was a kind gift of J. Han, Department of 
Immunology, The Scripps Research Institute, La Jolla, USA (Jiang et al., 1996). 
 
pCMVCα 
The pCMVCα plasmid that encodes the catalytic subunit of PKA (amino acids 2-351) was a 
kind gift of Michael Uhler from the University of Michigan, Ann Arbor (Uhler and 
McKnight, 1987). The modular structure of pCMVCα is shown in Fig. 13. 
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NLSCα 
The NLSCα expression plasmid has a triple FLAG-tag and a nuclear localization signal on 
the N-terminus, followed by amino acids 19 to 351 of the catalytic subunit of PKA (Thiel et 
al., 2005a, b). The modular structure of NLSCα is shown in Fig. 13. 
 
pSV40LacZ 
The pSV40LacZ plasmid encodes β-galactosidase under the control of the Simian Virus 40 
promoter (Schoch et al., 2001). 
 
pRSVβ 
The pRSVβ plasmid encodes β-galactosidase under the control of the LTR (Long Terminal 
Repeat) of the Rous Sarcoma Virus derived from the Escherichia coli (Jüngling et al., 1994). 
 
 
B.1.3.2. Reporter plasmids 
 
pGTPCHIluc 
The pGTPCHIluc reporter plasmid contains the luciferase open reading frame under control 
of the GTP cyclohydrolase I promoter sequences from –97 to –60 upstream of a minimal 
promoter encompassing a TATA box derived from the HIV long terminal repeat and an 
initiator element from the adenovirus major late promoter. The schematic representation of 
the modular structure of pGTPCHIluc is depicted in Fig. 6A. 
 
pGTPCHICREmutluc 
The pGTPCHICREmutluc reporter plasmid contains three point mutations within the CRE-
like sequence of the GTP cyclohydrolase I promoter/luciferase reporter gene. The schematic 
representation of the modular structure of pGTPCHIluc is depicted in Fig. 8A. 
 
pTNFα(-1311)luc 
The TNFα promoter/luciferase reporter plasmid pTNFα(-1311)luc (Rhoades et al., 1992) was 
a kind gift of James S. Economou, UCLA, Los Angeles. The schematic representation of the 
modular structure of pTNFα(-1311)luc is depicted in Fig. 28. 
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pTNFα(-131)luc 
The pTNFα(-131)luc reporter plasmid consists of a TNFα promoter/luciferase reporter gene 
containing one copy of the cAMP Response Element/Activating Protein 1 (CRE/AP1) 
element of the human TNFα gene. The schematic representation of the modular structure of 
pTNFα(-131)luc is depicted in Fig. 11B. 
 
pTNFα(CRE/AP1)2luc 
The pTNFα(CRE/AP1)2luc reporter plasmid consists of a TNFα promoter/luciferase reporter 
gene containing two copies of the CRE/AP1 element of the human TNFα gene. (Thiel et al., 
2005b). The schematic representation of the modular structure of pTNFα(CRE/AP1)2luc is 
depicted in Fig. 11A. 
 
pASluc 
The asparagine synthetase promoter/luciferase reporter gene contains nucleotides from –79 to 
–35 of the human asparagine synthetase gene. The schematic representation of the modular 
structure of pASluc is depicted in Fig. 46B. 
 
2xC/EBPluc 
The 2xC/EBPluc reporter plasmid has two C/EBP binding sites upstream of a minimal herpes 
simplex virus thymidine kinase promoter. It was a kind gift from Peter F. Johnson, NCI-
Frederick Cancer Research and Development Center (Thiel et al., 2005a). The schematic 
representation of the modular structure of 2xC/EBPluc is depicted in Fig. 61A. 
 
pSgIICRE4luc 
The pSgIICRE4luc reporter plasmid contains four copies of the CRE derived from the 
secretogranin II gene upstream of the HIV-LTR TATA box and the adenovirus later promoter 
initiator element. (Thiel et al., 2005a). The schematic representation of the modular structure 
of pSgIICRE4luc is depicted in Fig. 31. 
 
pSgIIluc 
The pSgIIluc reporter plasmid contains a secretogranin II promoter/luciferase reporter gene 
encompassing the sequence from –167 to +35 of the murine secretogranin II gene (Thiel et 
 MATERIALS AND METHODS  
 40 
al., 2005a). The schematic representation of the modular structure of pSgIIluc is depicted in 
Fig. 32. 
 
pc-fosCRE4luc 
The pc-fosCRE4luc reporter plasmid contains four copies of the CRE derived from the c-Fos 
gene upstream of the HIV LTR TATA box and the adenovirus later promoter initiator element 
(Thiel et al., 2005a). The schematic representation of the modular structure of pc-fosCRE4luc 
is depicted in Fig. 35. 
 
pUAS5luc 
The pUAS5luc reporter plasmid contains five binding sites for the yeast transcription factor 
GAL4 in pHIVTATAluc (Thiel et al., 2000). The schematic representation of the modular 
structure of pUAS5luc is depicted in Fig. 16C. 
 
pEgr-1.1luc 
The pEgr-1.1luc reporter plasmid consists of an Egr-1 promoter/luciferase reporter plasmid 
encompassing sequence from –237 to +235 of the human Egr-1 gene was inserted into pGL3-
Basic (Promega) (Groot et al., 2000). The schematic representation of the modular structure 
of pEgr-1.1luc is depicted in Fig. 20B. 
 
pTHluc 
The pTHluc reporter plasmid consists of the tyrosine hydroxylase/luciferase reporter plasmid 
which expression is controlled by the tyrosine hydroxylase promoter sequences from -760 to 
+18 (Thiel et al., 2005a). The schematic representation of the modular structure of pTHluc is 
depicted in Fig. 36. 
 
pG6PCRE1/CRE2luc 
The pG6PCRE1/CRE2luc reporter plasmid contains the luciferase open reading frame under 
control of glucose-6-phosphatase promoter sequences from –166 to –122 encompassing both 
CRE-like sequences CRE1 and CRE2, upstream of a minimal promoter consisting of the 
TATA box of the human immunodeficiency virus and the adenovirus major late promoter 
initiator element (Thiel et al., 2005b). The schematic representation of the modular structure 
of pG6PCRE1/CRE2luc is depicted in Fig. 9B. 
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pG6PCRE1mut/CRE2luc and pG6PCRE1/CRE2mutluc 
The pG6PCRE1mut/CRE2luc and pG6PCRE1/CRE2mutluc are glucose-6-phosphatase 
promoter/luciferase reporter genes carrying mutations inactivating either the CRE1 or the 
CRE2 sites (Thiel et al., 2005b). The schematic representation of the modular structure of 
pG6PCRE1mut/CRE2luc and pG6PCRE1/CRE2mutluc is depicted in Fig. 9B. 
 
pG6PCRE1luc 
The pG6PCRE1luc reporter plasmid contains glucose-6-phosphatase promoter sequences 
from –173 to –140 encompassing the CRE1 motif (Thiel et al., 2005b). The schematic 
representation of the modular structure of pG6PCRE1luc is depicted in Fig. 9C. 
 
pG6PCRE2luc 
The pG6PCRE2luc reporter plasmid contains glucose-6-phosphatase promoter sequences 
from –152 to –117 encompassing the CRE2 motif (Thiel et al., 2005b). The schematic 
representation of the modular structure of pG6PCRE2luc is depicted in Fig. 9C. 
 
 
B.1.4. Cell Culture 
 
The human hepatoma cell line HepG2 was purchased from DSMZ-Deutsche Sammlung von 
Mikroorganismen und Zellkulturen GmbH, Germany. 
 
The mouse microglial cell line BV-2 was obtained from G. Cibelli, Department of Biomedical 
Science, University of Foggia, Italy. 
 
The locus coeruleus-like cell line CATH.a was obtained from D. Chikaraishi, Duke 
University Medical Center, Durham, NC, USA.  
 
The mouse gonadotrope cell line αT3M3 was obtained from G. Willars, Department of Cell 
Physiology and Pharmacology, University of Leicester, Leicester, U.K. 
 
The human embryonal kidney cell line 293T/17 was obtained from D. Baltimore, Rockefeller 
University, New York, USA. 
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HepG2, BV-2, αT3M3 and 293T/17 cells were maintained in Dulbecco´s modified Eagles 
medium (DMEM) supplemented with: 
10% heat-inactivated fetal calf serum (FCS)  
100 U/ml penicillin  
100 µg/ml streptomycin  
2 mM glutamine  
Cells were incubated at 37°C in 5% CO2. 
For αT3M3 cells 300 µg/ml G418 were added to the medium. 
 
CATH.a cells were cultured in RPMI medium supplemented with:  
4% heat-inactivated fetal calf serum  
8% heat-inactivated horse serum 
100 U/ml penicillin  
100 µg/ml streptomycin 
Cells were incubated at 37°C in 5% CO2. 
 
PBS, used for all washing and harvesting steps, consists of:  
170 mM NaCl  
3.3 mM KCl  
4 mM Na2HPO4  
1.84 mM KH2PO4  
pH was adjusted to 7.2.  
 
 
B.2. Methods 
 
B.2.1. Transformation of competent E.coli 
 
1-2 µl of plasmid was added to a Falcon tube containing 60 µl CM buffer and 50 µl of 
competent E.coli. The mixture was incubated for 20 min on ice and then at room temperature 
for 10 min. 500 µl LB medium was added and the mixture was incubated at 37°C for 1 h with 
shacking. The mixture was then plated on LB agar supplemented with ampicillin plates and 
incubated overnight at 37°C. 
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Solutions 
- CM buffer: 33 mM CaCl2, 55 mM MgCl2, 110 mM KCl 
- LB medium: 10 g/l Trypton, 5 g/l yeast extract, 5 g/l NaCl 
 
 
B.2.2. DNA preparation 
 
A bacterial conlony was picked from plate with transformed competent cells and dissolved in 
200 µl LB medium containing ampicillin. The mixture was incubated overnight at 37°C with 
shacking and then centrifuged for 30 min at 4000 rpm. The pellet was used to purify the 
plasmids according to the standard protocols of Qiagene company. 
 
 
B.2.3. Transfection applying calcium phosphate method 
 
The calcium phosphate method was used to transfect HepG2 and CATH.a cells. HepG2 cells 
were seeded in quadruplicate at a density of 8x105 cells/60 mm plate. Cells were maintained 
overnight in 10% DMEM at 37°C in 5% CO2.  
CATH.a cells were seeded in quadruplicate at a density of 125x104 cells/60 mm plate. Cells 
were maintained overnight in RPMI complete medium at 37°C in 5% CO2. 
For each calcium phosphate transfection a mix “calcium phosphate/DNA suspension” of two 
solutions was prepared as follows: 
Solution 1: certain amount of the DNA was filled up to a final volume of 1 ml with H2O 
mixed with 110 µl 2.5 M CaCl2, which was slowly added to solution 2 and mixed by bubbling 
for 20 sec. 
Solution 2: 1100 µl 2 x HBSS (274 mM NaCl, 25 mM KCl, 3.75 mM Na2HPO4, 27.75 mM 
glucose and 105 mM HEPES, pH 7.05-7.12, sterile filtration). 
 
HepG2 cells: The medium in which the cells were maintained overnight was aspirated, 500 µl 
of the calcium phosphate/DNA suspension was added to the cells. After 20 min incubation at 
37°C in 5% CO2, 10% medium containing 10 µM chloroquine was added and the cells were 
again incubated at 37°C in 5% CO2. Four to six hours later a glycerol shock was performed as 
follows: 
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Cells were washed twice with 1x PBS and incubated for two min with 15% glycerol (in 1x 
PBS) then washed two times with 1x PBS and again incubated with 10% DMEM overnight. 
Forty eight hours later cells were harvested and the β-galactosidase and luciferase activities 
were determined as described in the next chapter. 
 
CATH.a cells: Cells were seeded and maintained overnight in complete RPMI medium at 
37°C in 5% CO2. The next day cells were transfected using the same way used to transfect 
HepG2. Three hours post-transfection a glycerol shock was performed, cells were incubated 
with RPMI complete medium overnight. Forty eight hours later cells were harvested and the 
β-galactosidase and luciferase activities were determined as described in the next chapter. 
 
 
B.2.3.1. Determination of β-galactosidase and luciferase activities 
 
The pellet obtained after transfection was lyzated using 50 µl 1x reporter lysis buffer 
(Promega, Heidelberg, # E3971), incubated for five min on ice and then centrifuged at 16000 
x g at 4°C for 5 min, the supernatant was used for the following measurement: 
 
1- Measurement of β-galactosidase activity: 
30 µl cell extract were added to: 
3 µl 100 x Mg  
66 µl 1x ONPG (O-nitrophenyl-2-D-galactopyranoside) 
201 µl 0.1 M Sodium phosphate (pH 7.5) 
The reaction was incubated at 37°C maximum for two hours. When the color turned yellow 
the absorption was measured using a test wavelength of 405 nm.  
The β-galactosidase activity was calculated as follow:  
 
(380 x OD405) 
         
 
Reaction time [min] 
 
 
Solutions:  
- 100 x Mg: 0.1 M MgCl2, 4.5 M β-Mercaptoethanol 
 MATERIALS AND METHODS  
 45 
- ONPG: 13 mM ONPG in 0.1 M sodium phosphate buffer, pH 7.5 
- 0.1 M Sodium phosphate: 41 ml 0.2 M Na2HPO4.2H2O, 9 ml 0.2 M NaH2PO4.2H2O, 50 ml 
distelled water 
 
2- Measurement of luciferase activity: 
 
10 µl of cell extracts were mixed with 100 µl ”Working Luciferase Assay Reagent” the 
luminescence was measured using the luminometer (Berthold Detection Systems). Luciferase 
activities were normalized for transfection efficiency by dividing luciferase light units by β-
galactosidase activities in order to obtain the relative luciferase activity. 
 
Solutions: 
- Working Luciferase Assay Reagent (WLAR): 
20 mM Tricin (N-[Tris(hydroxymethyl)methyl]glycin) pH 7.8 
1.07 mM (MgCO3)4Mg(OH)2 5 H2O 
2.67 mM MgSO4 7 H2O 
0.1 mM EDTA 
33 mM DTT 
270 µM Coenzyme A 
530 µM ATP 
470 µM Luciferin 
 
 
B.2.4. Preparation of nuclear extracts 
 
This preparation was performed according to Gerber et al., 1992 and also according to 
Andrews and Faller, 1991. BV-2 and αT3M3 cells were seeded at a density of 1x106 cells/60 
mm plate and 2.5x106 cells/60 mm plate, respectively. Cells were maintained in 10% DMEM 
(standard medium) at 37°C in 5% CO2. Twenty-four hours later cells were washed for two 
times with PBS and incubated with serum free medium for further twenty-four hours and then 
stimulated. Cells were then harvested with cold PBS and centrifuged at 16000 x g for 5 min 
and the pellet was redissolved in 100 µl lysis buffer containing: 
10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-KOH, pH 7.9  
1.5 mM MgCl2 
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10 mM KCl 
0.2% NP40 (was added freshly) 
0.5 mM DTT (was added freshly) 
0.2 mM PMSF (was added freshly) 
25xconc Complete Protease Inhibitor (was added freshly) 
10 mM NaF (was added freshly) 
1 mM Na3VO4 (was added freshly) 
 
Pellet was incubated on ice for 10 min, vortexed, incubated for further 10 min and centrifuged 
for 3 min at 16000 x g at 4°C. After removing the supernatant, then the pellet was 
resuspended in 20 µl of nuclear extraction buffer consisting of:  
20 mM HEPES-KOH, pH 7.9 
25% glycerol  
420 mM NaCl 
1.5 mM MgCl2 
0.2 mM PMSF (was added freshly) 
25xconc Complete Protease Inhibitor (was added freshly) 
 
Pellet was incubated for 20 min on ice and centrifuged for 3 min at 16000 x g at 4°C to 
extract the nuclear proteins. Supernatant was collected in a new tube, some of the supernatant 
was used to measure the protein concentrations and the rest was stored at –20°C after adding 
SDS-Stop buffer and boiling for 5 min at 95°C. 
 
SDS-Stop buffer (stock solution): 
125 mM Tris pH 6.8 
3 mM EDTA 
20% (v/v) Glycerol 
9% SDS 
0.05% Bromophenol blue 
 
SDS-Stop working buffer: 
9 Vol. SDS-Stop buffer (stock solution) 
1 Vol. β-Mercaptoethanol 
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B.2.5. Preparation of whole cell extracts 
 
BV-2 cells were seeded at a density of 1x106 cells/60 mm plate. Cells were maintained in 10% 
DMEM (standard medium) at 37°C in 5% CO2. Twenty-four hours later cells were washed 
two times with PBS and incubated with serum free medium for further twenty-four hours and 
then stimulated. Twenty-four hours later cells were harvested with cold PBS and centrifuged 
at 16000 x g for 5 min and the pellet was redissolved in 50-100 µl lysis buffer containing: 
10 mM Tris pH 7.5 
400 mM NaCl 
0.1 mM EDTA 
0.5% Triton 
0.02% NaN3 
0.2 mM PMSF (was added freshly) 
0.5 mM DTT (was added freshly) 
25xconc Complete Protease Inhibitor (was added freshly) 
 
Pellet was strongly vortexed and incubated on ice for 20 min and then centrifuged for 10 min 
at 16000x g at 4°C. Supernatant was collected in a new tube, some of supernatant was used 
for protein estimation and the rest was stored at –20°C after adding SDS-Stop buffer and 
boiling for 5 min at 95°C. 
 
 
B.2.6. Protein estimation 
 
Protein concentrations were determined using BCA Protein Assay Reagent (Pierce, # 23225) 
by mixing: 
5 ml reagent A [Bicinchoninic acid solution (BCA)] 
100 µl reagent B (CuSO4 4%) 
Bovine serum albumin was used as standard proteins. The reaction was incubated at 37°C for 
30 min and the absorbance was measured using a test wavelength of 490 nm. 
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B.2.7. Western blot analysis 
 
Preparing SDS-PAGE gel: 
- Separating gel is prepared as follow (final volume 10 ml): 
 
%polyacrylamide Buffer A Buffer C H2O 
7.5% 2.5 ml 2.5 ml 5 ml 
10% 2.5 ml 3.3 ml 4.2 ml 
 
Polymerization: 200 µl APS 10% 
   20 µl TEMED 
 
- Stacking gel is prepared as follow (final volume 5 ml): 
1.25 ml buffer B 
583 µl buffer C 
3.17 ml H2O 
Polymerization: 200 µl APS 10% 
   20 µl TEMED 
 
Buffer A (separating gel buffer, store at RT):  
1.5 M Tris, pH 8.9 
0.4% SDS 
 
Buffer B (stacking gel buffer, store at RT): 
0.5 M Tris, pH 6.8 
0.4% SDS 
 
Buffer C (store at 4°C): 
Acrylamide/Bisacrylamide buffer (Rotiphorese Gel 30, Roth # 3029.1) 
 
Running buffer (Laemmli buffer): 
250 mM Tris 
2.5 M Glycine 
1% SDS 
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The proteins were first denaturated at 95°C for 5 min. Twenty micrograms of the proteins 
were separated on 7.5% or 10% gel SDS-PAGE and electrophoretically transferred to 
nitrocellulose membranes (0,2 µm pore size). Membranes were blocked in 3%-5% non-fat dry 
milk in 1x TBS or 1x TBS containing 0.05% Tween 20 (1x TBST) for 30 min-1 h at room 
temperature or overnight at 4°C on an orbital shaker. Blots were washed three times with 
distilled water then incubated for 2.5 h at room temperature with the primary antibodies and 
then washed three times with distilled water. Secondary antibodies were incubated for 1-1.5 h 
at room temperature and then washed three times in H2O. Blots were developed using ECL 
plus (Amersham, Freiburg, Germany).  
 
Solutions for Immunoblotting: 
- Blotting buffer (transfer buffer): 
25 mM Tris 
250 mM Glycine 
20% Methanol 
 
- 10x TBS: 
10 mM Tris-HCl, pH 8.0 
150 mM NaCl 
 
 
Antibodies 
 
Different primary antibodies were used; the source, species and dilution are shown in the 
table below. The secondary antibodies were obtained from: 
- Goat anti-rabbit peroxidase-labeled antibody, Dianova, Hamburg, Germany # 111-035-003 
- Goat anti-mouse antibody, Sigma, Taufkirchen, Germany # A-4416 
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Primary 
Antibody 
Source Species Dilution Secondary 
Antibody 
Dilution 
Anti- 
i-NOS/NOSII 
Upstate, 
Biomol, 
Hamburg, 
Germany # 
06-573 
Mouse, 
bovine, sheep 
and guinea 
pig 
1:1000 in 3% 
non-fat dry 
milk in TBS 
Goat anti-
rabbit 
peroxidase-
labeled 
antibody 
1:10000 in 
3% non-fat 
dry milk in 
TBS 
ATF2 (N-96) Santa Cruz, 
Heidelberg, 
Germany # 
sc-6233 
Human, 
mouse and rat 
1:3000 in 3% 
non-fat dry 
milk in TBS 
Goat anti-
rabbit 
peroxidase-
labeled 
antibody 
1:10000 in 
3% non-fat 
dry milk in 
TBS 
p-ATF2 (F-1) Santa Cruz, 
Heidelberg, 
Germany # 
sc-8398 
Human, 
mouse and rat 
1:1000 in 3% 
non-fat dry 
milk in TBS 
containing 
0.05% Tween 
20 (TBST) 
Goat anti-
mouse 
antibody 
1:10000 in 
3% non-fat 
dry milk in 
TBST 
Anti-c-Jun Upstate, 
Biomol, 
Hamburg, 
Germany # 
06-225 
Human and 
mouse 
1:1000 in 3% 
non-fat dry 
milk in TBS 
Goat anti-
rabbit 
peroxidase-
labeled 
antibody 
1:10000 in 
3% non-fat 
dry milk in 
TBS 
Anti-
phospho-c-
Jun (Ser 73) 
Upstate, 
Biomol, 
Hamburg, 
Germany # 
06-659 
Human and 
mouse 
1:2500 in 5% 
non-fat dry 
milk in TBST 
Goat anti-
rabbit 
peroxidase-
labeled 
antibody 
1:10000 in 
5% non-fat 
dry milk in 
TBST 
c-FOS(4) Santa Cruz, 
Heidelberg, 
Germany # 
sc-52 
Human, 
mouse and rat 
1:1000 in 
TBST 
Goat anti-
rabbit 
peroxidase-
labeled 
antibody 
1:10000 in 
TBST 
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B.2.8. Stripping and reprobing of membranes 
 
This method was perfomed as described in ECL Plus booklet as follow: 
1- Submerge the membrane in stripping buffer (100 mM 2-mercaptoethanol, 2% SDS, 
62.5 mM Tris-HCL pH 6.7) and incubate at 50°C for 30 min with occasional agitation. 
2- Wash the membrane twice in 1xTBST at room temperature using large volumes of 
wash buffer. 
3- Block the membrane in blocking solution (non-fat dry milk in TBS or TBST). 
4-  Perform immunodetection. 
 
 
B.2.9. Lentiviral gene transfer 
 
293T/17 cells were seeded at a density of 2.3x106 cells/60 mm plate and were maintained in 
10% DMEM (standard medium) at 37°C in 5% CO2. Next day the viral particles were 
produced by performing transient transfection experiment using the calcium phosphate co-
precipitation technique described earlier. Three plasmids were transfected into the cells: 6.6 
µg of lentiviral transfer vector, 5 µg of packaging vector (pCMV∆R8.91) and 2.3 µg of 
plasmid encoding the vesicular stomatitis virus glycoprotein (pCMVG). Seventy-two hours 
post-transfection viral supernatants were collected, filtered through a 0.45 µm filter and used 
to infect BV-2 and/or αT3M3 cells in the presence of 8 µg/ml polybrene. The cells were 
maintained at 37°C in 5% CO2. Forty-eight to seventy-two hours later the infected cells were 
harvested, part of the cells were used to prepare nuclear extracts in order to detect the 
presence of the construct by performing Western blot analysis and the rest of the cells was 
seeded at a density of 1x106 cells/60 mm plate (for BV-2) and 2.5x106 cells/60 mm plate (for 
αT3M3) and, following induction, nuclear extracts and/or whole cells extracts were prepared. 
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C. Results  
 
 
C.1. Regulation of gene expression by CREB 
 
C.1.1. The constitutively active CREB mutant C2/CREB activates transcription of 
reporter genes containing CRE-like sequences 
 
The bZIP transcription factor CREB is transcriptionally silent in the unphosphorylated state 
and this excludes a simple overexpression strategy to analyze the biological impact of the 
CRE or CRE-like sequences within different genes. Therefore, to study CREB-mediated gene 
transcription a constitutively active CREB mutant termed C2/CREB was used. 
 
 
C.1.1.1. Modular structure of CREB, CREB2 and the constitutively active CREB 
mutant C2/CREB 
 
The bZIP proteins CREB and CREB2 contain on their C-termini a bZIP domain responsible 
for DNA-binding and dimerization, while the N-termini contain activation domains. The 
activation domain of CREB2 is constitutively active and transferable to heterologous DNA-
binding domains (Schoch et al., 2001), while the activation domain of CREB is controlled by 
phosphorylation. The bZIP domain of CREB, which is responsible for DNA-binding and 
dimerization, was expressed as a fusion protein with the constitutively active transcriptional 
activation domain of CREB2, generating the chimeric transcription factor C2/CREB. 
Additionally, the C2/CREB fusion protein contains an immunological tag used for detection 
of the protein. This mutant is constitutively active and does not require phosphorylation for 
activation. 
 
bZIP CREB
KID1 326
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Fig. 5. Modular structure of CREB, CREB2 and C2/CREB. 
Schematic representation of the bZIP proteins CREB, CREB2 and the constitutively active mutant 
C2/CREB. 
 
 
C.1.1.2. C2/CREB mutant transactivates a reporter gene under the control of the 
proximal regulatory region of the human GTP cyclohydrolase I gene 
 
GTP cyclohydrolase I is the rate-limiting enzyme in the biosynthesis of tetrahydrobiopterin, it 
catalyzes the formation of dihydroneopterin triphosphate from GTP. It has been shown that 
signaling molecules that elevate the intracellular concentration of cAMP may also be involved 
in the regulation of GTP cyclohydrolase I expression, because cell-permeable analogues of 
cAMP and the adenylate cyclase activator forskolin activate GTP cyclohydrolase I gene 
transcription in PC12 and mesangial cells (Plüss et al., 1996, 1997; Hirayama et al., 2001). 
Additionally, the sequence motif 5`-TGACGCGA-3`, that resembles the cAMP response 
element (CRE), has been identified in the core promoter of the human GTP cyclohydrolase I 
gene (Kapatos et al., 2000). The constitutively active CREB mutant C2/CREB was used to 
test whether the GTP cyclohydrolase I gene is transactivated by CREB via the CRE-like 
sequence. In addition, a reporter plasmid containing the proximal region of the human GTP 
cyclohydrolase I gene upstream of a minimal promoter was also used (Fig. 6A). Transient 
transfection experiments of the human hepatoma cell line HepG2 were performed to study the 
regulation of the GTP cyclohydrolase I promoter/luciferase reporter gene by C2/CREB. GTP 
cyclohydrolase I was purified from rat liver (Hatakeyama et al., 1989) and it was cloned from 
rat and human hepatocytes (Hatakeyama et al., 1991; Togari et al., 1992). The result shows 
that transcription of the GTP cyclohydrolase I reporter gene was strongly activated by the 
constitutively active CREB mutant C2/CREB and the induction was on the order of 77-fold 
(Fig. 6B). 
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Fig. 6. C2/CREB activates the transcription of a GTP cyclohydrolase I promoter/luciferase 
reporter gene. 
(A) Schematic representation of the reporter plasmid GTPCHIluc. Position and sequence of the CRE-
like motif are shown. (B) The reporter plasmid pGTPCHIluc (1 µg/plate) was transfected into HepG2 
cells together with the internal standard plasmid pRSVβ, encoding β-galactosidase under the control 
of the Rous sarcoma virus long-terminal repeat, to correct for variations in transfection efficiencies (2 
µg/plate). In addition, either an empty expression vector pCMV5 (25 ng/plate) or an expression vector 
encoding C2/CREB (pCMV-FLAG-C2/CREB) (25 ng/plate) was transfected. Forty-eight hours post-
transfection cell extracts were prepared and the luciferase activities were normalized for transfection 
efficiency by dividing luciferase light units by β-galactosidase activities. Data are mean ±SD. 
 
 
C.1.1.2.1. C2/CREB-induced transcription of the GTP cyclohydrolase I reporter gene is 
impaired by dominant-negative CREB mutant (A-CREB) 
 
The DNA-binding and dimerization specificity of C2/CREB and CREB are identical, since 
they share an identical bZIP domain. To check whether other bZIP proteins are able to 
interfere with C2/CREB-induced transcriptional activation of the GTP cyclohydrolase I 
promoter, the dominant-negative mutants A-ZIPs were used. The result shows that only A-
CREB was able to inhibit C2/CREB-induced transcription of the GTP cyclohydrolase I 
reporter gene (Fig. 7). Expression of A-ATF2, a dominant-negative of ATF2, did not change 
 RESULTS  
 55 
C2/CREB-induced reporter gene transcription, indicating that ATF2 does not heterodimerize 
with CREB. A-ATF4, a dominant-negative of CREB2/ATF4, A-Fos, a dominant-negative of 
c-Jun, and A-C/EBP, a dominant-negative of C/EBP, even enhanced transcription of the 
reporter gene, maybe by sequestering inhibitory cofactors away from the transcription units. 
These data indicate that only A-CREB interferes with C2/CREB-induced transactivation of 
the GTP cyclohydrolase I/luciferase reporter gene and that the bZIP proteins CREB2/ATF4, 
c-Jun, ATF2 and C/EBP are unable to heterodimerize with CREB. 
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Fig. 7. Dominant-negative mutant of CREB impairs C2/CREB-induced transcriptional 
activation of the GTP cyclohydrolase I reporter gene. 
HepG2 cells were transfected with 1 µg/plate of the reporter plasmid pGTPCHIluc, 2 µg/plate of the 
internal standard plasmid pRSVβ, 25 ng/plate of either an empty expression vector “pCMV5” or an 
expression vector encoding C2/CREB and 250 ng/plate of expression vectors encoding either A-
CREB, A-ATF4, A-Fos, A-ATF2 or A-C/EBP. Forty-eight hours post-transfection cell extracts were 
prepared and the relative luciferase activities were determined by measuring β-galactosidase and 
luciferase activities of the transfected cells. Data are mean ± SD. 
 
 
C.1.1.2.2. Mutations of the CRE-like sequence of the GTP cyclohydrolase I promoter 
impair transactivation by CREB 
 
From the data shown above, it was presumed that the CRE-like sequence is important for 
CREB-mediated transactivation of the GTP cyclohydrolase I/luciferase reporter gene. To 
confirm this observation, GTP cyclohydrolase I reporter gene that contains three point 
mutations within the CRE-like sequence was generated (Fig. 8A). In vitro DNA/protein 
binding experiments with annealed oligonucleotides carrying these point mutations showed 
decreased but not eliminated binding of nuclear proteins by these mutations. Furthermore, 
these mutated oligonucleotides retained the ability to compete with the wild-type 
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oligonucleotide that contains the intact CRE-like sequence (Kapatos et al., 2000). 
Transfection experiments employing both the intact and the CRE-like mutated reporter genes 
show that the CRE-like sequence is of major importance for the constitutively active CREB 
mutant to transactivate the GTP cyclohydrolase I promoter/luciferase reporter gene (Fig. 8B). 
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Fig. 8. Point mutations within the CRE-like sequence of the GTP cyclohydrolase I promoter 
impair transactivation mediated by C2/CREB. 
(A) Schematic representation of the GTP cyclohydrolase I reporter plasmids containing an intact or a 
mutated CRE-like sequence. (B) 1 µg/plate of the wild-type or the mutated GTP cyclohydrolase I 
reporter plasmid was transfected into HepG2 cells, together with the standard plasmid RSVβ (2 
µg/plate). In addition, either an empty expression vector pCMV5 (25 ng/plate) or an expression vector 
encoding C2/CREB (25 ng/plate) was transfected. Forty-eight hours post-transfection cell extracts 
were prepared and the relative luciferase activities were determined. Data are mean ±SD. 
 
 
C.1.1.3. C2/CREB transactivates the transcription of glucose-6-phosphatase promoter 
 
Glucose-6-phosphatase is a multicomponent system located in the endoplasmic reticulum that 
catalyzes the terminal step in glycogenolysis in the liver and gluconeogenesis in the liver and 
kidney (Foster et al., 1997; Mithieux, 1997; Van de Werve et al., 2000). The proximal region 
of the human glucose-6-phosphatase promoter contains two CRE-like sequences that 
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resemble the canonical CRE sequence 5´-TGACGTCA-3´ (Lin et al., 1997; Schmoll et al., 
1999). The distal CRE-like site (CRE1) and the proximal CRE-like site (CRE2) differ on two 
or three positions, respectively, in comparison to the canonical CRE. To study the biological 
function of these elements reporter plasmids that contain both CRE-like elements or only one 
of them were used. All the reporter genes contained a TATA box derived from the HIV long 
terminal repeat, an initiator element from the adenovirus major late promoter and the 
luciferase open reading frame (Fig. 9). 
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Fig. 9. The human glucose-6-phosphatase gene promoter. 
(A) Sequence of a portion of the human glucose-6-phosphatase gene promoter including the CRE-like 
sequences CRE1 and CRE2. (B) The reporter plasmid pG6PCRE1/CRE2luc contains a minimal 
promoter consisting of the TATA box of the human immunodeficiency virus, the adenovirus major 
late promoter initiator element, the luciferase open reading frame and glucose-6-phosphatase promoter 
sequences encompassing both CRE-like sequences CRE1 and CRE2. The reporter plasmids 
pG6PCRE1mut/CRE2luc and pG6PCRE1/CRE2mutluc carry mutations in either the CRE1 or the 
CRE2, respectively, to inactivate these sites. (C) Reporter plasmids pG6PCRE1luc and pG6PCRE2luc 
contain glucose-6-phosphatase promoter sequences encompassing either the CRE1 or the CRE2.  
 
 
The human hepatoma cell line HepG2 was chosen to study the regulation of the glucose-6-
phosphatase promoter/luciferase reporter genes by C2/CREB since it has been reported that 
activation of the cAMP signaling pathway stimulates glucose-6-phosphatase gene 
transcription in these cells (Li and Van de Werve, 2000; Hornbuckle et al., 2001; Streeper et 
al., 2001). Transient transfection experiments of HepG2 cells were performed and the data 
show that transcription of the pG6PCRE1/CRE2luc reporter gene, that contains both CRE-
like sequences in its regulatory region, was strongly induced following expression of 
C2/CREB (Fig. 10A, upper panel). Mutation of CRE1 or CRE2 did not abolish the 
transactivation potential of C2/CREB (Fig. 10A, bottom panel), indicating that both CRE-like 
sequences function independently. To confirm this observation reporter plasmids that contain 
only one of the CRE-like sequences in their regulatory regions were tested and the data show 
that both reporter genes pG6PCRE1luc and pG6PCRE2luc were transactivated by C2/CREB 
(Fig. 10B). This leads to the conclusion that both CRE1 and CRE2 motifs of the glucose-6-
phosphatase gene promoter function as bona fide CREs. 
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Fig. 10. Biological activity of C2/CREB. 
One of the reporter plasmids pG6PCRE1/CRE2luc, pG6PCRE1mut/CRE2luc, 
pG6PCRE1/CRE2mutluc (A), pG6PCRE1luc or pG6PCRE2luc (B) (1 µg/plate) was transfected into 
HepG2 cells together with the internal standard plasmid pRSVβ (2 µg/plate) and either the “empty“ 
expression vector pCMV5 or an expression vector encoding C2/CREB (20 ng/plate). Forty-eight hours 
post-transfection cell extracts were prepared and the relative luciferase activities were determined. 
Data are mean ±SD. 
 
 
C.1.1.4. C2/CREB activates the transcription of the tumor necrosis factor α (TNFα) 
reporter gene 
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It has been reported that the TNFα gene belongs to the target genes of CREB (Mayr and 
Montminy, 2001). To test whether C2/CREB is able to induce the transcription of the TNFα 
promoter, the reporter plasmids pTNFα(CRE/AP1)2luc and pTNFα(-131)luc were used. The 
reporter plasmid pTNFα(CRE/AP1)2luc contains two copies of the CRE/AP1-like element 
derived from TNFα gene promoter. It also contains a TATA box derived from the HIV long 
terminal repeat, an initiator element from the adenovirus major late promoter and the 
luciferase open reading frame (Fig. 11A). The reporter plasmid pTNFα(-131)luc contains 
only one copy of the CRE/AP1-like element derived from TNFα gene promoter. It also 
contains an initiator element from the adenovirus major late promoter and the luciferase open 
reading frame (Fig. 11B). 
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Fig. 11. The reporter plasmids pTNFα(CRE/AP1)2luc and pTNFα(-131)luc. 
(A) Schematic representation of the reporter plasmid pTNFα(CRE/AP1)2luc. It contains two copies of 
the composite CRE/AP1 sequence derived from the human TNFα gene, upstream of a minimal 
promoter. The sequence of the CRE-like motif within the promoter is depicted. (B) Schematic 
representation of the reporter plasmid pTNFα(-131)luc. It contains one copy of the composite 
CRE/AP1 sequence derived from the human TNFα gene, upstream of a minimal promoter. The 
sequence of the CRE-like motif within the promoter is depicted. 
 
 
 RESULTS  
 61 
To check whether overexpression of C2/CREB influences the transcriptional activity of the 
TNFα reporter genes, transient transfection experiments of HepG2 cells were performed. The 
results show that C2/CREB transactivated both the pTNFα(CRE/AP1)2luc (Fig. 12A) and 
pTNFα(-131)luc (Fig. 12B). 
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Fig. 12. C2/CREB activates the transcription of TNFα reporter genes. 
One of the reporter plasmids pTNFα(CRE/AP1)2luc (A) or pTNFα(-131)luc (B) (1 µg/plate) was 
transfected into HepG2 cells together with the internal standard plasmid pRSVβ (2 µg/plate) and either 
the “empty“ expression vector pCMV5 or an expression vector encoding C2/CREB [20 ng 
plasmid/plate (A) and 25 ng plasmid/plate (B)]. Forty-eight hours post-transfection cell extracts were 
prepared and the relative luciferase activities were determined. Data are mean ±SD. 
 
 
C.1.2. Expression of a nuclear targeted mutant of the catalytic subunit of cAMP-
dependent protein kinase (NLSCα) 
 
C.1.2.1. Modular structure of the catalytic subunit of cAMP-dependent protein kinase 
(Cα) and the modified kinase NLSCα 
 
The modular structure of the catalytic subunit of cAMP-dependent protein kinase (Cα) and 
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the modified kinase NLSCα are shown in Fig. 13. The protein is myristylated on the N-
terminus, but myristylation is not essential for enzyme activation (Clegg et al., 1989). The 
mutant NLSCα should be sorted to the nuclear compartment, due to the presence of the 
nuclear localization signal (NLS). 
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Fig. 13. Modular structure of the catalytic subunit of cAMP-dependent protein kinase (Cα) and 
the modified kinase NLSCα. 
Schematic representation of Cα and NLSCα. The wild-type enzyme is myristylated as indicated 
(Myr). The location of the nuclear localization signal (sequence PPKKRKV) and the triple FLAG 
epitope in the NLSCα are shown. 
 
 
C.1.2.2. Activation of GTP cyclohydrolase I promoter/luciferase reporter gene 
transcription following expression of the nuclear targeted mutant of the catalytic 
subunit of cAMP-dependent protein kinase 
 
To check whether the transcription of the GTP cyclohydrolase promoter/luciferase reporter 
gene is increased following overexpression of NLSCα, transfection experiments of HepG2 
cells were performed. As expected, the data show that transfection of a nanomolar 
concentration of an expression vector encoding the wild-type form of CREB did not change 
the basal transcription of the reporter gene, because only the concentration of inactive and 
unphosphorylated CREB was increased. However, transfection of an NLSCα expression 
vector stimulated reporter gene transcription in the order of 9-fold (Fig. 14). In contrast, 
overexpression of the wild-type form of the catalytic subunit (Cα) did not activate the 
transcription of the reporter gene. These results confirm the previous observations, obtained 
by overexpression experiments of C2/CREB, that the cAMP/PKA signaling pathway 
enhances GTP cyclohydrolase I gene expression via CREB. 
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Fig. 14. Expression of the catalytic subunit of cAMP-dependent protein kinase in the nucleus 
stimulates GTP cyclohydrolase I promoter activity. 
The reporter plasmid pGTPCHIluc (1 µg/plate) was transfected into HepG2 cells together with pRSVβ 
internal standard plasmid (2 µg/plate) and either an "empty" expression vector or an expression vector 
encoding wild-type CREB (25 ng/plate). In addition, an expression vector encoding either Cα or 
NLSCα (100 ng/plate) was transfected. Cell extracts were prepared forty-eight hours later and β-
galactosidase and luciferase activities were determined. Data are mean ±SD. 
 
 
C.1.2.2.1. NLSCα-mediated upregulation of the GTP cyclohydrolase I 
promoter/luciferase reporter gene is impaired by the dominant-negative CREB mutant 
(A-CREB) 
 
Competition experiment using the dominant-negative mutants A-ZIPs was performed and the 
result shows that expression of wild-type CREB did not stimulate reporter gene transcription, 
whereas expression of NLSCα strongly enhanced transcription of the reporter gene. The 
competition assay showed that only A-CREB impaired CREB/NLSCα-mediated transcription 
(Fig. 15). These data indicate that only A-CREB interferes with NLSCα-induced 
transactivation of the GTP cyclohydrolase I/luciferase reporter gene and confirm the previous 
observation that the bZIP proteins CREB2/ATF4, c-Jun, ATF2 and C/EBP are unable to 
heterodimerize with CREB. 
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Fig. 15. Dominant-negative mutant of CREB impairs NLSCα-induced transcriptional activation 
of the GTP cyclohydrolase I reporter gene. 
HepG2 cells were transfected with the reporter plasmid pGTPCHIluc (1 µg/plate), the internal 
standard plasmid pRSVβ (2 µg/plate), an expression vector encoding wild-type CREB (25 ng/plate), 
an expression vector encoding NLSCα (100 ng/plate) and expression vectors encoding either A-
CREB, A-ATF4, A-Fos, A-ATF2 or A-C/EBP (250 ng/plate). Forty-eight hours post-transfection cell 
extracts were prepared and the β-galactosidase and luciferase activities were determined. Data are 
mean ±SD. 
 
 
C.1.2.3. Expression of a nuclear targeted mutant of the catalytic subunit of cAMP- 
dependent protein kinase strongly stimulated transcription of the glucose-6-phosphatase 
promoter/luciferase reporter genes 
 
To test the biological activity of NLSCα, in comparison to the wild-type form of the catalytic 
subunit (Cα), the activity of CREB was measured using a fusion protein consisting of the 
GAL4 DNA-binding domain fused to the kinase inducible activation domain of CREB. 
Transcriptional activation was monitored by co-transfection of the reporter plasmid pUAS5luc 
that contains five copies of the GAL4 binding site termed "upstream activating sequence" 
(UAS) upstream of a luciferase reporter gene. Since mammalian cells do not express 
transcription factors that bind to the UAS, this system directly measures the effect of NLSCα 
or Cα on the transcriptional activation potential of CREB. The results show that the nuclear 
targeted mutant of the catalytic subunit of PKA (NLSCα) was highly potent in stimulating the 
transcriptional activation potential of CREB. The activation was on the order of 60-fold. In 
contrast, no transcriptional activation was observed following overexpression of the wild-type 
form of the catalytic subunit (Fig. 16). 
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Fig. 16. Biological activity of the nuclear targeted mutant of the catalytic subunit of cAMP-
dependent protein kinase. 
(A) Modular structure of the GAL4-CREB fusion protein. This protein consists of the DNA-binding 
domain of GAL4 (amino acids 1-147) and the activation domain of CREB (amino acids 1-281). (B) 
Schematic representation of the reporter plasmid pUAS5luc that contains a transcription unit 
encompassing the luciferase open reading frame and a minimal promoter that consists of five copies of 
the upstream activating sequence (UAS), a TATA box derived from the HIV long terminal repeat and 
the initiator element from the adenovirus major late promoter. (C) The reporter plasmid pUAS5luc (1 
µg/plate) was transfected into HepG2 cells together with the internal standard plasmid pRSVβ (2 
µg/plate) and either an expression vector encoding the DNA-binding domain of GAL4 (plasmid pM1) 
or the GAL4-CREB fusion protein (1 µg/plate). In addition, cells were transfected with an expression 
vector encoding either Cα or NLSCα (100 ng/plate). Forty-eight hours post-transfection cell extracts 
were prepared and the relative luciferase activity was determined. Data are mean ±SD. 
 
 
Next, the biological activity of NLSCα in controlling the transcription of the glucose-6- 
phosphatase promoter/luciferase reporter genes was tested. In addition, wild-type CREB, 
CREBS133A, a CREB mutant containing a serine to alanine mutation at position 133, and K-
CREB, a CREB mutant containing the point mutation R286L within the basic DNA-binding 
domain, impairing DNA-binding (Walton et al., 1992) were overexpressed. The results show 
that transfection of a nanomolar concentration of expression vectors encoding the wild-type 
form of CREB, CREBS133A or K-CREB did not significantly change the basal 
transcriptional activity of the reporter genes. However, transfection of an NLSCα expression 
vector strongly stimulated transcription of the glucose-6-phosphatase promoter/luciferase 
reporter genes (Fig. 17). These results confirm the previous observations obtained via 
overexpression of C2/CREB that both CRE motifs of the glucose-6-phosphatase gene 
function as independent genetic elements responsive to couple elevated cAMP and PKA 
levels with enhanced glucose-6-phosphatase gene transcription. Surprisingly, reporter genes 
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are still activated following coexpression of NLSCα with CREBS133A, lacking the major 
PKA phosphorylation site. Compared to the coexpression experiments of NLSCα with the 
wild-type form of CREB, the reduced activation of reporter gene transcription in coexpression 
experiments of NLSCα with CREBS133A indicates that NLSCα-catalyzed phosphorylation 
of serine residue 133 of CREB is important for reporter gene transcription. The fact that 
CREBS133A is still able to transactivate the reporter genes following expression of NLSCα 
suggests that NLSCα triggers further phosphorylation reactions leading to enhanced 
transcription via the CRE-like sequences within the glucose-6-phosphatase gene. In contrast, 
expression of K-CREB is transcriptionally inactive in the presence or absence of NLSCα 
indicating that DNA-binding is of major importance for CREB and CREBS133A to 
transactivate the reporter genes. 
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Fig. 17. Transcriptional activity of CREB and CREB mutants in the presence of a nuclear 
targeted mutant of the catalytic subunit of cAMP-dependent protein kinase. 
One of the reporter plasmids pG6PCRE1/CRE2luc, pG6PCRE1mut/CRE2luc 
pG6PCRE1/CRE2mutluc, pG6PCRE1luc or pG6PCRE2luc (1 µg/plate) was transfected into HepG2 
cells together with the internal standard plasmid pRSVβ (2 µg/plate) and the "empty" expression 
vector pCMV5 or an expression vector encoding either CREB, CREBS133A or K-CREB (20 ng 
plasmid/plate). In addition, an expression vector encoding NLSCα (100 ng/plate) was transfected. 
Forty-eight hours post-transfection cell extracts were prepared and the β-galactosidase and luciferase 
activities were determined. The mean +/- SD is depicted. 
 
 
C.1.2.4. Expression of NLSCα strongly stimulated transcription of the TNFα reporter 
gene containing two copies of the CRE/AP1 site 
 
The biological activity of NLSCα in controlling the transcription of the TNFα reporter gene 
(pTNFα(CRE/AP1)2luc) was tested. In addition, wild-type CREB, CREBS133A and K-
CREB were overexpressed. Transfection of expression vectors encoding the wild-type form 
of CREB, CREBS133A or K-CREB did not change the basal transcriptional activity of the 
reporter gene. However, transfection of an NLSCα expression vector strongly stimulated 
transcription of the TNFα promoter/luciferase reporter gene (Fig. 18). These results confirm 
the previous observations, obtained by overexpression experiments of C2/CREB, that the 
cAMP/PKA signaling pathway enhances TNFα gene expression via CREB.  
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Fig. 18. Expression of the catalytic subunit of cAMP-dependent protein kinase in the nucleus 
stimulates TNFα promoter activity. 
The reporter plasmid pTNFα(CRE/AP1)2luc (1 µg/plate) was transfected into HepG2 cells together 
with the internal standard plasmid pRSVβ (2 µg/plate) and the "empty" expression vector pCMV5 or 
an expression vector encoding either CREB, CREBS133A or K-CREB (20 ng/plate). In addition, an 
expression vector encoding NLSCα (100 ng/plate) was transfected. Forty-eight hours post-transfection 
cell extracts were prepared and the β-galactosidase and luciferase activities were determined. The 
mean +/- SD is depicted. 
 
 
C.2. Regulation of gene expression by ATF2 
 
C.2.1. Biological activity of a constitutively active ATF2 mutant C2/ATF2 towards CRE-
containing reporter genes 
 
The bZIP transcription factor ATF2 binds to the classical cAMP responsive element (CRE) 
5´-TGACGTCA-3´ (Maekawa et al., 1989) and also with high affinity to the related DNA 
target sequence 5´-TTACGTAA-3´ (Benbrook and Jones, 1994). ATF2 contains a 
phosphorylation-regulated activation domain, therefore, it is inactive in the dephosphorylated 
state. Nonetheless ATF2 turns into a biologically active transcriptional activator upon 
phosphorylation. To test the effect of ATF2 on CRE-containing reporter genes, a 
constitutively active ATF2 mutant C2/ATF2 was used. 
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C.2.2. Modular structure of ATF2 and the constitutively active ATF2 mutant C2/ATF2 
 
The protein ATF2 contains on its C-terminus a bZIP domain that is responsible for DNA-
binding and dimerization. The N-terminus contains an activation domain which is controlled 
by phosphorylation (Livingstone et al., 1995). The bZIP domain of ATF2, which is 
responsible of DNA-binding and dimerization, was expressed as a fusion protein with the 
constitutively active transcriptional activation domain of CREB2, generating the chimeric 
transcription factor C2/ATF2. The C2/ATF2 fusion protein contains additionally an 
immunological tag used for protein detection. 
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Fig. 19. Schematic representation of ATF2 and C2/ATF2. 
Modular structure of the bZIP proteins ATF2 and the constitutively active mutant C2/ATF2. 
 
 
C.2.3. C2/ATF2 activates the transcription of the GTP cyclohydrolase I 
promoter/luciferase reporter gene 
 
The constitutively active mutant C2/ATF2 has been shown to transactivate luciferase reporter 
genes under control of the c-Jun, TNFα, Fas ligand or CHOP promoter, whereas the 
unphosphorylated wild-type ATF2 was inactive (Steinmüller and Thiel, 2003; Averous et al., 
2004). In vitro DNA/protein binding experiments suggested that ATF2 binds to the GTP 
cyclohydrolase core promoter (Hirayama et al., 2001). To test the biological activity of ATF2 
on the GTP cyclohydrolase I promoter/luciferase reporter gene, expression experiments using 
the mutant C2/ATF2 were performed. As a control, the effect of ATF2 and C2/ATF2 on the 
Egr-1 promoter activity was tested. The results show that C2/ATF2 transactivated both 
reporter genes (Fig. 20A, B). The transcriptional activation of the GTP cyclohydrolase I and 
Egr-1 promoter was on the order of 10-fold and 2.8-fold, respectively. In contrast, the wild-
type ATF2 was inactive. 
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Fig. 20. The constitutively active ATF2 mutant C2/ATF2 activates the transcription of GTP 
cyclohydrolase I promoter/luciferase reporter gene. 
(A) The reporter plasmid pGTPCHIluc was transfected into HepG2 cells, together with the internal 
standard plasmid pRSVβ (2 µg/plate), the empty expression vector pCMV5 or expression vectors 
encoding ATF2 or C2/ATF2 (500 ng/plate). Forty-eight hours post-transfection lysates were prepared 
and the relative luciferase activities were determined. The mean ±SD is depicted. (B) Schematic 
representation of the Egr-1 promoter/luciferase reporter plasmid (pEgr-1.1luc). The sequence of CRE-
like motif within this promoter is depicted. The reporter plasmid pEgr-1.1luc (1 µg/plate) was 
transfected into HepG2 cells, together with the internal standard plasmid pRSVβ (2 µg/plate), the 
expression vector pCMV5 or expression vectors encoding ATF2 or C2/ATF2 (500 ng/plate). Forty-
eight hours post-transfection lysates were prepared and the relative luciferase activities were 
determined. The mean ±SD is depicted. 
 
 
C.2.3.1. C2/ATF2-stimulated GTP cyclohydrolase I reporter gene was impaired by 
dominant-negative ATF2 mutant A-ATF2, and by A-Fos, a dominant-negative of c-Jun 
 
 RESULTS  
 71 
Competition experiments using the A-ZIP expression vectors were performed. The results 
show that C2/ATF2-induced GTP cyclohydrolase I promoter/luciferase reporter was impaired 
by A-ATF2 and A-Fos, a dominant-negative of c-Jun. Neither A-CREB, nor A-ATF4 nor A-
C/EBP were able to block the transcriptional activity of C2/ATF2 (Fig. 21). These results, 
together with the competition assay performed after expression of C2/CREB (depicted in Fig. 
7), indicate that constitutively active mutants of CREB and ATF2 are independently able to 
transactivate the GTP cyclohydrolase I gene, although these experiments argue against a 
heterodimerization of CREB and ATF2.  
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Fig. 21. The dominant-negative mutants A-ATF2 and A-Fos impair C2/ATF2-induced 
transcriptional activation of the GTP cyclohydrolase I reporter gene. 
HepG2 cells were transfected with the reporter plasmid pGTPCHIluc (1 µg/plate), the internal 
standard plasmid pRSVβ (2 µg/plate), an expression vector encoding C2/ATF2 (500 ng/plate) and 
expression vectors encoding either A-CREB, A-ATF4, A-Fos, A-ATF2 or A-C/EBP (50 ng/plate). 
Forty-eight hours post-transfection cell extracts were prepared and the β-galactosidase and luciferase 
activities were determined. Data are mean ±SD. 
 
 
C.2.3.2. CREB and ATF2 independently transactivate the GTP cyclohydrolase I 
reporter gene transcription 
 
To check whether CREB and ATF2 can heterodimerize, the effect of the dominant-negative 
CREB mutants GST-CREB and GST-KCREB on C2/ATF2-mediated GTP cyclohydrolase I 
promoter/luciferase reporter gene transcription was tested. GST-CREB has an intact bZIP 
domain derived from CREB and is therefore able to bind to the cognate sites of CREB, 
making these sites unavailable to bind to any wild-type bZIP protein. In addition, GST-CREB 
may also form inactive heterodimers with the wild-type CREB. In contrast, GST-KCREB is 
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unable to bind to DNA, due to a point mutation R286L in the basic region (Walton et al., 
1992) (Fig. 22A). As depicted in Fig. 22B, GST-CREB impaired C2/ATF2-stimulated 
transcription of the reporter gene. GST-KCREB did not show any negative effect on 
C2/ATF2-mediated transactivation, because of its inability to bind to the CRE. Thus, 
constitutively active mutants of CREB and ATF2 are independently able to transactivate the 
GTP cyclohydrolase gene, without forming heterodimers, suggesting that ATF2 and CREB 
compete for the same DNA-binding site, the CRE. 
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Fig. 22. ATF2 and CREB compete for the same DNA-binding site. 
(A) Schematic representation of the modular structure of the CREB mutants GST-CREB and GST-
KCREB. These mutants consist of amino-terminal glutathione-S-transferase, a nuclear localization 
signal derived from the SV40 large T antigen, and the bZIP domains of CREB or KCREB on the C-
termini. (B) HepG2 cells were transfected with the pGTPCHIluc reporter plasmid (1 µg/plate), the 
internal standard plasmid pRSVβ (2 µg/plate), an expression vector encoding C2/ATF2 (500 ng/plate) 
and expression vectors encoding either GST-CREB or GST-KCREB (250 ng/plate). Forty-eight hours 
post-transfection cell extracts were prepared and the relative luciferase activities were determined. 
Data are mean ±SD. 
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C.2.3.3. Stimulation of GTP cyclohydrolase I promoter/luciferase reporter gene 
transcription by p38 MAP kinase and a constitutively active MAP kinase kinase 6 
 
ATF2 is activated via phosphorylation of the threonine residues 69 and 71 situated within its 
activation domain. This phosphorylation is catalyzed by the protein kinases p38 MAP kinase 
(p38 MAPK) or c-Jun N-terminal protein kinase (JNK). In order to activate p38 protein 
kinase, a constitutively active mutant of p38 MAPKK, MKK6 [MKK6(E)] was used. p38 
MAPK is phosphorylated by MKK6 on the residues Ser207 and Thr211. These residues have 
been exchanged to glutamic acid residues, generating a constitutively active protein kinase 
mutant termed MKK6(E) (Jiang et al., 1996). To study the transcriptional activation of ATF2, 
the activity of the GAL4-ATF2 fusion protein depicted in Fig. 23A was measured. The 
transcriptional activation was monitored by co-transfection of the reporter plasmid pUAS5luc 
described earlier. Transfection efficiency was monitered by co-transfecting pSV40lacZ due to 
an observed effect of p38 and MKK6(E) upon Rous sarcoma virus long terminal repeat 
controlled β-galactosidase expression. The data show that the transcriptional activation 
potential of the GAL4-ATF2 fusion protein was elevated following expression of MKK6(E) 
on the order of 2.5-fold (Fig. 23B). As shown in Fig. 23C, transfection of a nanomolar 
concentration of an expression vector encoding wild-type p38 MAPK did not change reporter 
gene transcription since only the concentration of an inactive and unphosphorylated p38 
protein kinase was increased. However, coexpression of the p38 protein kinase together with 
the constitutively active MKK6 mutant MKK6(E) strongly increased the ATF2 
transactivation potential. The protein consisting of the GAL4 DNA-binding domain 
(GAL4DBD) did not stimulate transcription of the luciferase reporter gene under any condition. 
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Fig. 23. Transcriptional activation of ATF2. 
(A) Modular structure of GAL4 fusion protein GAL4-ATF2. The protein contains the DNA-binding 
domain of the yeast transcription factor GAL4 (amino acids 1-147) and the phosphorylation-dependent 
activation domain of ATF2 (amino acids 1-96). The sequence encompassing the phosphorylation sites 
is depicted. (B, C) The reporter plasmid pUAS5luc (1 µg/plate) and the expression plasmid encoding 
GAL4-ATF2 (1 µg/plate) were transfected into HepG2 cells together with either only expression 
vector encoding MKK6(E) (25 ng/plate) (B) or with expression vectors encoding MKK6(E) (25 
ng/plate) and p38 MAPK (50 ng/plate) (C). As a control, plasmid pM1 encoding only the DNA-
binding domain of GAL4 (GAL4DBD) was used (1 µg/plate). As a reference plasmid pSV40lacZ (3 
µg/plate) was transfected. Forty-eight hours post-transfection cell extracts were prepared and the 
relative luciferase activities were determined. Data are mean ±SD. 
 
 
Additionally, the impact of activating the p38 MAPK signaling pathway on GTP 
cyclohydrolase I promoter/luciferase reporter gene transcription was tested. The results show 
that MKK6(E) alone was not able to induce reporter gene transcription (Fig. 24A), while 
expression of MKK6(E) in the presence of p38 MAPK increased GTP cyclohydrolase I 
promoter/luciferase gene transcription on the order of 9.6-fold (Fig. 24B). These data indicate 
that the activation of p38 protein kinase signaling pathway activated GTP cyclohydrolase I 
gene transcription. 
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Fig. 24. Activation of GTP cyclohydrolase I promoter by p38 MAPK and a constitutively active 
mutant of MAP kinase kinase 6. 
HepG2 cells were transfected with the pGTPCHIluc reporter plasmid (1 µg/plate), the reference 
plasmid pSV40lacZ (3 µg/plate) and only expression vector encoding MKK6(E) (100, 250 ng/plate) 
(A) or expression vectors encoding MKK6(E) (25 ng/plate) and p38 MAPK (50 ng/plate) (B). Forty-
eight hours post-transfection cell extracts were prepared and the relative luciferase activities were 
determined. Data are mean ±SD. 
 
 
C.2.3.4. p38/MKK6(E)-stimulated GTP cyclohydrolase I promoter/luciferase reporter 
gene was impaired by dominant-negative ATF2 mutant A-ATF2, and by A-Fos, a 
dominant-negative of c-Jun 
 
Competition experiment using the A-ZIP mutants was performed. The results revealed that 
p38/MKK6(E)-stimulated GTP cyclohydrolase I promoter/luciferase reporter was inhibited by 
A-ATF2 and A-Fos, while A-CREB, A-ATF4 and A-C/EBP had no effect (Fig. 25). This 
competition experiment confirms that the GTP cyclohydrolase I gene transcription is 
regulated by ATF2. It also confirms that CREB, CREB2/ATF4 and C/EBP do not 
heterodimerize with ATF2. 
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Fig. 25. p38/MKK6(E)-stimulated GTP cyclohydrolase I reporter gene was impaired by the 
dominant-negative mutants A-ATF2 and A-Fos. 
The reporter plasmid pGTPCHIluc (1 µg/plate) was transfected into HepG2 cells together with the 
reference plasmid pSV40lacZ (3 µg/plate), expression vectors encoding either MKK6(E) (25 ng/plate) 
or p38 MAPK (50 ng/plate) and expression vectors encoding either A-CREB, A-ATF4, A-Fos, A-
ATF2 or A-C/EBP (50 ng/plate). Forty-eight hours post-transfection cell extracts were prepared and 
the β-galactosidase and luciferase activities were determined. Data are mean ±SD. 
 
 
C.2.3.5. Mutations of the CRE-like sequence of the GTP cyclohydrolase I promoter 
impair transactivation by ATF2 
 
To test whether the CRE-like sequence is essential for ATF2-mediated transactivation of the 
GTP cyclohydrolase I promoter/luciferase reporter gene, transfection experiments employing 
reporter genes carrying the intact or the mutated CRE-like site, together with the expression 
vector encoding C2/ATF2, were performed. The results show that the CRE-like sequence is 
of major importance for the constitutively active ATF2 mutant to transactivate the GTP 
cyclohydrolase I reporter gene (Fig. 26). 
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Fig. 26. Point mutations within the CRE-like sequence of the GTP cyclohydrolase I promoter 
impair transactivation mediated by C2/ATF2. 
1 µg/plate of the wild-type or the mutated GTP cyclohydrolase I reporter plasmid, together with 500 
ng/plate of C2/ATF2 and 2 µg/plate of RSVβ were transfected into HepG2 cells. Forty-eight hours 
post-transfection lysates were prepared and the relative luciferase activities were determined. Data are 
mean ±SD. 
 
 
C.2.4. C2/ATF2 transactivates a reporter gene containing one copy of the CRE/AP1 
motif derived from the TNFα promoter 
 
The biological activity of ATF2 on the TNFα promoter/luciferase reporter gene was tested. 
Transient transfection experiments of HepG2 cells using the wild-type ATF2 and the 
constitutively active mutant C2/ATF2 show that C2/ATF2 transactivated the TNFα reporter 
gene that contains one copy of CRE/AP1 motif. This induction was on the order of 5.8-fold, 
in contrast, the wild-type ATF2 was inactive (Fig. 27). 
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Fig. 27. C2/ATF2 activates the transcription of a TNFα reporter gene. 
The reporter plasmid pTNFα(-131)luc (1 µg/plate) was transfected into HepG2 cells, together with the 
internal standard plasmid pRSVβ (2 µg/plate), the expression vector pCMV5 or expression vectors 
encoding ATF2 or C2/ATF2 (500 ng/plate). Forty-eight hours post-transfection lysates were prepared 
and the relative luciferase activities were determined. The mean ±SD is depicted. 
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C.2.4.1. Induction of TNFα promoter/luciferase reporter gene expression by p38 MAPK 
and a constitutively active mutant of  MAPKK 6 
 
Members of the MAPKs have been identified to be responsible for TNFα gene expression in 
lymphocytes and non-lymphocyte tissues. It has been shown that in T lymphocytes the 
MAPKs, ERK, JNK and p38 MAPK cooperate in regulating the TNFα gene expression 
(Hoffmeyer et al., 1999). The role of p38 MAPK signaling pathway in the regulation of TNFα 
gene transcription was analyzed by overexpressiong a constitutively active mutant of 
MAPKK6 [MKK6(E)]. Two reporter plasmids were used, first, a reporter plasmid that 
contains -1311 nucleotides of the regulatory region of TNFα gene (Fig. 28) and second, a 
reporter gene that contains two copies of the CRE/AP1 site of the TNFα promoter. 
 
luciferase
-1311
CRE/AP1
 
 
Fig. 28. The TNFα promoter/luciferase reporter gene (pTNFα(-1311)luc). 
The reporter plasmid pTNFα(-1311)luc contains the luciferase reporter gene and the regulatory region 
derived from the human TNFα gene. 
 
 
Transient transfection experiments employing the constitutively active mutant MKK6(E) 
were performed and the results show that expression of MKK6(E) was not sufficient to 
increase the transcription of the TNFα promoter/luciferase reporter gene containing -1311 
nucleotides of the regulatory region of TNFα gene, while expression of MKK6E in the 
presence of p38 MAPK elevated promoter/luciferase reporter gene transcription (Fig. 29A). 
Similarly, MKK6(E) enhanced the transcription of the TNFα reporter gene controlled by the 
CRE/AP1 motif only in the presence of p38 MAPK (Fig. 29B). 
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Fig. 29. Activation of TNFα promoter/luciferase reporter genes by p38 MAPK and a 
constitutively active MAPKK 6. 
HepG2 cells were transfected with one of the reporter plasmids pTNFα(-1311)luc (A) or 
pTNFα(CRE/AP1)2luc (B) (1 µg/plate), the reference plasmid pRSVβ (2 µg/plate) and one of the 
expression vectors p38 MAPK (50 ng/plate) and/or MKK6(E) (25 ng/plate). Forty-eight hours post-
transfection cell extracts were prepared and the relative luciferase activities were determined. Data are 
mean ±SD. 
 
 
C.2.4.2. Stimulation of TNFα promoter gene by p38/MKK6(E) was impaired by MKP-1 
 
The MAPK phosphatase-1 (MKP-1) is known to inactivate p38 MAPK in the nucleus via 
dephosphorylation (Raingeaud et al., 1995; Liu et al., 1995). To dephosphorylate p38 in the 
nucleus, MKP-1 was overexpressed. The results show that MKP-1 blocked the transactivation 
of both TNFα reporter genes mediated by p38/MKK6(E) (Fig. 30A, B). The results obtained 
by using the p38/MKK6(E) and p38/MKK6(E)/MKP-1 lead to the conclusion that p38 MAPK 
signaling pathway regulates TNFα gene expression in HepG2 cells. These date together with 
the data obtained by using C2/ATF2 suggest that TNFα gene transcription is regulated by 
ATF2. 
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Fig. 30. The stimulating effect of p38/MKK6(E) expression upon TNFα reporter genes was 
attenuated by expressing MKP-1. 
HepG2 cells were transfected with one of the reporter plasmids pTNFα(-1311)luc (A) or 
pTNFα(CRE/AP1)2luc (B) (1 µg/plate), the internal standard plasmid pRSVβ (2 µg/plate) and one of 
the expression vectors p38 MAPK (50 ng/plate) and/or MKK6(E) (25 ng/plate). An expression vector 
encoding MKP-1 (1 µg/plate) was also transfected. Forty-eight hours post-transfection cell extracts 
were prepared and the relative luciferase activities were determined. Data are mean ±SD. 
 
 
C.2.5. C2/ATF2 transactivates a reporter gene containing four copies of the CRE 
derived from the secretogranin II gene 
 
Secretogranin II, a member of the granin family, is an acidic secretory protein found in 
secretory granules of most peptidergic endocrine cells and neurons. It has been reported that 
secretogranin II plays a role in the sorting process to secretory granules (Scammell, 1993; 
Rosa and Gerdes, 1994; Huttner and Natori, 1995). The genes encoding the granin proteins 
contain CRE motifs in their promoter region. To test the biological activity of ATF2 towards 
a reporter gene containing four copies of the CRE derived from the secretogranin II gene in 
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noradrenergic locus coeruleus-like CATH.a cells, expression experiments employing 
C2/ATF2 were performed. The results show that C2/ATF2 transactivated the secretogranin II 
promoter/luciferase reporter gene (plasmid pSgIICRE4luc). The transcriptional activation was 
approximately on the order of 6-fold (Fig. 31). 
 
reporter plasimd: pSgIICRE4luc
C2/ATF2
1
2
3
4
5
6
- +
re
la
tiv
e 
lu
ci
fe
ra
se
 
ac
tiv
ity
 
(R
LU
 
/ ß
-
ga
l u
n
its
 
x
 
10
 
-
3 )
GAGCCGGTGACGTCAGCGTGGAA
luciferase
T A
TA
CRE
 
 
Fig. 31. Biological activity of C2/ATF2 towards a reporter gene containing four copies of the 
CRE derived from the secretogranin II gene. 
Modular structure of the reporter plasmid pSgIICRE4luc that contains a minimal promoter consisting 
of the human immunodeficiency virus TATA box, the adenovirus major late promoter initiator 
element, the luciferase open reading frame and four copies of CRE derived from the secretogranin II 
regulatory region. CATH.a cells were transfected with the reporter plasmid pSgIICRE4luc (1 
µg/plate), the internal reference plasmid pRSVβ (2 µg/plate) and either the ‘empty’ expression vector 
pCMV5 or an expression vector encoding C2/ATF2 (100 ng/plate). Lysates were prepared forty-eight 
hours post-transfection and β-galactosidase and luciferase activities were measured. The mean ± SD is 
depicted. 
 
 
To confirm that the CRE within the secretogranin II gene serves as a target for C2/ATF2, a 
secretogranin II reporter gene, containing one copy of the canonical CRE was tested. The 
results show that expression of either C2/ATF2 or C2/CREB transactivated the secretogranin 
II reporter gene (Fig. 32), indicating that both ATF2 and CREB target the secretogranin II 
gene promoter. 
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Fig. 32. Biological activity of C2/ATF2 towards a reporter gene containing one copy of the CRE 
derived from the secretogranin II gene. 
Modular structure of the reporter plasmid pSgIIluc that contains secretogranin II promoter sequences 
from -167 to +35. The position of the CRE is depicted. CATH.a cells were transfected with the 
reporter plasmid pSgIIluc (1 µg/plate) together with the internal reference plasmid pRSVβ (2 µg/plate) 
and either the ‘empty’ expression vector pCMV5 or an expression vector encoding either C2/ATF2 or 
C2/CREB (100 ng/plate). Forty-eight hours post-transfection cell extracts were prepared and β-
galactosidase and luciferase activities were measured. Data are mean ±SD. 
 
 
C.2.5.1. C2/ATF2 and C2/CREB compete for DNA-binding 
 
As shown in Fig. 22, CREB and ATF2 do not heterodimerize to activate the GTP 
cyclohydrolase I reporter gene but they rather compete for the same DNA-binding site. To 
confirm that CREB and ATF2 do not heterodimerize, secretogranin II reporter gene 
transcription was activated by expression of C2/ATF2 and competed with the various 
dominant-negative bZIP mutants. As expected, the results show that A-ATF2 and A-Fos 
inhibited C2/ATF2-stimulated transcription, whereas A-CREB, A-ATF4 and A-C/EBP had 
no effect (Fig. 33).  
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Fig. 33. A-ATF2 and A-Fos impaired C2/ATF2-induced secretogranin II reporter gene 
transcription. 
CATH.a cells were transfected with the pSgIICRE4luc reporter plasmid (1 µg/plate), an expression 
vector encoding C2/ATF2 (100 ng/plate) and the reference plasmid pRSVβ (2 µg/plate). In addition, 
expression vectors encoding either A-CREB, A-ATF4, A-Fos, A-ATF2 or A-C/EBP (100 ng/plate) 
were transfected. Forty-eight hours post-transfection cell extracts were prepared and the β-
galactosidase and luciferase activities were determined. 
 
 
Additionally, the fusion proteins GST-CREB and GST-KCREB were used as competitors. 
The results show that GST-CREB impaired C2/ATF2-induced transcriptional activity, 
whereas GST-KCREB, which can not bind to DNA, had no inhibiting activity (Fig. 34). 
Taken together, these data indicate that both ATF2 and CREB compete for the same DNA-
binding site, the CRE. 
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Fig. 34. CREB and ATF2 compete for binding to the CRE. 
CATH.a cells were transfected with the pSgIICRE4luc reporter plasmid (1 µg/plate), an expression 
vector encoding C2/ATF2 (100 ng/plate) and the internal standard plasmid pRSVβ (2 µg/plate). In 
addition, expression vectors encoding GST-CREB or GST-KCREB (100 ng/plate) were transfected. 
Forty-eight hours post-transfection cell extracts were prepared and the relative luciferase activities 
were determined. 
 
 
C.2.6. C2/ATF2 marginally activated the transcription of pc-fosCRE4luc reporter gene 
 
The c-Fos promoter has been shown to contain a consensus CRE (Sassone-Corsi et al., 
1988b). The biological activity of ATF2 towards a reporter gene that contains four copies of 
the CRE derived from the c-Fos gene in noradrenergic locus coeruleus-like CATH.a cells was 
tested. Expression experiments using the mutant C2/ATF2 were performed and the results 
show that the pc-fosCRE4luc reporter gene was only marginally activated by C2/ATF2. The 
induction was approximately on the order of 1.4-fold (Fig. 35). 
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Fig. 35. Biological activity of constitutively active ATF2 mutant towards a reporter gene 
containing four copies of the CRE derived from the c-Fos gene. 
Modular structure of the reporter plasmid pcfosCRE4luc that contains a minimal promoter consisting 
of the human immunodeficiency virus TATA box, the adenovirus major late promoter initiator 
element, the luciferase open reading frame and four copies of CRE derived from the c-Fos regulatory 
region. CATH.a cells were transfected with the reporter plasmid pc-fosCRE4luc (1 µg/plate), the 
internal reference plasmid pRSVβ (2 µg/plate) and either the ‘empty’ expression vector pCMV5 or an 
expression vector encoding C2/ATF2 (100 ng/plate). Lysates were prepared forty-eight hours post-
transfection and β-galactosidase and luciferase activities were measured. The mean ± SD is depicted. 
 
 
C.2.7. C2/ATF2 is unable to transactivate the tyrosine hydroxylase promoter/luciferase 
reporter gene 
 
Tyrosine hydroxylase is the rate-limiting enzyme in the biosynthesis of catecholamines. 
Tyrosine hydroxylase promoter has been shown to contain a CRE sequence (D’Mello et al., 
1989; Huang et al., 1991). The biological activity of ATF2 towards the tyrosine hydroxylase 
promoter/luciferase reporter gene in noradrenergic locus coeruleus-like CATH.a cells was 
tested by performing expression experiments using the constitutively active ATF2 mutant 
C2/ATF2. The results show that the tyrosine hydroxylase promoter/luciferase reporter gene 
was not transactivated following the expression of C2/ATF2 (Fig. 36). These data together 
with the data obtained by pSgIICRE4luc, pSgIIluc and pc-fosCRE4luc indicate that C2/ATF2 
can select between different CRE sequences. 
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Fig. 36. Biological activity of C2/ATF2 towards the tyrosine hydroxylase reporter gene. 
Modular structure of the tyrosine hydroxylase promoter/luciferase reporter gene that contains tyrosine 
hydroxylase promoter sequences from -760 to +18. The position and sequence of the CRE are shown. 
CATH.a cells were transfected with the reporter plasmid pTHluc (1 µg/plate), the internal reference 
plasmid pRSVβ (2 µg/plate) and either the ‘empty’ expression vector pCMV5 or an expression vector 
encoding C2/ATF2 (100 ng/plate). Lysates were prepared forty-eight hours post-transfection and β-
galactosidase and luciferase activities were measured. The mean ± SD is depicted. 
 
 
C.3. Regulation of gene expression by c-Jun 
 
C.3.1. Biological activity of a constitutively active c-Jun mutant C2/c-Jun towards CRE-
containing reporter genes 
 
The transcription factor ATF2 preferentially forms heterodimers through the leucine zipper 
with c-Jun, and ATF2/c-Jun heterodimers have been described to regulate c-Jun and TNFα 
gene transcription (Van Dam et al., 1993; Tsai et al., 1996). The transcription factor c-Jun 
contains a phosphorylation-regulated activation domain, therefore, it is inactive in the 
dephosphorylated state. Nonetheless c-Jun turns into a biologically active transcriptional 
activator upon phosphorylation, this phosphorylation occurs on the serine residues 63 and 73 
present within the activation domain of c-Jun and is catalyzed by c-Jun N-terminal kinase. To 
test the effect of c-Jun on CRE-containing reporter genes, a constitutively active c-Jun mutant 
C2/c-Jun was used. 
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C.3.2. Modular structure of c-Jun and the constitutively active c-Jun mutant C2/c-Jun 
 
The transcription factor c-Jun contains on its C-terminus a bZIP domain, which is responsible 
for DNA binding and dimerization, while its N-terminus contains an activation domain which 
is controlled by phosphorylation. The bZIP domain of c-Jun was expressed as a fusion protein 
with the constitutively active transcriptional activation domain of CREB2, generating the 
chimeric transcription factor C2/c-Jun. In addition the C2/c-Jun fusion protein contains an 
immunological tag used for detection of the protein. This construct is constitutively active and 
does not need phosphorylation to be activated. 
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Fig. 37. Schematic representation of c-Jun and C2/c-Jun 
Modular structure of the bZIP proteins c-Jun and the constitutively active mutant C2/c-Jun. 
 
 
C.3.3. C2/c-Jun activates the transcription of the GTP cyclohydrolase I 
promoter/luciferase reporter gene 
 
The biological activity of the constitutively active c-Jun mutant C2/c-Jun towards the GTP 
cyclohydrolase I reporter gene was measured. As a control, the impact of c-Jun and C2/c-Jun 
on the Egr-1 promoter activity was tested. The results show that C2/c-Jun activated both 
reporter genes (Fig. 38). The activation of the GTP cyclohydrolase I and Egr-1 promoter was 
on the order of 2.4-fold and 2.3-fold, respectively. In contrast, the wild-type c-Jun was 
inactive. 
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Fig. 38. The constitutively active c-Jun mutant C2/c-Jun activates the transcription of GTP 
cyclohydrolase I promoter/luciferase reporter gene. 
One of the reporter plasmids pGTPCHIluc or pEgr-1.1luc (1 µg/plate) was transfected into HepG2 
cells, together with the internal standard plasmid pRSVβ (2 µg/plate), the empty expression vector 
pCMV5 or expression vectors encoding c-Jun or C2/c-Jun (500 ng/plate). Forty-eight hours post-
transfection cell extracts were prepared and the relative luciferase activities were determined. The 
mean ±SD is depicted. 
 
 
C.3.3.1. Do CREB and c-Jun heterodimerize in order to activate the GTP cyclohydrolase 
I reporter gene transcription? 
 
To check whether CREB and c-Jun are able to heterodimerize, the effect of the dominant-
negative CREB mutants GST-CREB and GST-KCREB upon C2/c-Jun-mediated GTP 
cyclohydrolase I promoter gene activity was tested. The results show that GST-CREB 
impaired C2/c-Jun-stimulted transcription of the reporter gene, while GST-KCREB did not 
show any inhibiting effect, since it is unable to bind to the CRE (Fig. 39). Thus, constitutively 
active mutants of CREB and c-Jun are independently able to transactivate the GTP 
cyclohydrolase I reporter gene, without forming heterodimers, suggesting that c-Jun and 
CREB compete for the same DNA-binding site, the CRE. 
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Fig. 39. c-Jun and CREB compete for the same DNA-binding site. 
HepG2 cells were transfected with the pGTPCHIluc reporter plasmid (1 µg/plate), the internal 
standard plasmid pRSVβ (2 µg/plate), an expression vector encoding C2/c-Jun (500 ng/plate) and 
expression vectors encoding either GST-CREB or GST-KCREB (250 ng/plate). Forty-eight hours 
post-transfection cell extracts were prepared and the β-galactosidase and luciferase activities were 
determined. Data are mean ±SD. 
 
 
C.3.3.2. Expression of the constitutively active MAP3 kinase MEKK1∆ stimulates GTP 
cyclohydrolase I promoter/luciferase reporter gene 
 
c-Jun is phosphorylated by the c-Jun N-terminal kinase (JNK). The activity of JNK is 
controlled by the MAP3 kinase mitogen-activated/extracellular signal responsive kinase 
kinase (MEK) kinase 1. An expression vector encoding a truncated form of MEK kinase 1 
(MEKK1∆) was used to stimulate JNK activity. It has been shown that MEKK1∆ strongly 
activated the transcriptional activity of a fusion protein consisting of the GAL4 DNA-binding 
domain and the c-Jun transactivation domain (Lin et al., 1995). To test the role of MEKK1∆ 
on the GTP cyclohydrolase I promoter/luciferase reporter gene transcription, transient 
transfection experiments were performed. The data show that overexpression of MEKK1∆ 
induced the transcription of the GTP cyclohydrolase I promoter/luciferase reporter gene on 
the order of 4-fold (Fig. 40). Transfection efficiency was monitered by co-transfecting 
pSV40lacZ due to an observed effect of MEKK1∆ upon Rous sarcoma virus long terminal 
repeat controlled β-galactosidase expression. 
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Fig. 40. Expression of a constitutively active mutant of MEKK1 increased GTP cyclohydrolase I 
promoter activity. 
HepG2 cells were transfected with the pGTPCHIluc reporter plasmid (1 µg/plate) together with the 
internal standard plasmid pSV40lacZ (3 µg/plate) and either an empty expression vector “pCMV5” or 
an expression vector encoding MEKK1∆ (2 ng plasimd/plate). Forty-eight hours post-transfection cell 
extracts were prepared and the β-galactosidase and luciferase activities were determined. Data are 
mean ±SD. 
 
 
C.3.3.3. c-Jun and ATF2 mediate the MEKK1∆-induced upregulation of the GTP 
cyclohydrolase I reporter gene  
 
To check whether c-Jun and/or ATF2 mediate the MEKK1∆-induced upregulation of the GTP 
cyclohydrolase I promoter/luciferase reporter gene, competition assay using the A-ZIP 
expression vectors was performed. The results show that both A-ATF2 and A-Fos were able 
to block the transcriptional activation of the GTP cyclohydrolase I promoter gene mediated by 
MEKK1∆ (Fig. 41A). Additionally, another competition experiments involving dominant-
negative ATF2 and c-Jun mutants ATF2∆N and c-Jun∆N were performed. These mutants 
contain the intact bZIP domains of ATF2 or c-Jun, respectively, and are therefore able to bind 
to the cognate sites of ATF2 and c-Jun, making these sites unavailable for wild-type bZIP 
proteins. The results show that both mutants ATF2∆N and c-Jun∆N blocked the 
transcriptional activation of the GTP cyclohydrolase I gene promoter mediated by MEKK1∆ 
(Fig. 41B). Taken together, these data indicate that either c-Jun or ATF2 or a heterodimer of 
c-Jun and ATF2 mediate the MEKK1∆-induced upregulation of the GTP cyclohydrolase I 
promoter/luciferase reporter gene transcription.  
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Fig. 41. MEKK1∆-induced GTP cyclohydrolase I promoter activity was impaired by dominant-
negative mutants of ATF2 and c-Jun. 
(A) The reporter plasmid pGTPCHIluc (1 µg/plate) was transfected into HepG2 cells together with the 
internal standard plasmid pSV40lacZ (3 µg/plate), an expression vector encoding MEKK1∆ (2 ng 
plasmid/plate) and expression vectors encoding either A-CREB, A-ATF4, A-Fos, A-ATF2 or A-
C/EBP (50 ng/plate). Forty-eight hours post-transfection cell extracts were prepared and the β-
galactosidase and luciferase activities were determined. Data are mean ±SD. (B) Schematic 
representation of the modular structure of ATF2 and c-Jun and the dominant-negative mutants 
ATF2∆N and c-Jun∆N. HepG2 cells were transfected with the pGTPCHIluc reporter plasmid (1 
µg/plate) together with the standard plasmid pSV40lacZ (3 µg/plate), an expression vector encoding 
MEKK1∆ (2 ng/plate) and expression vectors encoding ATF2∆N and c-Jun∆N (250 ng/plate). Forty-
eight hours post-transfection cell extracts were prepared and the β-galactosidase and luciferase 
activities were determined. Data are mean ±SD. 
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C.3.3.4. Mutations of the CRE-like sequence of the GTP cyclohydrolase I promoter 
impair the activation by c-Jun 
 
GTP cyclohydrolase I reporter genes carrying the intact or the mutated CRE-like site were 
used to analyze the importance of the CRE-like sequence for c-Jun-mediated transactivation. 
The results reveal that the CRE-like sequence is of major importance for the constitutively 
active c-Jun mutant to transactivate the GTP cyclohydrolase I promoter/luciferase reporter 
gene (Fig. 42). 
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Fig. 42. Point mutations within the CRE-like sequence of the GTP cyclohydrolase I promoter 
impair transactivation mediated by C2/c-Jun. 
1 µg/plate of the wild-type or the mutated GTP cyclohydrolase I reporter plasmid was transfected into 
HepG2 cells together with 500 ng/plate of C2/c-Jun and 2 µg/plate of the internal standard plasmid 
pRSVβ. Forty-eight hours post-transfection cell extracts were prepared and the β-galactosidase and 
luciferase activities were determined. Data are mean ±SD. 
 
 
C.3.4. C2/c-Jun activates the transcription of the TNFα reporter gene containing one 
copy of the CRE/AP1 binding site 
 
The biological activity of c-Jun on the TNFα promoter gene was tested. Transient transfection 
experiments of HepG2 cells using the constitutively active mutant C2/c-Jun were performed 
and the results show that C2/c-Jun transactivated the TNFα reporter gene (plasmid pTNFα(-
131)luc). The transcriptional activation was approximately on the order of 20-fold. In 
contrast, the wild-type ATF2 was inactive (Fig. 43). 
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Fig. 43. C2/c-Jun activates the transcription of TNFα promoter/luciferase reporter gene. 
The reporter plasmid pTNFα(-131)luc (1 µg/plate) was transfected into HepG2 cells, together with the 
internal standard plasmid pRSVβ (2 µg/plate), the empty expression vector pCMV5 or expression 
vectors encoding c-Jun or C2/c-Jun (500 ng/plate). Forty-eight hours post-transfection lysates were 
prepared and the relative luciferase activities were determined. The mean ±SD is depicted. 
 
 
C.3.5. Expression of the constitutively active MAP3 kinase mutant MEKK1∆ activates 
TNFα reporter gene containing two copies of CRE/AP1 binding site 
 
To test whether the JNK pathway regulates TNFα gene expression in HepG2 cells, an 
expression vector encoding a truncated form of MEK kinase 1 (MEKK1∆) was used to 
stimulate JNK activity. To analyze the role of MEKK1∆ on the human TNFα gene promoter 
activity, a reporter gene containing two copies of the CRE/AP1 sequence upstream of a 
minimal promoter was used. Transient transfection experiments of HepG2 cells show that 
transfection of 2 ng of the expression plasmid MEKK1∆ was sufficient to activate the 
transcription of the luciferase reporter gene controlled by the CRE/AP1 element (Fig. 44). 
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Fig.44. Expression of MEKK1∆ increased the transcription of TNFα reporter gene containing 
two copies of CRE/AP1 binding site. 
HepG2 cells were transfected with the pTNFα(CRE/AP1)2luc reporter plasmid (1 µg/plate), together 
with the internal standard plasmid pRSVβ (2 µg/plate) and an expression vector encoding MEKK1∆ 
(2 or 100 ng plasmid/plate). Forty-eight hours post-transfection cell extracts were prepared and the β-
galactosidase and luciferase activities were determined. Data are mean ±SD. 
 
 
C.3.5.1. MKP-1 inhibits MEKK1∆-induced TNFα promoter/luciferase reporter gene 
containing two copies of CRE/AP1 binding site 
 
MKP-1 is known to inactivate the protein kinase JNK in the nucleus (Sun et al., 1994; Liu et 
al., 1995; Gupta et al., 1996) via dephosphorylation, therefore the MKP-1 was overexpressed 
to dephosphorylate JNK in the nucleus. The results show that MKP-1 blocked MEKK1∆-
induced upregulation of TNFα promoter/luciferase reporter gene transcription via the 
CRE/AP1 site (Fig. 45). The results obtained by using the MEKK1∆ and MEKK1∆/MKP-1 
lead to the conclusion that JNK regulates TNFα gene expression in HepG2 cells. These data 
also suggest that the transcription of the TNFα gene is regulated by c-Jun and ATF2. 
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Fig. 45. The stimulating effect of MEKK1∆ expression upon TNFα reporter gene was attenuated 
by expressing MKP-1. 
HepG2 cells were transfected with the pTNFα(CRE/AP1)2luc reporter plasmid (1 µg/plate), together 
with the internal standard plasmid pRSVβ (2 µg/plate), either an empty expression vector “pCMV5” 
or an expression vector encoding MEKK1∆ (2 ng/plate) and an expression vector encoding MKP-1 (1 
µg/plate). Forty-eight hours post-transfection cell extracts were prepared and the β-galactosidase and 
luciferase activities were determined. Data are mean ±SD. 
 
 
C.4. Regulation of gene expression by CREB2/ATF4 
 
C.4.1. CREB2/ATF4 is unable to transactivate a GTP cyclohydrolase I 
promoter/luciferase reporter gene 
 
It has been reported that CREB2/ATF4 transactivates the GTP cyclohydrolase I promoter in 
PC12 cells (Kapatos et al., 2000). An expression vector encoding CREB2 was used to test the 
biological effect of CREB2 on GTP cyclohydrolase I promoter activity. The results show that 
overexpression of CREB2 did not enhance the GTP cyclohydrolase I promoter activity, while 
C2/CREB strongly enhanced the transcription of the reporter gene (Fig. 46A). As a positive 
control, a reporter gene containing the nutrient-sensing response unit of the asparagine 
synthetase promoter upstream of a minimal promoter and the luciferase open reading frame 
(plasmid pASluc) was used. The results show that overexpression of CREB2/ATF4 activates 
transcription of asparagine synthetase promoter via the nutrient-sensing response unit (Fig. 
46B). 
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Fig. 46. CREB2/ATF4 does not upregulate the GTP cyclohydrolase I promoter activity. 
(A) The reporter plasmid pGTPCHIluc (1 µg/plate) was transfected into HepG2 cells, together with 
the internal standard plasmid pRSVβ (2 µg/plate), the expression vector pCMV5 or expression vectors 
encoding CREB2/ATF4 or CREB (25 ng/plate). For comparison, an expression vector encoding 
C2/CREB was transfected (25 ng/plate). Forty-eight hours post-transfection cell extracts were 
prepared and the relative luciferase activities were determined. Data are mean ±SD. (B) Schematic 
representation of the reporter plasmid pASluc. The reporter plasmid pASluc contains the nutrient-
sensing response unit upstream of a minimal promoter and the luciferase open reading frame. The 
reporter plasmid pASluc (1 µg/plate) was transfected into HepG2 cells, together with the internal 
standard plasmid pRSVβ (2 µg/plate), the empty expression vector pCMV5 or expression vector 
encoding CREB2/ATF4 (25 ng/plate). Forty-eight hours post-transfection cell extracts were prepared 
and the relative luciferase activities were determined. Data are mean ±SD. 
 
 
Likewise, CREB2/ATF4 did not activate a reporter gene under control of the Egr-1 promoter 
(plasmid pEgr-1.1luc). The Egr-1 promoter contains a CRE-like sequence within its proximal 
region. As shown in Fig. 47, C2/CREB strongly transactivated Egr-1 promoter/luciferase 
reporter gene. As a conclusion, CREB2 is unable to transactivate the genes encoding GTP 
cyclohydrolase I or Egr-1 via the CRE-like sequences in their proximal promoter region. 
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Fig. 47. CREB2/ATF4 does not upregulate the Egr-1 promoter activity. 
The reporter plasmid pEgr-1.1luc (1 µg/plate) was transfected into HepG2 cells, together with the 
internal standard plasmid pRSVβ (2 µg/plate), the empty expression vector pCMV5 or expression 
vectors encoding CREB2/ATF4 or CREB (25 ng/plate). For comparison, an expression vector 
encoding C2/CREB was transfected (25 ng/plate). Forty-eight hours post-transfection cell extracts 
were prepared and the relative luciferase activities were determined. Data are mean ±SD. 
 
 
C.4.2. CREB2/ATF4 is unable to transactivate a TNFα reporter gene that contains one 
copy of CRE/AP1 site 
 
The biological effect of CREB2 on the TNFα promoter activity was tested and the results 
show that overexpression of CREB2 does not activate the TNFα reporter gene via the CRE-
like sequence in its proximal promoter region (Fig. 48). For comparison C2/CREB was also 
transfected.  
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Fig. 48. CREB2/ATF4 does not upregulate the TNFα reporter gene transcription. 
The reporter plasmid pTNFα(-131)luc (1 µg/plate) was transfected into HepG2 cells, together with the 
internal standard plasmid pRSVβ (2 µg/plate), the empty expression vector pCMV5 or expression 
vectors encoding CREB2/ATF4 or CREB (25 ng/plate). For comparison, an expression vector 
encoding C2/CREB was transfected (25 ng/plate). Forty-eight hours post-transfection cell extracts 
were prepared and the relative luciferase activities were determined. Data are mean ±SD. 
 
 
C.5. Regulation of gene expression by ATF5 and CHOP 
 
C.5.1. Deprivation of human hepatoma cells of amino acids triggers a strong 
upregulation of the asparagine synthetase gene transcription 
 
In mammals, plasma concentration of amino acids are affected by nutritional or pathological 
conditions. Recently, evidence has accumulated that amino acid availability regulates the 
expression of several genes involved in the regulation of a number of cellular functions or 
amino acid metabolism (Jousse et al., 2000). It has been shown that the transcription of the 
gene encoding asparagine synthetase is regulated by nutrient availability. To study the effect 
of amino acids deprivation on asparagine synthetase gene transcription HepG2 cells were 
cultured for 16 hours either in medium containing amino acids (DMEM) or in amino acid-free 
Krebs-Ringer-bicarbonate buffer (KRB). The results show that maintaining the cells in 
medium containing amino acids (incubation in DMEM) no asparagine synthetase mRNA was 
detectable, while maintaining the cells in medium lacking amino acids (KRB) strongly 
induced the biosynthesis of asparagine synthetase (Fig. 49).  
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Fig. 49. Activation of asparagine synthetase gene transcription by amino acid deprivation. 
HepG2 human hepatoma cells were cultured in either DMEM or Krebs-Ringer-bicarbonat (KRB) 
medium lacking all amino acids for 16 hours. Cytoplasmic RNA was isolated and analyzed by RNase 
protection mapping using cRNAs specific for asparagine synthetase (AS) and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). An aliquot of the undigested riboprobes is shown. Size marker 
MspI–cut PUC19 are shown in lane “marker”. This experiment was performed by G.Thiel. 
 
 
C.5.2. Amino acid deprivation induces the asparagine synthetase promoter/luciferase 
reporter gene transcription 
 
It has been shown that the activation of asparagine synthetase gene transcription by amino 
acids deprivation is accomplished by a genetic element termed the nutrient-sensing response 
unit. The nutrient-sensing response unit consists of two elements termed NSRE-1 and NSRE-
2, encompassing the sequences 5´-TGATGAAAC-3´ and 5´-GTTACA-3´, respectively 
(Kilberg and Barbosa-Tessmann, 2002). A reporter gene (pASluc) that contains both elements 
was used. To analyze the induction of asparagine synthetase reporter gene transcription by 
amino acid deprivation, transient transfection experiments of the human hepatoma cell line 
HepG2 were performed. The results show that amino acid deprivation induced asparagine 
synthetase promoter/luciferase reporter gene transcription (Fig. 50). The induction was on the 
order of 14-fold. 
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Fig. 50. Asparagine synthetase gene transcription is induced by amino acid deprivation. 
The reporter plasmid pASluc (1 µg/plate) was transfected into HepG2 hepatoma cells together with 
the internal standard plasmid pRSVβ (2 µg/plate). Cells were cultured in medium containing amino 
acids (DMEM) or in amino acid-free Krebs-Ringer-bicarbonate (KRB) medium. Cells were harvested 
16 hours later, cell extracts were prepared and the relative luciferase activities were determined. Data 
are mean ±SD. 
 
 
C.5.3. Amino acid deprivation-induced asparagine synthetase gene transcription was 
reduced by dominant-negative CREB2/ATF4 (A-ATF4) and C/EBP (A-C/EBP) mutants 
 
It has been reported that the bZIP transcription factors ATF3, ATF4, and C/EBPβ mediate the 
signaling cascade from amino acid deprivation to enhanced asparagine synthetase gene 
transcription. Additionally, the bZIP protein ATF2 has been shown to be involved in the 
leucine deprivation-induced upregulation of CHOP gene transcription (Averous et al., 2004). 
To test the effect of the bZIP proteins CREB, ATF2, CREB2/ATF4, c-Jun and C/EBP on 
amino acid-deprivation induced asparagine synthetase gene transcription, the dominant-
negative mutants A-ZIPs were used. The results show that A-ATF4 and A-C/EBP reduced the 
upregulation of reporter gene transcription, indicating that these bZIP proteins are important 
to stimulate gene transcription via the nutrient-sensing response unit. In contrast, dominant-
negative mutants of CREB, ATF2 and c-Jun did not significantly impair reporter gene 
transcription (Fig. 51).  
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Fig. 51. Stimulation of asparagine synthetase gene transcription by amino acid deprivation 
involves the bZIP transcription factors CREB2/ATF4 and C/EBP. 
The reporter plasmid pASluc (1 µg/plate) was transfected into HepG2 hepatoma cells together with 
the internal standard plasmid pRSVβ (2 µg/plate) and expression vectors encoding the dominant-
negative mutants A-CREB, A-ATF4, A-Fos, A-ATF2 or A-C/EBP. Cells were cultured in KRB 
medium for 16 hours. The control cells were maintained in DMEM. Cell extracts were prepared and 
the relative luciferase activities were determined. Data are mean ± SD. 
 
 
C.5.4. Comparison of the primary structures of the bZIP transcription factors 
CREB2/ATF4 and ATF5 
 
It has been shown that CREB2/ATF4 activates gene transcription of reporter genes containing 
the nutrient-sensing response unit (Siu et al., 2002). The primary structures of the bZIP 
transcription factors CREB2/ATF4 and ATF5 were compared. The comparison show that 
ATF5 is closely related to CREB2/ATF4 particularly in the bZIP domain. ATF5 contains a 
characteristic leucine-valine zipper, consisting of three leucine and three valine residues. An 
arginine-lysine rich basic region is N-terminal from this leucine-valine zipper that is required 
for sequence-specific binding to DNA (Fig. 52). 
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Fig. 52. Comparison of the amino acid sequences of the bZIP transcription factors 
CREB2/ATF4 and ATF5. 
The basic residues of the "basic domain" are shown in bold. The leucine-valine zipper residues are 
indicated by stars above the amino acids. 
 
 
C.5.5. Comparison of the transcriptional activation domains of CREB2/ATF4, ATF5, 
CREB, c-Jun and ATF2  
 
CREB2/ATF4 contains a constitutively active transcriptional activation domain, while the 
bZIP proteins CREB, c-Jun and ATF2 have phosphorylation-inducible transcriptional 
activation domains. The transcriptional activation domains of CREB2/ATF4, ATF5, CREB, 
c-Jun and ATF2 were compared by expressing these activation domains as fusion proteins 
with the DNA-binding domain derived from the yeast transcription factor GAL4. 
Transcriptional activation was monitored by co-transfection of the reporter plasmid pUAS5luc 
containing five copies of the GAL4 binding site upstream of a luciferase reporter gene. The 
data show that ATF5 and CREB2/ATF4 contain constitutively active trasncriptional 
activation domains. In contrast, transcription mediated by the fusion proteins GAL4-CREB, 
GAL4-c-Jun and GAL4-ATF2 is very low in the absence of stimulation.  
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Fig. 53. Comparison of the transcriptional activation domains of CREB2/ATF4, ATF5, CREB, 
c-Jun and ATF2. 
(A) Modular structure of the GAL4 fusion proteins GAL4-ATF5, GAL4-CREB2, GAL4-CREB, 
GAL4-c-Jun and GAL4-ATF2. (B) The reporter plasmid pUAS5luc (1 µg/plate), the internal standard 
plasmid pRSVβ (2 µg/plate) and one of the expression vectors encoding GAL4-ATF5, GAL4-
CREB2/ATF4, GAL4-CREB, GAL4-c-Jun or GAL4-ATF2 (1 µg/plate) were transfected into HepG2 
hepatoma cells. As a control, plasmid pM1 encoding only the DNA-binding domain of GAL4 
(GAL4DBD) was transfected (1 µg/plate). Cells were cultured in DMEM medium containing 10% fetal 
bovine serum for forty-eight hours. Cell extracts were prepared and the relative luciferase activities 
were determined. Data are mean ± SD. 
 
 
C.5.6. The biological activity of ATF5 
 
C.5.6.1. ATF5 transactivates the asparagine synthetase promoter/luciferase reporter 
gene 
 
The biological activity of ATF5 towards asparagine synthetase gene transcription was tested 
by performing transient transfection experiments using an expression vector encoding ATF5. 
As shown in Fig. 54, ATF5 transactivated a reporter gene containing the nutrient-sensing 
response unit of the asparagine synthetase gene in its regulatory region. 
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Fig. 54. ATF5 transactivates a reporter gene containing the nutrient-sensing response unit of the 
asparagine synthetase gene. 
The reporter plasmid pASluc (1 µg/plate) was transfected into HepG2 hepatoma cells together with 
the internal standard plasmid pRSVβ (2 µg/plate) and either an empty expression vector “pCMV5” or 
an expression vector encoding ATF5 (25 or 100 ng plasmid/plate). Forty-eight hours post-transfection 
cell extracts were prepared and the β-galactosidase and luciferase activities were determined. Data are 
mean ±SD. 
 
 
C.5.6.2. ATF5 can heterodimerize with CREB2/ATF4 and C/EBP proteins 
 
A recent analysis of the "dimerization code" of CREB2/ATF4 and CREB revealed that both 
proteins do not form heterodimers. In contrast, a dominant-negative C/EBP protein impaired 
transcriptional activation induced by CREB2/ATF4, as expected, because C/EBP is a well-
characterized dimerization partner of CREB2/ATF4 (Newman and Keating, 2003). To 
investigate the "dimerization code" of ATF5, the dominant-negative mutants A-ZIPs were 
used. The results show that dominant-negative mutants of CREB2/ATF4 and C/EBP impaired 
transcriptional activation of the reporter gene mediated by ATF5, indicating that ATF5 can 
heterodimerize with CREB2/ATF4 and C/EBP proteins. Expression of A-CREB, A-Fos or A-
ATF2 did not change ATF5-induced reporter gene transcription, indicating that CREB, c-Jun 
and ATF2 do not heterodimerize with ATF5. 
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Fig. 55. The dominant-negative mutants A-ATF4 and A-C/EBP block ATF5-induced 
transcription of the asparagine synthetase gene. 
The reporter plasmid pASluc (1 µg/plate) was transfected into HepG2 hepatoma cells together with 
the internal standard plasmid pRSVβ (2 µg/plate), an expression vector encoding ATF5 (25 ng/plate) 
and one of the expression vectors encoding either A-CREB, A-ATF4, A-Fos, A-ATF2 or A-C/EBP 
(50 ng/plate). Forty-eight hours post-transfection cell extracts were prepared and the β-galactosidase 
and luciferase activities were determined. Data are mean ±SD. 
 
 
C.5.6.3. ATF5 does not activate CRE-containing reporter genes 
 
It has been reported that ATF5 homodimers can bind in vitro to the cAMP response element 
(CRE) (Peters et al., 2001). In the study reported here, it was shown that CREB2/ATF4 did 
not transactivate CRE-containing reporter genes, indicating that CREB2/ATF4 targets distinct 
genetic elements. Due to the similarities between ATF5 and CREB2/ATF4, it was proposed 
that ATF5 does not transactivate CRE-containing reporter genes. To clarify this presumption 
two reporter genes containing either the distal (CRE1) or the proximal CRE-like site (CRE2) 
derived from the glucose-6-phosphatase gene (plasmids pG6PCRE1luc and pG6PCRE2luc) 
were used. Additionally, a reporter gene containing four copies of the CRE derived from the 
c-Fos gene upstream of a minimal promoter (plasmid pc-fosCRE4luc) was tested. The results 
show that ATF5 was not able to transactivate CRE-containing reporter genes. As a positive 
control, the constitutively active mutant C2/CREB was used and the data show that C2/CREB 
strongly induced the transcription of all three reporter genes (Fig. 56). 
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Fig. 56. ATF5 has no effect on CRE-containing reporter genes. 
One of the reporter plasmids pG6PCRE1luc, pG6PCRE2luc or pc-fosCRE4luc (1 µg/plate) was 
transfected into HepG2 cells, together with plasmid pRSVβ (2 µg/plate), the empty expression vector 
pCMV5 or expression vectors encoding either ATF5 or C2/CREB (25 ng/plate). Cell extracts were 
prepared forty-eight hours later and the relative luciferase activities of these extracts were determined. 
Data are mean ± SD. 
 
 
C.5.7. The role of the C/EBP homologous transcription factor CHOP on amino acid 
deprivation-induced upregulation of asparagine synthetase gene transcription 
 
As shown earlier the transcriptional activation mediated by the nutrient-sensing response unit 
of the asparagine synthetase gene involves C/EBP proteins or dimerization partners of C/EBP 
such as CREB2/ATF4 and ATF5. The role of the C/EBP homologous transcription factor 
CHOP on amino acid deprivation-induced upregulation of asparagine synthetase gene 
transcription was studied. Likewise, the role of CHOP upon CREB2/ATF4 or ATF5-induced 
upregulation of pASluc reporter gene transcription was tested.  
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C.5.7.1. CHOP inhibited the upregulation of reporter gene transcription, induced by 
amino acid deprivation 
 
It has been reported that the biosynthesis of CHOP is strongly stimulated by nutrient 
deprivation (Bruhat et al., 1997; Averous et al., 2004). The role of CHOP on amino acid 
deprivation-induced asparagine synthetase gene transcription was tested and the results show 
that CHOP efficiently blocked the upregulation of asparagine synthetase reporter gene 
transcription, induced by amino acid deprivation in HepG2 cells.  
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Fig. 57. CHOP functions as a shut-off-device of nutrient deprivation-induced gene transcription. 
The reporter plasmid pASluc (1 µg/plate) was transfected into HepG2 hepatoma cells together with 
the internal standard plasmid pRSVβ (2 µg/plate) and either the "empty" expression vector pCMV5 or 
an expression vector encoding CHOP (25 ng/plate). Cells were cultured in KRB medium for 16 hours. 
The control cells were transfected with an "empty" expression vector and cultured in DMEM medium. 
Cell extracts were prepared and the relative luciferase activities were determined. Data are mean ± SD. 
 
 
C.5.7.2. The expression of CHOP blocked the activation of asparagine synthetase 
promoter/luciferase reporter gene by either CREB2/ATF4 or ATF5 
 
The role of CHOP on CREB2/ATF4- or ATF5-induced upregulation of asparagine synthetase 
gene transcription was tested and the data show that the overexpression of CHOP abrogated 
the transactivation of the pASluc reporter gene mediated by CREB2/ATF4 or ATF5 (Fig. 58). 
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Fig. 58. CHOP inhibited the activation of the pASluc reporter gene by either CREB2/ATF4 or 
ATF5. 
The reporter plasmid pASluc (1 µg/plate) was transfected into HepG2 hepatoma cells together with 
the internal standard plasmid pRSVβ (2 µg/plate) and expression vectors encoding CREB2/ATF4 or 
ATF5 (25 ng/plate). In addition, cells were transfected with either an "empty" expression vector or an 
expression vector encoding CHOP (25 ng/plate). Cells were cultured in DMEM medium. Forty-eight 
hours post-transfection cell extracts were prepared and the relative luciferase activities were 
determined. Data are mean ± SD. 
 
 
The expression of CHOP has been linked to cell cycle arrest and programmed cell death 
(Wang et al., 1998). To clarify that the induction of cell death is not responsible for the 
impairment of asparagine synthetase gene transcription following CHOP overexpression, the 
glucose-6-phosphatase promoter/luciferase reporter genes were induced by C2/CREB in the 
presence or absence of CHOP. The results show that CHOP did not interfere with the ability 
of C2/CREB to transactivate the reporter genes pG6PCRE1luc and pG6PCRE2luc (Fig. 59). 
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Fig. 59. CHOP does not interfere with the ability of C2/CREB to transactivate the reporter 
genes pG6PCRE1luc and pG6PCRE2luc. 
One of the reporter plasmids pG6PCRE1luc or pG6PCRE2luc (1 µg/plate) was transfected into 
HepG2 cells, together with the standard plasmid pRSVβ (2 µg/plate), the empty expression vector 
pCMV5 or expression vectors encoding C2/CREB or CHOP (25 ng/plate). Cell extracts were prepared 
forty-eight hours later and the relative luciferase activities were determined. Data are means ± SD. 
 
 
C.6. Regulation of gene expression by C/EBPα 
 
C.6.1. Biological activity of C/EBPα and a constitutively active C/EBPα mutant 
C2/C/EBPα towards specific reporter genes 
 
The proteins of the C/EBP family of bZIP proteins bind specifically to the dyad symmetric 
sequence 5´-ATTGCGCAAT-3´ (Agre et al., 1989), a motif quite distinct from the canonical 
CRE sequence 5´-TGACGTCA-3´. However, C/EBP proteins have also been reported to bind 
to ATF/CRE motifs (Bakker and Parker, 1991). To study C/EBP-mediated gene transcription 
expression vectors encoding either C/EBPα or the constitutively active mutant C2/C/EBPα 
were used. 
 
 
C.6.2. Modular structure of C/EBPα and the constitutively active C/EBPα mutant 
C2/C/EBPα 
 
The bZIP transcription factor C/EBPα contains in its C-terminus a bZIP domain, responsible 
for DNA-binding and dimerization, while the N-terminus contains an activation domain. The 
constitutively active C/EBPα mutant, C2/C/EBPα, consists of the transcriptional activation 
domain of CREB2 and the bZIP domain of C/EBPα. 
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Fig. 60. Schematic representation of C/EBPα and C2/C/EBPα. 
Modular structure of the bZIP proteins C/EBPα and the constitutively active mutant C2/C/EBPα. 
 
 
C.6.3. C/EBPα and C2/C/EBPα strongly activate the C/EBP-specific reporter gene 
2xC/EBPluc 
 
The transcriptional activity of C/EBPα and C2/C/EBPα was compared by using the C/EBP-
specific reporter gene 2xC/EBPluc (Fig. 61A). The data show that both C/EBPα and 
C2/C/EBPα proteins strongly transactivate the reporter gene on the order of 800- and 1200-
fold, respectively (Fig. 61B). Transfection efficiency was monitored by co-transfecting 
pSV40lacZ due to an observed effect of C/EBPα and C2/C/EBPα upon Rous sarcoma virus 
long terminal repeat controlled β-galactosidase expression. 
 
Reporter plasmid: 2xC/EBPluc
luciferaseTK
CCTGATTGGGCAATCTGGATCCAGATTGCCCATGCC
2xC/EBP
A
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Fig. 61. C/EBP-specific reporter gene is strikingly induced by C/EBPα and C2/C/EBPα. 
(A) Schematic representation of the reporter plasmid 2xC/EBPluc. The transcription unit includes two 
C/EBP binding sites upstream of a minimal thymidine kinase promoter. (B) The reporter plasmid 
2xC/EBPluc (1 µg/plate) was transfected into HepG2 cells together with the internal reference plasmid 
pSV40lacZ (3 µg/plate) and either the "empty" expression vector pCMV5 or an expression vector 
encoding either C/EBPα or C2/C/EBPα (100 ng/plate). Forty-eight hours post-transfection cell 
extracts were prepared and the β-galactosidase and luciferase activities were determined. Data are 
mean ±SD. 
 
 
C.6.4. C/EBPα proteins only marginally influence GTP cyclohydrolase I promoter 
activity 
 
The influence of C/EBPα proteins on the GTP cyclohydrolase I promoter activity was tested. 
The results show that the GTP cyclohydrolase I promoter/luciferase reporter gene was only 
marginally transactivated by C/EBPα (1.8-fold). Overexpression of C2/C/EBPα increased 
GTP cyclohydrolase I reporter gene transcription on the order of 3.6-fold (Fig. 62). These 
results lead to the conclusion that the C/EBPα proteins play only a marginal role in the 
regulation of GTP cyclohydrolase I gene transcription. 
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Fig. 62. C/EBPα and C2/C/EBPα marginally transactivated the GTP cyclohydrolase I 
promoter/luciferase reporter gene. 
The reporter plasmid pGTPCHIluc (1 µg/plate) was transfected into HepG2 cells together with the 
internal reference plasmid pSV40lacZ (3 µg/plate) and either the "empty" expression vector pCMV5 
or an expression vector encoding either C/EBPα or C2/C/EBPα (100 ng/plate). Forty-eight hours post-
transfection cell extracts were prepared and the relative luciferase activities were determined. Data are 
mean ±SD. 
 
 
C.6.5. Expression of C/EBPα slightly induced the transcription of the secretogranin II 
reporter gene that contains four copies of the CRE sequence 
 
The effect of C/EBPα protein on a reporter gene that contains four copies of the CRE derived 
from the secretogranin II gene in noradrenergic locus coeruleus-like cell line CATH.a cells 
was tested. The results show that overexpression of C/EBPα slightly transactivated the 
secretogranin II reporter gene containing four copies of the CRE sequence (plasmid 
pSgIICRE4luc). The induction was on the order of 1.5-fold (Fig.63). 
 
 
 
 
 
 
 RESULTS  
 113 
0,25
0,5
0,75
1
C/EBPα-
re
la
tiv
e 
lu
ci
fe
ra
se
 
ac
tiv
ity
 
(R
L U
 
/ ß
-
ga
l  u
n
its
 
x
 
1 0
 
-
3 )
reporter: pSgIICRE4luc
 
 
Fig. 63. C/EBPα marginally transactivated the secretogranin II promoter/luciferase 
reporter gene. 
The reporter plasmid pSgIICRE4luc (1 µg/plate) was transfected into CATH.a cells together with the 
pRSVβ internal reference plasmid (2 µg/plate) and either the ‘empty’ expression vector pCMV5 or an 
expression vector encoding C/EBPα (25 and 100 ng/plate). Lysates were prepared forty-eight hours 
post-transfection and β-galactosidase and luciferase activities were measured. The mean ± SD is 
depicted. 
 
 
C.7. Test systems: activation of signaling cascades leading to the activation of target 
genes 
 
Two test systems were studied in which the expression of genes embedded in the chromatin 
was analyzed and the involvement of different bZIP transcription factors was also 
investigated. The first gene studied is the inducible nitric oxide synthase (iNOS) gene in BV-2 
murine microglial cells, while the second test system investigated the regulation of c-Jun and 
c-Fos in αT3M3 gonadotrope cells. 
 
 
C.7.1. Expression of inducible nitric oxide synthase (iNOS) in microglial cells 
 
iNOS generates nitric oxide from the amino acid arginine. Upon inflammatory conditions, 
iNOS is expressed by activated microglia (Perry et al., 1993; Kreutzberg, 1996; Merrill and 
Benveniste, 1996). Microglia are resident macrophages with wide distribution in nervous 
tissues (Barron, 1995). The regulation of iNOS expression by bZIP proteins in BV-2 
microglial cells was analyzed.  
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C.7.1.1. LPS stimulates the expression of iNOS in BV-2 microglial cells 
 
The lipopolysaccharide (LPS) is a component of the outer membrane of Gram negative 
bacteria. LPS has been shown to induce iNOS expression in BV-2 cells (Watters et al., 2002). 
To confirm these data the BV-2 cells were stimulated with different concentrations of LPS 
and then Western blot analysis was performed. The results show that LPS was able to induce 
iNOS expression in these cells in a dose dependent manner (Fig. 64). 
 
 
 
Fig. 64. LPS induces iNOS biosynthesis in BV-2 cells. 
The BV-2 cells were serum starved for twenty-four hours then incubated with LPS (0.1, 1, 10 µg/ml) 
for further twenty-four hours. Whole cell extracts were prepared and then analyzed by Western 
blotting using iNOS specific antibody. 
 
 
C.7.1.1.1. Activation of JNK is required for LPS-induced iNOS expression in BV-2 
microglial cells 
 
It has been shown that the MAPK signaling pathway is involved in LPS-mediated iNOS 
induction in primary glial cells (Da Silva et al., 1997; Bhat et al., 1998, 1999). To test whether 
JNK is required for LPS-induced iNOS expression in BV-2 microglial cells, a JNK peptide 
inhibitor termed L-JNK1 was used. This product is a potent inhibitor which is specific for 
JNK because it inhibits the interaction between JNK and its substrate, resulting in a JNK 
knockout phenotype (Bonny et al., 2001), in contrast to the chemical inhibitors that directly 
affect the kinase activity. The results show that L-JNK1 inhibited LPS-induced iNOS 
expression in BV-2 cells (Fig. 65). 
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Fig. 65. L-JNK1 inhibits LPS-induced iNOS expression in BV-2 cells. 
The BV-2 cells were serum starved for twenty-four hours. The cells were pretreated with the JNK 
inhibitor “L-JNK1” (1 µM) for 6 hours and then stimulated with LPS (0.1 µg/ml) for twenty-four 
hours. Whole cell extracts were prepared and then analyzed by Western blotting using iNOS specific 
antibody. 
 
 
C.7.1.1.2. Activation of p38 MAPK is also required for LPS-induced iNOS expression in 
BV-2 microglial cells 
 
A prominent role for p38-MAPK-mediated signaling in the transcriptional control of iNOS 
gene expression in primary glial cells (Bhat et al., 1998, 1999) and cultured rat glial cells 
(Bhat et al., 2002) has been suggested. To analyze the role of p38 MAPK upon LPS-induced 
iNOS expression in BV-2 cells, the p38 inhibitor SB203580 was used. The results show that 
SB203580 inhibited LPS-induced iNOS expression in a dose dependent manner (Fig. 66).  
 
 
 
Fig. 66. SB203580 inhibited LPS-induced iNOS expression in BV-2 cells. 
The BV-2 cells were serum starved for twenty-four hours. The cells were pretreated with the p38 
inhibitor SB203580 (10, 20 and 30 µM) for 30 min then stimulated with LPS (0.1 µg/ml) for twenty-
four hours. Whole cell extracts were prepared and then analyzed by Western blotting using an 
antibody against iNOS. 
 
 
The MKP-1 is known to inactivate the phosphorylated forms of JNK and p38 in the nucleus. 
To study the role of MKP-1 in LPS-induced iNOS expression, the BV-2 cells were infected 
with lentiviruses expressing MKP-1. Lentiviral gene transfer was performed, the cells were 
then induced and subjected to Western blot analysis. The results show that MKP-1 completely 
blocked the induction of iNOS expression upon LPS stimulation (Fig. 67). This leads to the 
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conclusion that activation of JNK and p38 MAPK signaling pathways is required for LPS-
induced iNOS gene expression in microglial cells. 
 
 
 
Fig. 67. MKP-1 overexpression impairs LPS-induced iNOS biosynthesis. 
Lentiviral gene transfer of MKP-1. Viruses were pseudotyped with the vesicular stomatitis virus and 
used to infect BV-2 cells. As a control mock-infected cells were analyzed. The cells were serum 
starved for twenty-four hours then incubated with LPS (0.1 µg/ml) for further twenty-four hours. 
Whole cell extracts were prepared and then analyzed by Western blotting using an antibody against 
iNOS. The infection was performed by G. Thiel. 
 
 
C.7.1.1.3. ATF2 is part of the signaling pathway involved in LPS-induced iNOS 
expression in microglial cells 
 
p38 and JNK are the kinases that phosphorylate and activate the transcription factor ATF2. To 
analyze whether ATF2 is involved in LPS-induced iNOS expression, BV-2 cells were 
infected with lentiviruses expressing the dominant-negative mutant of ATF2 termed A-ATF2. 
The results show that A-ATF2 impaired LPS-induced iNOS gene expression. As a negative 
control, the dominant-negative CREB mutant A-CREB was used and the results indicate that 
CREB do not play any role in LPS-stimulated iNOS gene expression (Fig. 68). 
 
 
 
Fig. 68. ATF2 is involved in LPS-induced iNOS expression. 
Lentiviral gene transfer of A-ATF2. Viruses were pseudotyped with the vesicular stomatitis virus and 
used to infect BV-2 cells. As a control mock-infected cells were analyzed. The cells were serum 
starved for twenty-four hours then incubated with LPS (0.1 µg/ml) for further twenty-four hours. 
Whole cell extracts were prepared and then analyzed by Western blotting using iNOS specific 
antibody. The infection was performed by G. Thiel. 
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Next, the expression of ATF2 upon LPS stimulation of BV-2 cells was tested. The cells were 
stimulated with LPS and then subjected to Western blot analysis using antibodies directed 
against both ATF2 and the phosphorylated and active form of ATF2. The results show that 
LPS strikingly induced the expression of the phosphorylated form of ATF2. In contrast, ATF2 
is constitutively expressed in BV-2 cells and no changes in its expression were observed after 
stimulation with LPS (Fig. 69A). To test the kinetics of LPS-induced ATF2 expression, BV-2 
cells were incubated with 0.1 µg/ml LPS for 1, 2, 4 and 6 hours. The induction of the 
phosphorylated form of ATF2 was observed after 2 hours and this induction lasts 6 hours 
following stimulation (Fig. 69B). 
 
 
 
 
Fig. 69. LPS induces the phosphorylation of ATF2 in BV-2 microglial cells. 
The BV-2 cell line was serum starved for twenty-four hours and then incubated with LPS (0.1, 1, 10 
µg/ml) for 3 h (A) or incubated with LPS (0.1 µg/ml) for 1, 2, 4 and 6 hours (B). Nuclear extracts were 
prepared and then analyzed by Western blotting using specific antibodies against ATF2 and Phospho-
ATF2. 
 
 
C.7.1.1.4. c-Jun is part of the signaling pathway involved in LPS-induced iNOS 
expression in a microglial cell line 
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To check whether LPS induces c-Jun expression in BV-2 microglial cells, the cells were 
stimulated with LPS and then subjected to Western blot analysis using antibodies directed 
against both c-Jun and the phosphorylated and active form of c-Jun. The results show that 
LPS induced the expression of the phosphorylated form of c-Jun. In contrast, c-Jun is 
constitutively expressed in BV-2 cells (Fig. 70A). To study the kinetics of LPS-induced c-Jun 
expression, BV-2 cells were incubated with 0.1 µg/ml LPS for 1, 2, 4 and 6 hours. The 
induction of the phosphorylated form of c-Jun was observed after 2 hours (Fig. 70B). 
 
 
 
 
Fig. 70. LPS induces phosphorylation of c-Jun in BV-2 microglial cells. 
The BV-2 cells were serum starved for twenty-four hours and then incubated with LPS (0.1, 1, 10 
µg/ml) for 3 h (A) or incubated with LPS (0.1 µg/ml) for 1, 2, 4 and 6 hours (B). Nuclear extracts were 
prepared and then analyzed by Western blotting using specific antibodies against c-Jun and Phospho-
c-Jun. 
 
 
C.7.1.2. The constitutively active CREB mutant C2/CREB stimulates iNOS expression in 
microglial cells 
 
It has been reported that cAMP-elevating agents such as forskolin and dibutyryl cAMP 
slightly increased nitrate production and the iNOS mRNA and protein contents and that these 
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agents markedly enhanced the cytokine-induced expression of iNOS in vascular smooth 
muscle cells (Koide et al., 1993). Additionally, it has been shown that the iNOS promoter 
contains several regulatory elements including NF-κB, C/EBP, AP-1 and CRE (Lowenstein et 
al., 1993; Xie et al., 1993; Keinanen et al., 1999; Taylor and Geller, 2000). To test whether 
CREB induces iNOS expression in microglial cells, the cells were infected with lentiviruses 
expressing the constitutively active mutant C2/CREB and then Western blot analysis was 
performed. The data show that C2/CREB is able to induce iNOS expression in BV-2 cells 
(Fig. 71). 
 
 
Fig. 71. C2/CREB induces iNOS expression in BV-2 cells. 
Lentiviral gene transfer of C2/CREB. Viruses were pseudotyped with the vesicular stomatitis virus 
and used to infect BV-2 cells. As a control mock-infected cells were analyzed. Whole cell extracts 
were prepared and then analyzed by Western blotting using an antibody against iNOS. The infection 
was performed by G. Thiel. 
 
 
C.7.2. Regulation of the immediate early genes c-Jun and c-Fos in gonadotrope cells 
 
 
C.7.2.1. Buserelin, a gonadotropin-releasing hormone analogue, induces c-Jun and c-Fos 
expression in αT3M3 cells 
 
The pituitary gonadotroph is the major site of action of gonadotropin-releasing hormone 
(GnRH). The activation of GnRH receptor in cultured pituitary cells and αT3-1 cell line has 
been shown to be associated with increased expression and levels of mRNA transcripts of c-
fos and c-jun (Cesnjaj et al., 1994). Therefore, the regulation of c-Jun and c-Fos by GnRH in 
the gonadortope cell line αT3M3 was studied. These cells express the GnRH receptor as well 
as the M3 muscarinic acetylcholine receptor. The αT3M3 cells were stimulated with the 
GnRH analogue buserelin and Western blot analysis was performed. The results show that 
buserelin transiently induced the expression of c-Jun, Phospho-c-Jun and c-Fos. The induction 
was observed after 2 hours of incubating the cells with buserelin (Fig. 72). 
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Fig. 72. Buserelin induces the levels of c-Jun, Phospho-c-Jun and c-Fos proteins in αT3M3 cells. 
αT3M3 cells were serum starved for twenty-four hours and then incubated with buserelin (10 nM) for 
different times (0, 2, 4, 6, 24 h) as indicated. Nuclear extracts were prepared and then analyzed by 
Western blotting using antibodies directed against c-Jun, Phospho-c-Jun or c-Fos.  
 
 
C.7.2.2. Carbachol induces c-Jun and c-Fos expression in αT3M3 cells 
 
It has been shown that the muscarinic acetylcholine receptor agonist carbachol induced c-Jun 
and c-Fos mRNA in a glial cell line (1321N1) (Trejo and Brown, 1991), therefore, the effect 
of carbachol on c-Jun and c-Fos expression in αT3M3 cells was tested. The results show that 
carbachol transiently induced the expression of c-Jun, Phospho-c-Jun and c-Fos. The 
induction was observed after 2 hours of incubating the cells with carbachol (Fig. 73). 
 
 
 
Fig. 73. Carbachol induces the levels of c-Jun, Phospho-c-Jun and c-Fos proteins in αT3M3 cells. 
αT3M3 cells were serum starved for twenty-four hours and then incubated with carbachol (1 mM) for 
different times (0, 2, 4, 6, 24 h) as indicated. Nuclear extracts were prepared and then analyzed by 
Western blotting using antibodies directed against c-Jun, Phospho-c-Jun or c-Fos.  
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C.7.2.3. Chelation of intracellular calcium reduced buserelin-stimulated both c-Jun and 
c-Fos expression 
 
It has been reported that GnRH receptor occupancy is linked with an increase in intracellular 
calcium through mobilization of two distinct pools in both αT3-1 cells and rat pituitary 
gonadotrope (Horn et al., 1991; Stojilkovic et al., 1994; McArdle et al., 1996). To investigate 
the requirement of intracellular calcium mobilization in buserelin-stimulated c-Jun and c-Fos 
expression, the cell-permeable calcium chelator BAPTA-AM was used. Different 
concentrations of BAPTA-AM were used to eliminate intracellular calcium and the results 
show that BAPTA-AM inhibited buserelin-induced c-Jun, Phospho-c-Jun and c-Fos 
expression in a dose dependent manner. The expression of c-Jun and Phospho-c-Jun was 
inhibited by 15 µM of BAPTA-AM, while 25 µM of BAPTA-AM were needed to inhibit c-
Fos expression (Fig. 74). 
 
 
 
Fig. 74. BAPTA-AM inhibits buserelin-induced c-Jun, Phospho-c-Jun and c-Fos expression in 
αT3M3 cells. 
αT3M3 cells were serum starved for twenty-four hours then pretreated for forty-five min with 
different concentrations of BAPTA-AM as indicated and then incubated with buserelin (10 nM) for 2 
h. Nuclear extracts were prepared and then analyzed by Western blotting using c-Jun, Phospho-c-Jun 
or c-Fos specific anitbodies.  
 
 
C.7.2.4. Calcium/calmodulin kinases mediate buserelin-induced c-Jun and c-Fos 
expression in αT3M3 cells 
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Because the intracellular effects of calcium are mediated by calcium/calmodulin-dependent 
protein kinases, the involvement of these kinases in the regulation of c-Jun and c-Fos 
expression in response to buserelin stimulation was tested. This was accomplished by using 
the Ca2+/calmodulin-dependent protein kinases inhibitor KN-62. The results show that 
pretreatment of the αT3M3 cells with KN-62 impaired buserelin-induced c-Jun, Phospho-c-
Jun and c-Fos expression (Fig. 75).  
 
 
 
Fig. 75. KN-62 inhibits buserelin-induced c-Jun, Phospho-c-Jun and c-Fos expression in αT3M3 
cells. 
αT3M3 cells were serum starved for twenty-four hours then pretreated for forty-five min with KN-62 
(10 µM) and then incubated with buserelin (10 nM) for 2 h. Nuclear extracts were prepared and then 
analyzed by Western blotting using c-Jun, Phospho-c-Jun or c-Fos specific antibodies.  
 
 
C.7.2.5. Calcium/calmodulin kinases marginally influence carbachol-induced c-Jun and 
c-Fos expression in αT3M3 cells 
 
The involvement of calcium/calmodulin-dependent protein kinases in the regulation of c-Jun 
and c-Fos expression in response to carbachol stimulation was also tested by using 
Ca2+/calmodulin-dependent protein kinases inhibitor KN-62. The results show that 
pretreatment of the αT3M3 cells with KN-62 only marginally reduced carbachol-induced c-
Jun, Phospho-c-Jun and c-Fos expression (Fig. 76).  
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Fig. 76. KN-62 only marginally impaired carbachol-induced c-Jun, Phospho-c-Jun and c-Fos 
expression in αT3M3 cells. 
αT3M3 cells were serum starved for twenty-four hours then pretreated for forty-five min with KN-62 
(10 µM) and then incubated with carbachol (1 mM) for 3 h. Nuclear extracts were prepared and then 
analyzed by Western blotting using c-Jun, Phospho-c-Jun or c-Fos specific antibodies.  
 
 
C.7.2.6. Buserelin- and carbachol-induced c-Jun and c-Fos expression require the 
activation of ERK 
 
It has been shown that GnRHa, a GnRH agonist, activates ERK in pituitary organ culture 
(Mitchell et al., 1994) and the αT3-1 gonadotrope cell line (Sundaresan et al., 1996; Reiss et 
al., 1997). To evaluate whether buserelin and carbachol stimulate c-Jun and c-Fos expression 
via activation of ERK, αT3M3 cells were preincubated for 6 h with the MAPKK inhibitor 
PD98059. This compound inhibits the phosphorylation of the MAPKK, thus blocking the 
activation of ERK (Dudley et al., 1995). The results show that PD98059 blocked buserelin- 
and carbachol-induced c-Jun, Phospho-c-Jun and c-Fos expression in αT3M3 cells (Fig. 77A, 
B). 
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Fig. 77. PD98059 impairs buserelin- and carbachol-induced c-Jun, Phospho-c-Jun and c-Fos 
expression in αT3M3 cells. 
αT3M3 cells were serum starved for twenty-four hours then pretreated for 6 h with PD98059 (50 µM) 
and then incubated with either buserelin (10 nM) for 2 h (A) or carbachol (1 mM) for 3 h (B). Nuclear 
extracts were prepared and then analyzed by Western blotting using c-Jun, Phospho-c-Jun or c-Fos 
specific antibodies. 
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D. Discussion 
 
 
D.1. CREB-mediated gene transcription 
 
Transcription of a number of cellular genes is activated by the second messenger cAMP that 
acts through specific protein kinases. Induction of cellular genes by cAMP requires first, the 
presence of a consensus cAMP response element (CRE) (Comb et al., 1986; Montminy et al., 
1986; Delegeane et al., 1987; Hurst and Jones, 1987; Hardy and Shenk, 1988; Lin and Green, 
1988; Sassone-Corsi, 1988; Sassone-Corsi et al., 1988b) and second, the catalytic subunit of 
PKA (Montminy and Bilezikjian, 1987; Riabowol et al., 1988; Mellon et al., 1989). PKA 
phosphorylates the bZIP transcription factor CREB that binds to CRE motifs and activates the 
transcription of these genes (Yamamoto et al., 1988; Jones and Jones, 1989). In this study 
several genes that are proposed to be regulated by CREB and/or other bZIP transcription 
factors were investigated, including GTP cyclohydrolase I (GTPCHI) gene, glucose-6-
phosphatase (G6P) gene, TNFα gene, asparagine synthetase (AS) gene, secretogranin II (Sg 
II) gene, Egr-1 gene, c-Fos gene and tyrosine hydroxylase (TH) gene. As shown in Fig. 81, 
some of these genes have a canonical CRE within their regulatory regions, while others have 
a consensus sequence that resembles the CRE. The asparagine synthetase gene contains 
NSRE site, which has some similarity with the CRE.  
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T G A C G T C A CRE consensus
T G A C G T C A SgII CRE (-67/-60)
TH CRE (-44/-37)T G A C G T C A
GTPCHI CRE (-88/-81)
G6P CRE1 (-161/152)
T T G C A T C A G6P CRE2 (-136/-129)
TNFα CRE (-106/-99)T G A G C T C A
Egr-1 CRE (-138/-131)T C A C G T C A
c-Fos CRE (-67/-60)T G A C G T T T
AS NSRE (-68/-60)T G A T G A A A 
T G A C G C G A
T T A C G T A A
 
 
Fig. 81. Sequence comparison of the CRE-like sequences in mammalian promoters. 
Comparison of CRE-like sequences within different mammalian promoters. Different promoters are 
shown, SgII (accession # AF037451), TH (accession # X53503), GTPCHI (accession # BC025415), 
G6P (accession # BC020700), TNFα (accession # X02910), Egr-1 (accession # AJ245926), c-Fos 
(accession # X06769) and AS (accession # BC014621). The mismatches between the consensus CRE 
and the CRE-like sequences of the other promoters are shown in bold.  
 
 
GTP cyclohydrolase I is the rate-limiting enzyme in the biosynthesis of tetrahydrobiopterin, 
which is an essential cofactor for the aromatic amino acid hydroxylases; phenylalanine, 
tyrosine and tryptophan hydroxylases (Whitworth, 1994) and also for nitric oxide synthases 
(Gross et al., 2000). The expression of GTP cyclohydrolase I is regulated at the transcriptional 
level by extracellular signaling molecules, including the proinflammatory cytokines 
interferon-γ (IFN-γ), interleukin 1β (IL-1β) and tumor necrosis factor α (TNFα) (D’Sa et al., 
1996; Plüss et al., 1996, 1997; Frank et al., 1998; Geller et al., 2000; Vann et al., 2000; 
Golderer et al., 2001). The transcription of the GTP cyclohydrolase I is stimulated by agents 
that elevate the intracellular levels of cAMP (Plüss et al., 1996, 1997; Hirayama et al., 2001), 
suggesting that CREB may be responsible for transactivation of the GTP cyclohydrolase I 
gene. Moreover, A CRE-like genetic element has been identified within the GTP 
cyclohydrolase I promoter (Kapatos et al., 2000). The bZIP transcription factors CREB, ATF2 
and CREB2/ATF4 have been proposed to connect elevated intracellular cAMP concentrations 
with enhanced GTP cyclohydrolase I gene transcription (Kapatos et al., 2000; Hirayama et al., 
2001). The transcriptional activation of a GTP cyclohydrolase I promoter/luciferase reporter 
gene was measured instead of in vitro transcription factor/DNA binding, because although 
DNA-binding is required for a subsequent transcriptional activation, enhanced binding 
activity of a transcription factor to DNA, monitored by an in vitro binding assay, does not 
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necessarily prove enhanced transcriptional activation potential of this protein. Overexpression 
of C2/CREB in HepG2 human hepatoma cells strongly activated the transcription of a GTP 
cyclohydrolase I promoter/reporter gene, containing an intact CRE-like motif. Furthermore, 
mutations within the CRE-like sequence significantly impaired transcriptional activation by 
C2/CREB. Although the CRE-like sequence is mutated, transcription of the GTP 
cyclohydrolase I reporter gene was still slightly induced. The slightly induced transcription 
might be due to the presence of a conserved family of coactivators of CREB termed TORCs 
(Transducers of Regulated CREB activity). These coactivators enhance CRE-dependent 
transcription via a phosphorylation-independent interaction with the bZIP DNA 
binding/dimerization domain of CREB (Conkright et al., 2003). Additionally, nanomolar 
concentrations of the expression vector encoding the modified catalytic subunit of PKA 
(NLSCα) strongly enhanced transcription of the GTP cyclohydrolase I promoter/luciferase 
reporter gene. Only 100 ng expression plasmid/plate were used, while usually 1-5 µg 
expression plasmid/plate were needed to affect gene transcription (Grewal et al., 2000; 
Streeper et al., 2000, 2001). Taken together, these data show that the GTP cyclohydrolase I 
gene is regulated by CREB and that the CRE-like motif within the regulatory region of the 
human GTP cyclohydrolase I gene functions as a bona fide CRE.  
The TNFα gene promoter is known to contain a CRE-like site within its regulatory region and 
it has been suggested this CRE-like element is implicated in the regulation of TNFα gene 
expression (Leitman et al., 1999). Overexpression of the constitutively active mutant 
C2/CREB transactivated the TNFα reporter gene in HepG2 cells. Additionally, 
overexpression of the modified catalytic subunit of PKA (NLSCα) enhanced transcription of 
a TNFα reporter gene that contains two copies of the CRE/AP1 site as regulatory sequence, 
indicating that the TNFα gene is regulated by CREB in HepG2 cells. 
The Egr-1 gene, encoding a zinc finger transcription factor, also contains a CRE-like site 
within its regulatory region (Tsai-Morris et al., 1988). CREB binding to the CRE is involved 
in the regulation of Egr-1 gene expression in response to certain stimuli (Lee et al., 1995; 
Rolli et al., 1999; Bernal-Mizrachi et al., 2000). Overexpression of C2/CREB transactivated 
the Egr-1 reporter gene in HepG2 cells. 
Glucose-6-phosphatase catalyzes the final step of the metabolic pathways that are central to 
hepatic glucose production, i.e. gluconeogenesis and glycogen breakdown (Van Schaftingen 
and Gerin, 2002). Hepatic glucose-6-phosphatase gene expression is regulated by a variety of 
extracellular signaling molecules, including glucose, insulin, glucocorticoids and cAMP. 
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Conflicting results were published concerning the stimulation of glucose-6-phosphatase 
promoter activity by elevated intracellular levels of cAMP. It has been reported that the cell 
permeable analogue of cAMP, dibutyryl cAMP, did not significantly stimulate transcription 
of a glucose-6-phosphatase promoter/luciferase reporter gene in H4IIIE hepatoma cells 
(Schmoll et al., 1996), while a later report by the same group showed that dibutyryl cAMP 
stimulated glucose-6-phosphatase promoter activity on the order of 2-fold (Schmoll et al., 
1999). It had been suggested that two distinct genetic elements are important for cAMP-
induced glucose-6-phosphatase gene expression (Lin et al., 1997; Schmoll et al., 1999). The 
mutant C2/CREB transactivated the glucose-6-phosphatase reporter genes containing either 
CRE1 or CRE2 or both CREs and this activation is shown to be mediated via the two reported 
genetic elements: the sequence from –161 to –152 termed “CRE1” (Schmoll et al., 1999) and 
the sequence from –136 to –129 termed “CRE2”(Lin et al., 1997) of the human glucose-6-
phosphatase gene promoter. These two genetic elements function as bona fide CREs. Streeper 
and his group demonstrated that PKA stimulated reporter gene transcription under control of 
CRE1, while CRE2 region contains an accessory factor binding site that likely enhances the 
effect of cAMP mediated through CRE1. Thus, it was suggested that in the glucose-6-
phosphatse gene promoter only CRE1, but not CRE2 functions as a bona fide CRE. The 
authors used 5 µg of expression vector encoding the catalytic subunit of PKA. In the study 
reported here, a modified catalytic subunit of PKA was used. Transfection of nanomolar 
amounts of the expression vector encoding the modified catalytic subunit of PKA (NLSCα) 
strongly activated the transcription of reporter genes containing either CRE1 or CRE2 or both 
CREs. In contrast, transfection of nanomolar concentrations of an expression plasmid 
encoding the wild-type of the catalytic subunit of PKA did not show any effect on reporter 
gene transcription. These experiments involving overexpression of NLSCα confirm the 
previous finding that both CRE1 and CRE2 function as bona fide CREs. Activation of 
glucose-6-phosphatase promoter/luciferase reporter gene transcription following coexpression 
of NLSCα together with CREBS133A, a CREB mutant lacking the major PKA 
phosphorylation site, was also observed. Phosphorylation of the serine 133 residue of CREB 
is the predominant mechanism to enhance the transcriptional activation potential of CREB via 
recruitment of the coactivator CREB binding protein (CBP) and its paralogue p300 to the 
promoter. Accordingly, in coexpression studies of NLSCα together with CREBS133A instead 
of wild-type CREB a clear reduction of reporter gene transcription was observed. However, 
expression of CREBS133A is still contributed to reporter gene transcription in the presence of 
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NLSCα, suggesting that either other residues of CREBS133A or other promoter bound 
proteins involved in the regulation of CREB-mediated transcription are phosphorylated. 
Furthermore, PKA can directly phosphorylate CBP or other components of the transcriptional 
machinery downstream from CREB (Xu et al., 1998; Zanger et al., 1999). Nevertheless, here 
the experiments confirmed that both CRE-like sequences within the glucose-6-phosphatase 
gene function as genetic elements to mediate transactivation via CREB. 
 
 
D.2. Role of ATF2 in regulating the transcription of CRE-containing reporter genes 
 
ATF2 has been described to function as CRE-binding protein, connecting cellular stimulation 
with transcription of CRE-containing genes (Maekawa et al., 1989). ATF2 has been proposed 
to be involved in cAMP-enhanced GTP cyclohydrolase I gene transcription in human 
neuroblastoma cells (Hirayama et al., 2001). In HepG2 cells, overexpression of C2/ATF2 
induced GTP cyclohydrolase I reporter gene transcription. Additionally, mutations within the 
CRE-like sequence of the GTP cyclohydrolase I gene significantly impaired transcriptional 
activation by C2/ATF2. These data indicate that the GTP cyclohydrolase I gene is a bona fide 
target of ATF2 and that the CRE-like site within the GTP cyclohydrolase I promoter is 
functional. Competition experiments between C2/CREB and dominant-negative bZIP mutants 
or C2/ATF2 and dominant-negative bZIP mutants revealed that CREB and ATF2 do not 
heterodimerize but they rather compete for binding to the CRE-like motif of the GTP 
cyclohydrolase I promoter. ATF2 contains at its N-terminus an activation domain. The 
transactivation capacity of the N-terminal domain of ATF2 can be enhanced through 
phosphorylation by the MAPK members p38 and JNK/SAPK (Davis, 2000; Chang and Karin, 
2001; Kyriakis and Avruch, 2001). Overexpression of a constitutively active mutant of the 
MAPKK [MKK6(E)], together with the expression of the p38 MAPK, stimulated 
transcription of a GTP cyclohydrolase I promoter/luciferase reporter gene. It has been 
reported that p38 MAPK is constitutively active in the liver (Mendelson et al., 1996). 
However, here it is shown that the constitutively active protein kinase MKK6 was inactive 
towards the GTP cyclohydrolase I reporter gene, unless the concentration of the p38 protein 
kinase was experimentally elevated, suggesting that HepG2 hepatoma cells do not contain a 
constitutive p38 MAPK activity. Employment of dominant-negative bZIP mutants confirmed 
that ATF2 and c-Jun heterodimerize and that CREB, CREB2/ATF4 and C/EBP do not 
heterodimerize with ATF2. 
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The TNFα gene has been described to be activated by ATF2 (Tsai et al., 1996). 
Overexpression of C2/ATF2 in HepG2 cells induced the transcription of a TNFα reporter 
gene containing only the CRE/AP1 motif of the TNFα gene regulatory region. It has been 
suggested that in embryonic stem cells-derived cardiac myocytes the p38 MAPK positively 
regulates TNFα biosynthesis, while JNK represses TNFα gene expression (Minamino et al., 
1999). In contrast, the JNK pathway has been shown to be responsible for TNFα production 
in mast cells (Ishizuka et al., 1997). Overexpression of a constitutively active mutant of the 
MAPKK [MKK6(E)], together with the expression of the p38 MAPK, stimulated TNFα 
promoter/luciferase reporter gene transcription. Additionally, a reporter gene was also 
activated that contains only the CRE/AP1 motif of the TNFα gene as regulatory sequence. 
Taken together, the activation of p38 MAPK and subsequently the activation of the 
transcription factor ATF2 are involved in the regulation of TNFα gene transcription in HepG2 
cells. 
Egr-1 gene transcription has been reported to be regulated by ATF2, using a cAMP response 
element within the proximal Egr-1 promoter, coupling a phosphorylated ATF2 with enhanced 
Egr-1 biosynthesis (Rolli et al., 1999). Overexpression of C2/ATF2 only weakly stimulated 
the Egr-1 promoter/luciferase reporter gene in HepG2 cells. 
The genes encoding the granin proteins contain CRE motifs in their 5`-upstream regions. 
Conflicting results were published concerning cAMP-mediated transcriptional regulation of 
the secretogranin II gene. While the adenylyl cyclase activator forskolin increased 
secretogranin mRNA levels in chromaffin cells (Fischer-Colbrie et al., 1990), it caused a 
decrease in PC12 pheochromocytoma cells (Thompson et al., 1992, 1994). In CATH.a 
catecholaminergic cells, overexpression of C2/ATF2 transactivated the secretogranin II 
promoter/luciferase reporter genes that contain either one or four copies of CRE motif, 
suggesting that the secretogranin II gene is a target gene for ATF2. Competition experiments 
using dominant-negative bZIP mutants confirms the previous observation that CREB and 
ATF2 compete for the same DNA-binding site, the CRE, but they do not heterodimerize with 
each other. 
The tyrosine hydroxylase promoter is known to contain a CRE motif within its regulatory 
region (Lazaroff et al., 1995; Tinti et al., 1997). It has been shown that in PC12 cells the 
transcription of the tyrosine hydroxylase is enhanced by activation of ATF2, which directly 
acts on the CRE in the tyrosine hydroxylase promoter (Suzuki et al., 2002). On the contrary, 
in CATH.a catecholaminerigc cells overexpression of the mutant C2/ATF2 did not affect the 
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tyrosine hydroxylase reporter gene. These data are compatible with in vitro DNA-protein 
binding and antibody supershift experiments showing that antibodies directed against ATF2 
were unable to change the pattern of DNA-protein complexes bound to the CRE of the 
tyrosine hydroxylase gene (Lim et al., 2000). Additionally, the c-Fos gene promoter contains 
a CRE motif within its regulatory region (Berkowitz et al., 1989). Moreover, CREB and its 
closely related family members are shown to be general mediators of stimulus-dependent 
transcription of c-Fos gene (Ahn et al., 1998). Overexpression of the mutant C2/ATF2 only 
marginally activated a c-Fos promoter/luciferase reporter gene. Taken together, the data 
obtained by using C2/ATF2 lead to the conclusion that C2/ATF2 seems to select between 
different CRE elements. 
 
 
D.3. c-Jun transactivates CRE-containing reporter genes 
 
The bZIP transcription factors c-Jun and ATF2 are known to form heterodimers and bind to 
the consensus CRE within specific genes. Overexpression of C2/c-Jun transactivated GTP 
cyclohydrolase I promoter/luciferase reporter gene in HepG2 cells. Additionally, point 
mutations within the CRE-like sequence of the GTP cyclohydrolase I gene significantly 
impaired transcriptional activation mediated by C2/c-Jun. Taken together, these data suggest 
that the GTP cyclohydrolase I gene is a target gene for c-Jun and that the CRE-like motif 
present within the GTP cyclohydrolase I promoter is functional. Additionally, Overexpression 
of the mutant C2/c-Jun transactivated Egr-1 reporter gene. Competition experiments using 
dominant-negative bZIP mutants show that CREB and c-Jun do not heterodimerize but they 
compete for binding to the CRE element. The transcription factors c-Jun and ATF2 are 
activated by phosphorylating kinases such as JNK, which in turn, is controlled by MEKK1. 
Expression of a truncated form of MEKK1 (MEKK1∆) was shown to induce the GTP 
cyclohydrolase I promoter activity. Dominant-negative mutants of c-Jun and ATF2 inhibited 
MEKK1∆-induced reporter gene transcription, indicating that either c-Jun or ATF2 or 
heterodimers of these bZIP proteins are responsible for the transcriptional effect of MEKK1∆ 
expression. 
It has been shown that a heterodimer consisting of c-Jun and ATF2 is essential to mediate 
stimulus-transcription coupling of the TNFα gene (Falvo et al., 2000). Moreover, the ATF2/c-
Jun heterodimer binds to the CRE-element within the TNFα gene (Tsai et al., 1996). 
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Overexpression of C2/c-Jun transactivated the TNFα reporter gene that contains only the 
CRE/AP1 motif of the TNFα gene as regulatory sequence. Furthermore, overexpression of a 
truncated form of MEKK1 (MEKK1∆) induced the TNFα promoter/luciferase reporter gene 
transcription in HepG2 cells. Additionally, a reporter gene that contains only the CRE/AP1 
motif of the TNFα gene as regulatory sequence was also activated. Taken together, the 
activation of JNK and subsequently the activation of the transcription factors c-Jun and ATF2 
are involved in the regulation of TNFα gene transcription in HepG2 cells.  
 
 
D.4. CREB2/ATF4 regulates transcription of specific-reporter genes 
 
The transcription factor CREB2 was originally described as a repressor of CREB and CRE-
mediated transcription (Karpinski et al., 1992), however, no transcriptional repression domain 
could be found in the CREB2 molecule (Schoch et al., 2001). Rather, there are today good 
evidences that CREB2 functions as a transcriptional activator (Liang and Hai, 1997; He et al., 
2001; Schoch et al., 2001; Luo et al., 2003; Thiel et al., 2005a). It has been shown by 
DNA/protein binding experiments that CREB2/ATF4 is recruited by the GTP cyclohydrolase 
CRE-like motif (Kapatos et al., 2000). Furthermore, overexpression of CREB2/ATF4 in PC12 
cells transactivates the GTP cyclohydrolase promoter in the presence of the cAMP analogue 
8-Br-cAMP (Kapatos et al., 2000). In HepG2 cells, expression of CREB2/ATF4 was not able 
to transactivate the GTP cyclohydrolase I reporter gene. Additionally, CREB2/ATF4 did not 
transactivate the TNFα or the Egr-1 promoters, which both contain a CRE-like sequence 
within their regulatory region. These three reporter genes are transactivated by the mutant 
C2/CREB. To explain these observations it is important to mention that CREB2/ATF4 and 
C2/CREB contain an identical transcriptional activation domain and differ only in their bZIP 
DNA-binding and dimerization domains. Thus, the differences between CREB2/ATF4 and 
C2/CREB in transactivating reporter genes containing CRE-like motifs can be attributed to 
their different DNA-binding abilities. In contrast, nanomolar concentrations of the expression 
vector encoding CREB2/ATF4 strongly induced transcription of asparagine synthetase 
promoter/luciferase reporter gene via the nutrient-sensing response unit, which has some 
similarities to the CRE sequence. Taken together, these data indicate that CREB2/ATF4 has 
different transactivation potential towards reporter genes containing CRE-like motifs. 
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D.5. CREB2/ATF4, ATF5 and CHOP but not CREB regulate asparagine synthetase 
gene transcription 
 
Asparagine synthetase is expressed in most mammalian cells as a housekeeping enzyme 
responsible for the biosynthesis of asparagine from aspartate and glutamine (Andrulis et al., 
1987). It has been shown that cells lacking sufficient asparagine synthetase activity, 
asparagine deprivation results in cell cycle arrest (Patterson and Maxwell, 1970; Greco et al., 
1989) and induction of apoptosis (Story et al., 1993; Bussolati et al., 1995). The expression of 
asparagine synthetase activity has been shown to be enhanced by amino acid deprivation 
(Arfin et al., 1977), and this regulation is transcriptional in nature (Guerrini et al., 1993; 
Hutson et al., 1997). The asparagine synthetase promoter contains a nutrient-sensing response 
element that have some similarity with the CRE sequence, this element has been proposed to 
be responsible for the activation of asparagine synthetase gene transcription by amino acids 
deprivation (Barbosa-Tessmann et al., 2000; Kilberg and Barbosa-Tessmann, 2002). 
Additionally, the bZIP proteins C/EBPβ and ATF4 have been proposed to play a role in the 
transcriptional activation of the asparagine synthetase in response to nutrient deprivation (Siu 
et al., 2001, 2002). Depriving HepG2 cells of amino acids strongly induced asparagine 
synthetase biosynthesis. Furthermore, experiments involving the dominant-negative bZIP 
mutants showed that ATF4 and C/EBPα are the major regulators of amino acid deprivation-
induced asparagine synthetase gene transcription, while CREB and c-Jun do not play any role 
in this process. It has been shown that ATF2 phosphorylation is necessary to induce CHOP 
expression by amino acid starvation (Averous et al., 2004). Dominant-negative mutant of 
ATF2 did not significantly affect the asparagine synthetase gene transcription induced by 
amino acid deprivation, suggesting that ATF2 does not play a prominent role in connecting 
amino acid deprivation with enhanced asparagine synthetase gene transcription. The bZIP 
transcription factor ATF5, which is closely related to CREB2/ATF4, is shown in this study to 
contain a constitutively active transcriptional activation domain. Overexpression of ATF5 
induced asparagine synthetase gene transcription, suggesting that ATF5 is a positive regulator 
of amino acid deprivation-induced asparagine synthetase gene transcription. The C/EBP 
homologous protein (CHOP) has been demonstrated to act as a negative regulator of C/EBP 
proteins (Ron and Habener, 1992). Furthermore, CHOP is shown to downregulate 
CREB2/ATF4-dependent transcription (Gachon et al., 2001). In the study reported here 
CHOP blocked the upregulation of asparagine synthetase reporter gene transcription induced 
by either amino acid deprivation or overexpression of CREB2/ATF4 or ATF5, suggesting that 
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CHOP functions as a shut-off-device for amino acid deprivation-induced asparagine 
synthetase gene transcription. In contrast, CHOP failed to block the transcriptional activation 
of CRE-containing reporter genes induced by C2/CREB. Although additional details 
regarding interactions of different proteins and the definition of precise cascade of molecular 
events by which amino acids regulate gene expression remain to be established, the results 
shown here underscore the contribution of bZIP transcription family members to nutrient 
regulation of gene expression in mammalian cells. 
 
 
D.6. Role of C/EBPα in the regulation of specific reporter genes 
 
The C/EBPα molecule contains a Val296 residue, which is of main importance to restrict the 
interactions to C/EBP sites. C/EBPα is known to strongly bind to CRE sequences when Val296 
is mutated to alanine (Miller et al., 2003). Competition experiments using the dominant-
negative bZIP mutants revealed that CREB and C/EBPα recognize different genetic elements. 
The dominant-negative C/EBP mutant A-C/EBP did not block C2/CREB-induced 
transcription of the GTP cyclohydrolase I reporter gene. Rather, an activation of reporter gene 
transcription was observed, suggesting that A-C/EBP removes inhibitory constraints on CRE-
regulated transcription units. These data are complemented by in vitro DNA/protein binding 
experiments showing that A-C/EBP did not compete with CREB bound to its cognate site 
(Greenwel et al., 2000; Menard et al., 2002). Furthermore, expression of C/EBPα and the 
constitutively active mutant C2/C/EBPα in HepG2 cells strongly induced C/EBP-responsive 
reporter gene, while the GTP cyclohydrolase I reporter gene was only slightly induced.  
Additionally, overexpression of C/EBPα in CATH.a catecholaminergic cells only weakly 
induced the secretogranin II reporter gene transcription. The marginal stimulation in the 
transcription of both GTP cyclohydrolase I and secretogranin II reporter genes by C/EBPα 
argues against a functional role of C/EBPα protein in the control of CRE-containing genes. 
 
As a conclusion the bZIP proteins CREB and ATF2 compete for binding to CRE sequences 
and do not heterodimerize. CREB2/ATF4, ATF5 and C/EBP bind to the NSRE sequence and 
do not heterodimerize with CREB or ATF2. 
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D.7. Expression of genes embedded in the chromatin in two different cell lines 
 
In the first part of the thesis the transcriptional activation of specific reporter genes by bZIP 
proteins was investigated by performing transient transfection experiments. In the second part 
of the thesis the expression of endogenous genes was analysed: first, by studying the 
regulation of iNOS gene by bZIP proteins and second, by investigating the biosynthesis of the 
bZIP proteins c-Jun and c-Fos in response to extracellular stimuli. 
 
 
D.7.1. Regulation of iNOS gene expression in BV-2 microglial cells 
 
Inducible nitric oxide synthase (iNOS) was first identified in macrophages stimulated with 
IFN-γ and bacterial LPS (Lowenstein et al., 1992). It has been found that glial cells in the 
CNS produce NO in response to the induction of iNOS by bacterial LPS and a series of 
cytokines including IL-1β, TNFα and IFN-γ (Murphy et al., 1993; Feinstein, et al., 1994; 
Brosnan et al., 1997). Astrocytes in the healthy brain do not express iNOS, however, after 
ischemic, traumatic, neurotoxic or inflammatory damage the reactive astrocytes express iNOS 
in the mouse, rat and human (Galea at al., 1992; Hu et al., 1995; Pahan et al., 1997a, b, 1998). 
LPS is the ligand for Toll-like receptor 4 (TLR4), which is shown to be expressed in BV-2 
microglial cells (Jung et al., 2005) and it has been reported that LPS induces iNOS expression 
in BV-2 cells (Watters et al., 2002). Moreover, microarray analysis shows that in LPS-
stimulated BV-2 cells iNOS gene was upregulated on the order of 105.9 fold (Thomas et al., 
2005). It has been reported that multiple signaling pathways are activated in macrophages 
upon LPS exposure (Denlinger et al., 1996). NF-κB has been shown to be a critical regulator 
of iNOS transcription by LPS (Xie et al., 1994). Furthermore, the MAPK cascades have been 
shown to signal the induction of iNOS in glial cells (Bhat et al., 1998, 1999). Depending on 
the cell type and the stimulation used, p38 MAPK have been shown to have either an 
upregulatory role (Chen et al., 1999; Chen and Wang, 1999; Bhat et al., 2002), down-
regulatory role (Guan et al., 1997; Chan and Riches, 2001; Chan et al., 2001) or no role (Chan 
et al., 1999; Cho et al., 2002) in iNOS expression. Here the p38 MAPK specific inhibitor 
SB203580 is shown to inhibit LPS-induced iNOS expression in microglia. Furthermore, 
infection of the microglial cells with lentiviruses expressing the MKP-1, which is known to 
dephosphorylate p38 MAPK, also inhibited iNOS expression in response to LPS. Previous 
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studies have shown that JNK pathway contributes to the upregulation of iNOS expression 
(Guan et al., 1999; Hua et al., 2002; Lahti et al., 2003). A JNK specific inhibitor L-JNK1 
inhibited LPS-induced iNOS expression in microglial cells. The activity of L-JNK1 have to 
be verified to confirm that JNK plays a role in LPS-induced iNOS expression, maybe by 
expressing the collagenase promoter, which is a target gene for c-Jun, and then inducing the 
cells with LPS and using L-JNK1 as an inhibitor. Furthermore, a dominant-inhibitory mutant 
of MKP-1, which is known to dephosphorylate JNK, also inhibited iNOS expression in 
response to LPS. The bZIP transcription factor ATF2 is phosphorylated and subsequently 
activated by both JNK and p38 MAPKs, while c-Jun is phosphorylated only via the JNK 
pathway, indicating that ATF2 and c-Jun could be involved in the signaling pathways leading 
to the activation of iNOS expression in response to LPS stimulation. Dominant-inhibitory 
mutant of ATF2 (A-ATF2) inhibited LPS-induced iNOS expression in microglia. Moreover, 
experiments employing antibodies directed against the phosphorylated forms of ATF2 or c-
Jun show that the phosphorylated and active forms of ATF2 and c-Jun are induced in 
response to LPS stimulation, indicating that ATF2 and c-Jun are involved in the induction of 
iNOS in response to LPS stimulation. A schematic representation of the proposed signaling 
pathways implicated in LPS-induced iNOS expression in microglia is shown is Fig. 82.  
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Fig. 82. Schematic representation of the proposed signaling pathways inducing iNOS expression 
in response to LPS in microglia. 
LPS binds to TLR4 and activation of different signaling pathways, including NF-κB and the MAPKs 
p38 and JNK, leads to the activation of iNOS gene expression. 
 
 
Additionally, it has been reported that cAMP either enhances or reduces iNOS expression 
depending on the cell type and the stimuli used. cAMP-elevating agents, including cAMP 
analogues, norepinephrine and prostaglandins, suppressed LPS-induced iNOS expression in 
rat microglia (Minghetti et al., 1997), kupffer cells (Mustafa and Olson, 1998) and 
hepatocytes (Smith et al., 1997). In contrast, cAMP induced iNOS expression in rat vascular 
smooth muscle cells and mesengial cells (Imai et al., 1994; Eberhardt et al., 1998). Infection 
of the BV-2 microglial cells with lentiviruses expressing the constitutively active CREB 
mutant C2/CREB induced iNOS expression in these cells. The adenylyl cyclase activator 
forskolin induced iNOS expression in BV-2 microglial cells. This experiment was 
unfortunately not reproducible more than two times, the reason is unclear but further 
investigations are required to clarify the involvement of CREB in iNOS expression. Taken 
together, these data indicate that the bZIP proteins CREB, ATF2 and c-Jun belong to the key 
regulators of iNOS gene expression in microglial cells. 
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D.7.2. Expression of c-Jun and c-Fos in αT3M3 gonadotrope cells 
 
Both the biosynthesis and the secretion of the gonadotropins are under the regulation of the 
gonadotropin-releasing hormone (GnRH). When GnRH binds to its seven-transmembrane 
receptor (Tsutsumi et al., 1992), it induces interaction of the receptor with the heterodimeric 
Gq protein, which leads to the activation of phospholipase C and formation of inositol 1,4,5-
triphosphate and diacylglycerol, leading to elevation of intracellular Ca2+ and activation of 
protein kinase C (Huckle and Conn, 1988; Horn et al., 1991; Reinhart et al., 1992). It has been 
shown that activation of GnRH receptor in cultured pituitary cells and αT3-1 cell line is 
associated with increased expression and levels of mRNA of the transcription factors c-fos 
and c-jun (Cesnjaj et al., 1994). The GnRH analogue buserelin and the muscarinic 
acetylcholine receptor agonist carbachol induced the expression of c-Jun and c-Fos in αT3M3 
cells. It has been reported that Ca2+ is a critical mediator of the induction of gonadotropin 
secretion by GnRH (Chang et al., 1988; Huckle and Conn, 1988; Naor et al., 1988). 
Elimination of intracellular calcium by treating the αT3M3 cells with the cell-permeable 
intracellular calcium chelator BAPTA-AM inhibited buserelin-induced c-Jun and c-Fos 
expression. Many effects of Ca2+ in cells are mediated by protein phosphorylations catalyzed 
by calcium/calmodulin-dependent protein kinases. The Ca2+/calmodulin-dependent protein 
kinases inhibitor KN-62 was shown here to inhibit buserelin-induced c-Jun and c-Fos 
expression in αT3M3 cells, suggesting that the calcium/calmodulin-dependent signaling 
pathway may be implicated in the induction of c-Jun and c-Fos expression in gonadotrope 
cells. KN-62 slightly impaired carbachol-induced c-Jun and c-Fos expression in αT3M3 cells. 
In the gonadotrope-derived αT3-1 cell line, GnRH has been shown to activate multiple 
protein kinases including ERK (Roberson et al., 1995; Weck et al., 1998; Benard et al., 2001), 
JNK (Levi et al., 1998; Mulvaney and Roberson, 2000) and p38 MAPK (Roberson et al., 
1999). The MAPKK (MEK) inhibitor PD98059 inhibited buserelin- and carbachol-induced c-
Jun and c-Fos expression, suggesting that and the activation of ERK is required for the 
induction of c-Jun and c-Fos expression in αT3M3 cells. Further studies are required to 
investigate the role of other members of MAPK signaling pathways and the requirement of 
calcium signals in the regulation of the immediate early genes c-Jun and c-Fos in response to 
extracellular stimulation. 
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E. Summary 
 
The basic region leucine zipper (bZIP) transcription factors are proteins that bind as dimers to 
specific sequences within promoter genes to activate or repress the transcription of these 
genes. The best known member of the bZIP family is the cAMP response element (CRE) 
binding protein CREB that binds to the sequence 5`-TGACGTCA-3´ termed CRE. To 
investigate gene regulation by bZIP transcription factors constitutively active and dominant-
negative bZIP mutants were used. The results show that genes encoding GTP cyclohydrolase 
I, secretogranin II, tumor necrosis factor α (TNFα) and Egr-1 are regulated by CREB and 
ATF2 via CRE motifs or related sequences. CREB and ATF2 do not heterodimerize but they 
rather compete for DNA-binding. In contrast, the bZIP proteins CREB2/ATF4, ATF5 and 
C/EBP heterodimerize with each other but not with CREB or ATF2. CREB2/ATF4, ATF5 
and C/EBP transactivate the asparagine synthetase gene but has no or marginal impact on 
CRE-controlled genes. Furthermore, CREB2/ATF4, ATF5 and C/EBP mediate the activation 
of the asparagine synthetase gene transcription induced by amino acid deprivation. 
In a second series of experiments the regulation of the inducible nitric oxide synthase (iNOS) 
has been investigated as a result of Toll-like receptor 4 stimulation. The results show that 
stress-activated protein kinases and the bZIP proteins ATF2 and/or c-Jun are involved in the 
upregulation of iNOS gene following stimulation. 
Finally, the regulation of the c-Jun and c-Fos encoding genes has been investigated in 
pituitary cells. Stimulation of the gonadotropin-releasing hormone receptor or the muscarinic 
acetylcholine receptor type III stimulated c-Jun and c-Fos expression indicating that bZIP 
transcription factor synthesis is controlled by extracellular signals. 
 
 
 
 REFERENCES  
 140 
 
F. References 
 
Agre, P., Johnson, P. F. and McKnight, S. L., Cognate DNA binding specificity retained after 
leucine zipper exchange between HCN4 and C/EBP, Science, 1989, 246, 922-926. 
 
Ahn, S., Olive, M., Aggarwal, S., Krylov, D., Ginty, D. D. and Vinson, C., A dominant-
negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent 
transcription of c-fos, Mol. Cell. Biol., 1998, 18, 967-977. 
 
Andrews, N. C. and Faller, D. V., A micropreparation technique for extraction of DNA-
binding proteins from limiting numbers of mammalian cells, Nucleic Acid Res., 1991, 19, 
249. 
 
Andrulis, I. L., Chen, J. and Ray, P. N., Isolation of human cDNAs for asparagine synthetase 
and expression in Jensen rat sarcoma cells, Mol. Cell. Biol., 1987, 7, 2435-2443. 
 
Angel, P. and Karin, M., The role of Jun, Fos and the AP-1 complex in cell-proliferation and 
transformation, Biochim. Biophys. Acta., 1991, 1072, 129-157. 
 
Angelastro, J. M., Mason, J. L., Ignatova, T. N., Kukekov, V. G., Stengren, G. B., Goldman, 
J. E. and Greene, L. A., Downregulation of activating transcription factor 5 is required for 
differentiation of neural progenitor cells into astrocytes, J Neurosci., 2005, 25, 3889-3899. 
 
Antonson, P. and Xanthopoulos, K. G., Molecular cloning, sequence, and expression of the 
human gene encoding CCAAT/enhancer binding protein α (C/EBPα), Biochem. Biophys. 
Res. Commun., 1995, 215, 106-113. 
 
Arfin, S. M., Simpson, D. R., Chiang, C. S., Andrulis, I. L. and Hatfield, G. W., A role for 
asparaginyl-tRNA in the regulation of asparagine synthetase in a mammalian cell line, Proc. 
Natl. Acad. Sci. USA, 1977, 74, 2367-2369. 
 
 REFERENCES  
 141 
Averous, J., Bruhat, A., Jousse, C., Carraro, V., Thiel, G. and Fafournoux, P., Induction of 
CHOP expression by amino acid limitation requires both ATF4 expression and ATF2 
phosphorylation, J. Biol. Chem., 2004, 279, 5288-5297. 
 
Aznar, S., Tonder, N., Bele, S., Kiessling, M., Zimmer, J. and Gass, P., c-JUN, KROX-24, 
and c-FOS expression in hippocampal grafts placed in excitotoxic hippocampal lesions of the 
rat, Exp Neurol., 1995, 136, 205-211. 
 
Bakker, O. and Parker, M. G., CAAT/enhancer binding protein is able to bind to ATF/CRE 
elements, Nucl. Acids Res., 1991, 19, 1213-1217. 
 
Barbosa-Tessmann, I. P., Chen, C., Zhong, C., Siu, F., Schuster, S. M., Nick, H. S. and 
Kilberg, M. S., Activation of the human asparagine synthetase gene by amino acid response 
and the endoplasmic reticulum stress response pathways occurs by common genomic 
elements, J. Biol. Chem., 2000, 275, 26976-26985. 
 
Barone, M. V., Crozat, A. Y., Tabaee, A., Philipson, L. and Ron, D., CHOP (GADD153) and 
its oncogenic variant, TLS-CHOP, differ in their ability to induce G1/S arrest, Genes Dev., 
1994, 8, 453-464. 
 
Barron, K. D., The microglial cell. A historical review, J Neurol Sci., 1995, 134, 57-68. 
 
Batchvarova, N., Wang, X. Z. and Ron, D., Inhibition of adipogenesis by the stress-induced 
protein CHOP (gadd153), EMBO J., 1995, 14, 4654-4661. 
 
Bedogni, B., Pani, G., Colavitti, R., Riccio, A., Borrello, S., Murphy, M., Smith, R., Eboli, M. 
L. and Galeotti, T., Redox regulation of cAMP-responsive element-binding protein and 
induction of manganous superoxide dismutase in nerve growth factor-dependent cell survival, 
J. Biol. Chem., 2003, 278, 16510-16519. 
 
Behrens, A., Sibilia, M. and Wagner, E. F., Amino-terminal phosphorylation of c-Jun 
regulates stress-induced apoptosis and cellular proliferation, Nat. Genet., 1999, 21, 326-329. 
 
 REFERENCES  
 142 
Benard, O., Naor, Z. and Seger, R., Role of dynamin, Src, and Ras in the protein kinase C-
mediated activation of ERK by gonadotropin-releasing hormone, J. Biol. Chem., 2001, 276, 
4554-4563. 
 
Benbrook, D. M. and Jones, N. C., Different binding specificities and transactivation of 
variant CRE´s by CREB complexes, Nucl. Acids Res., 1994, 22, 1463-1469 
 
Berkowitz, L. A., Riabowal, K. T. and Gilman, M. Z., Multiple sequence elements of a single 
functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter, 
Mol. Cell. Biol., 1989, 9, 4272-4281. 
 
Bernal-Mizrachi, E., Wice, B., Inoue, H. and Permutt, M. A., Activation of serum response 
factor in the depolarization induction of Egr-1 transcription in pancreatic islet β-cells, J. Biol. 
Chem., 2000, 275, 25681-25689. 
 
Bhat, N. R., Zhang, P., Lee, J. C. and Hogan, E. L., Extracellular signal-regulated kinase and 
p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase 
and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures, J. 
Neurosci., 1998, 18, 1633-1641. 
 
Bhat, N. R., Zhang, P. and Bhat, A. N., Cytokine induction of inducible nitric oxide synthase 
in an oligodendrocyte cell line: role of p38 mitogen-activated protein kinase activation, J. 
Neurochem., 1999, 72, 472-478. 
 
Bhat, N. R., Feinstein, D. L., Shen, Q. and Bhat, A. N., p38 MAPK-mediated transcriptional 
activation of inducible nitric-oxide synthase in glial cells, J. Biol. Chem., 2002, 277, 29584-
29592. 
 
Bohmann, D., Bos, T. J., Admon, A., Nishimura, T., Vogt, P. K. and Tjian, R., Human proto-
oncogene c-jun encodes a DNA binding protein with structural and functional properties of 
transcription factor AP-1, Science, 1987, 238, 1386-1392. 
 
Bonny, C., Oberson, A., Negri, S., Sauser, C. and Schorderet, D. F., Cell-permeable peptide 
inhibitors of JNK: novel blockers of beta-cell death, Diabetes, 2001, 50, 77-82. 
 REFERENCES  
 143 
Brenner, B., Koppenhoefer, U., Weinstock, C., LinderKamp, O., Lang, F. and Gulbins, E., 
Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-
terminal kinase/p38 kinases and GADD153, J. Biol. Chem., 1997, 272, 22173-22181. 
 
Brewer, J. W., Cleveland, J. L. and Hendershot, L. M., A pathway distinct from the 
mammalian unfolded protein response regulates expression of endoplasmic reticulum 
chaperones in non-stressed cells, EMBO J., 1997, 16, 7207-7216. 
 
Brosnan, C. F., Lee, S. C. and Liu, J., Regulation of inducible nitric oxide synthase expression 
in human glia: implications for inflammatory central nervous system diseases, Biochem Soc. 
Trans., 1997, 25, 679-683. 
 
Bruhat, A., Jousse, C., Wang, X. Z., Ron, D., Ferrara, M. and Fafournoux, P., Amino acid 
limitation induces expression of CHOP, a CCAAT/enhancer binding protein-related gene, at 
both transcriptional and post-transcriptional levels, J. Biol. Chem., 1997, 272, 17588-17593. 
 
Bussolati, O., Belletti, S., Uggeri, J., Gatti, R., Orlandini, G., Dall’Asta, V. and Gazzola, G. 
C., Characterization of apoptotic phenomena induced by treatment with L-asparaginase in 
NIH3T3 cells, Exp. Cell Res., 1995, 220, 283-291. 
 
Cao, Z., Umek, R. M. and McKnight, S. L., Regulated expression of three C/EBP isoforms 
during adipose conversion of 3T3-L1 cells, Genes Dev., 1991, 5, 1538-1552. 
 
Carlson, S. G., Fawcett, T. W., Bartlett, J. D., Bernier, M. and Holbrook, N. J., Regulation of 
the C/EBP-regulated gene gadd153 by glucose deprivation, Mol. Cell. Biol., 1993, 13, 4736-
4744. 
 
Cesnjaj, M., Catt, K. J. and Stojilkovic, S. S., Coordinate activations of calcium and protein 
kinase-C in the expression of primary response genes in pituitary gonadotrophs, 
Endocrinology, 1994, 135, 692-701. 
 
Chan, E. D., Winston, B. W., Uh, S. T., Wynes, M. W., Rose, D. M. and Riches, D. W., 
Evaluation of the role of mitogen-activated protein kinases in the expression of inducible 
 REFERENCES  
 144 
nitric oxide synthase by IFN-gamma and TNF-alpha in mouse macrophages, J Immunol., 
1999, 162, 415-422. 
 
Chan, E. D., Morris, K. R., Belisle, J. T., Hill, P., Remigio, L. K., Brennan, P. J. and Riches, 
D. W., Induction of inducible nitric oxide synthase-NO by lipoarabinomannan of 
Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB 
signaling pathways, Infect Immun., 2001, 69, 2001-2010. 
 
Chan, E. D. and Riches, D. W., IFN-gamma + LPS induction of iNOS is modulated by ERK, 
JNK/SAPK, and p38(mapk) in a mouse macrophage cell line, Am J Physiol. Cell Physiol., 
2001, 280, C441-C450. 
 
Chang, J. P., Stojilkovic, S. S., Graeter, J. S. and Catt, K. J., Gonadotropin-releasing hormone 
stimulates luteinizing hormone secretion by extracellular calcium-dependent and -independent 
mechanisms, Endocrinology, 1988, 122, 87-97. 
 
Chang, L. and Karin, M., Mammalian MAP kinase signalling cascades, Nature, 2001, 410, 
37-40. 
 
Chen, C., Chen, Y. H. and Lin, W. W., Involvement of p38 mitogen-activated protein kinase 
in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages, 
Immunology, 1999, 97, 124-129. 
 
Chen, C. C. and Wang, J. K., p38 but not p44/42 mitogen-activated protein kinase is required 
for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 
macrophages, Mol. Pharmacol., 1999, 55, 481-488. 
 
Cho, M. K., Suh, S. H. and Kim, S. G., JunB/AP-1 and NF-kappa B-mediated induction of 
nitric oxide synthase by bovine type I collagen in serum-stimulated murine macrophages, 
Nitric Oxide, 2002, 6, 319-332. 
 
Christy, R. J., Yang, V. W., Ntambi, J. M., Geiman, D. E., Landschulz, W. H., Freidman, A. 
D., Nakabeppu, Y., Kelly, T. J. and Lane, M. D., Differentiation-induced gene expression in 
 REFERENCES  
 145 
3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the 
promoters of twp adipocyte-specific genes, Genes Dev., 1989, 3, 1323-1335. 
 
Chrivia, J. C., Kwok, R. P. S., Lamb, N., Hagiwara, M., Montminy, M. R. and Goodman, R., 
Phosphorylated CREB binds specifically to the nuclear protein CBP, Nature, 1993, 365, 855-
859. 
 
Cibelli, G., Jüngling, S., Schoch, S., Gerdes, H. H. and Thiel. G., Identification of a functional 
cAMP response element in the secretogranin II gene, Eur. J. Biochem., 1996, 236, 171-179. 
 
Clegg, C. H., Ran, W., Uhler, M. D. and McKnight, G. S., A mutation in the catalytic subunit 
of protein kinase A prevents myristylation but does not inhibit biological activity, J. Biol. 
Chem., 1989, 264, 20140–20146. 
 
Clerk, A. and Sugden, P. H., Cell stress induced phosphorylation of ATF-2 and c-Jun 
transcription factors in rat ventricular myocytes, Biochem. J., 1997, 325, 801-810. 
 
Comb, M., Birnberg, N. C., Seascholtz, A., Herbert, E. and Goodman, H. M., A cyclic-AMP- 
and phorbol ester-inducible DNA element, Nature, 1986, 323, 353-356. 
 
Conkright, M. D., Canettieri, G., Screaton, R., Guzman, E., Miraglia, L., Hogenesch, J. B. and 
Montminy, M., TORCs: Tranducers of Regulated CREB activity, Mol. Cell., 2003, 12, 413-
423. 
 
Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R. and 
Lee, J. C., SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated 
by cellular stresses and interleukin-1, FEBS Lett., 1995, 364, 229-233. 
 
Curran, T. and Franza, B. R. J., Fos and Jun: The AP-1 connection, Cell, 1988, 55, 395-397. 
 
D’Amico, M., Hulit, J., Amanatullah, D. F., Zafonte, B. T., Albanese, C., Bouzahzah, B., Fu, 
M., Augenlicht, L. H., Donehower, L. A., Takemaru, K., Moon, R. T., Davis, R., Lisanti, M. 
P., Shtutman, M., Zhurinsky, J., Ben-Ze’ev, A., Troussard, A. A., Dedhar, S. and Pestell, R. 
G., The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 
 REFERENCES  
 146 
3β and cAMP responsive element-binding protein dependent pathways, J. Biol. Chem., 2000, 
275, 32649-32657. 
 
Da Silva, J., Pierrat, B., Marry, J.-L. and Lesslauer, W., Blockade of p38 mitogen-activated 
protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse 
astrocytes, J. Biol. Chem., 1997, 272, 28373-28380. 
 
Davis, R. J., Signal transduction by the JNK group of MAP kinases, Cell, 2000, 103, 239-252. 
 
Delegeane, A. M., Ferlands, L. H. and Mellon, P. L., Tissue-specific enhancer of the human 
glycoprotein hormone alpha-subunit gene: dependence on cyclic AMP-inducible elements, 
Mol. Cell. Biol., 1987, 7, 3994-4002. 
 
Deng, T. and Karin, M., c-Fos transcriptional activity stimulated by H-Ras-activated protein 
kinase distinct from JNK and ERK, Nature, 1994, 371, 171-175. 
 
Denlinger, L. C., Fisette, P. L., Garis, K. A., Daugherty, S. K., Bertics, P. J. and Proctor, R. 
A., in Novel Therapeutic Strategies in the Treatment of Sepsis (Morrison, D. C. and Ryan, J. 
L., eds), Marcel Dekker, Inc., New York, 1996, pp227-252. 
 
Derijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., Karin, M. and Davis, R. J., 
JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the 
c-Jun activation domain, Cell, 1994, 76, 1025-1037. 
 
De Rooij, J., Zwartkruis, F. J., Verheijen, M. H., Cool, R. H., Nijman, S. M., Wittinghofer, A. 
and Bos, J. L., Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic 
AMP, Nature, 1998, 396, 474-477. 
 
Desdouets, C., Matesic, G., Molina, C. A., Foulkes, N. S., Sassone-Corsi, P., Brechot, C. and 
Sobczak-Thepot, J., Cell cycle regulation of cyclin A gene expression by the cAMP-
responsive transcription factors CREB and CREM, Mol. Cell. Biol., 1995, 15, 3301-3309. 
 
Diehl, A. M., Johns, D. C., Yang, S., Lin, H., Yin, L. A., Matelis, L. A. and Lowrence, J. H., 
Adenovirus-mediated transfer of CCAAT/Enhancer binding protein alpha identifies a 
 REFERENCES  
 147 
dominant antiproliferative role for this isoform in hepatocytes, J. Biol. Chem., 1996, 271, 
7343-7353. 
 
Distel, R. J., Ro, H.-S., Rosen, B. S., Groves, D. L. and Spiegelman, B. M., Nucleoprotein 
complexes that regulate gene expression in adipocyte differentiation: Direct participation of c-
fos, Cell, 1987, 49, 835-844. 
 
Dixit, V. M., Marks, R. M., Sarma, V. and Prochownik, E. V., The antimitogenic action of 
tumor necrosis factor is associated with increase AP-1/c-jun proto-oncogene transcription, J. 
Biol. Chem., 1989, 264, 16905-16909. 
 
D’Mello, S. R., Turzai, L. M., Gioio, A. E. and Kaplan, B. B., Isolation and structural 
characterization of the bovine tyrosine hydroxylase gene, J Neurosci Res., 1989, 23, 31-40. 
 
Dony, C. and Gruss, P., Proto-oncogene c-fos expression in growth regions of fetal bone and 
mesodermal web tissue, Nature, 1987, 328, 711-714. 
 
Downey, J. S. and Han, J., Cellular activation mechanisms in septic shock, Front Biosci., 
1998, 3, d468-476. 
 
D’Sa, C., Hirayama, K., West, A., Hahn, M., Zhu, M. and Kapatos, G., Tetrahyrobiopterin 
biosynthesis in C6 glioma cells: induction of GTP cyclohydrolase I gene expression by 
lipopolysaccharide and cytokine treatment, Mol Brain Res., 1996, 41, 105-110. 
 
Dudely, D. T., Pang, L., Decker, S. J., Bridges, A. J. and Saltiel, A. R., A synthetic inhibitor 
of the mitogen-activated protein kinase cascade, Proc. Natl. Acad. Sci. USA, 1995, 92, 7686-
7689. 
 
Eberhardt, W., Pluss, C., Hummel, R. and Pfeilschifter, J., Molecular mechanisms of 
inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells, 
J Immunol., 1998, 160, 4961-4969. 
 
Estes, S. D., Stoler, D. L. and Anderson, G. R., Normal fibroblasts induce the C/EBPβ and 
ATF-4 bZIP transcription factors in response to anoxia, Exp Cell Res., 1995, 220, 47-54. 
 REFERENCES  
 148 
Estus, S., Zaks, W. J., Freeman, R. S., Gruda, M., Bravo, R. and Johnson, E. M., Jr. Altered 
gene expression in neurons during programmed cell death: identification of c-jun as necessary 
for neuronal apoptosis, J. Cell. Biol., 1994, 127, 1717-1727. 
 
Falvo, J. V., Uglialoro, A. M., Brinkman, B. M. N., Merika, M., Parekh, B. S., Tsai, E. Y., 
Morielli, A. D., Peralta, E. G., Maniatis, T., Thanos, D. and Goldfeld, A. E., Stimulus-specific 
assembly of enhancer complexes on tumor necrosis-α gene promoter, Mol. Cell. Biol., 2000, 
20, 2239-2247. 
 
Fawcett, T. W., Martindale, J. L., Guyton, K. Z., Hai, T. and Holbrook, N. J., Complexes 
containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein 
(CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to 
regulate Gadd153 expression during the stress response, Biochem J., 1999, 339, 135-141. 
 
Feinstein, D. L., Galea, E., Roberts, S., Berquist, H., Wang, H. and Reis, D. J., Induction of 
nitric oxide synthase in rat C6 glioma cells, J. Neurochem., 1994, 62, 315-321. 
 
Ferreri, K., Gill, G. and Montminy, M., The cAMP regulated transcription factor CREB 
interacts with a component of the TFIID complex, Proc. Natl Acad. Sci. USA, 1994, 91, 1210-
1213. 
 
Fischer-Colbrie, R., Gutierrez, J., Hsu, C.-M., Iacangelo, A. and Eiden, L. E., Sequence 
analysis, tissue distribution and regulation by cell depolarization, and second messengers of 
bovine secretogranin II (Chromogranin C) mRNA, J. Biol. Chem., 1990, 265, 9208-9213. 
 
Flodby, P., Barlow, C., Kalefjord, H., Ahrlund-Richer, L. and Xanthopolous, K. G., Increased 
hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/Enhancer 
binding protein, J. Biol. Chem., 1996, 271, 24753-24760. 
 
Fornace, A., Alamo, I. and Hollander, M., DNA damage-inducible transcripts in mammalian 
cells, Proc. Natl. Acad. Sci. USA, 1988, 85, 8800-8804. 
 
Foster, J. D., Pederson, B. A. and Nordlie, R. C., Glusose-6-phosphatase structure, regulation, 
and function: an update, Proc Soc Exp Biol Med., 1997, 215, 314-332. 
 REFERENCES  
 149 
Frank, D. A. and Greenberg, M. E., CREB: a mediator of long-term memory from mollusks to 
mammals, Cell, 1994, 79, 5-8. 
 
Frank, S., Kolb, N., Werner, E. R. and Pfeilschifter, J., Coordinated induction of inducible 
nitric oxide synthase and GTP-cyclohydrolase I is dependent on inflammatory cytokines and 
interferon-γ in HaCaT keratinocytes: Implications for the model of cutaneous wound repair, J 
Invest Dermatol., 1998, 111, 1065-1071. 
 
Freytag, S. O. and Geddes, T. J., Reciprocal regulation of adipogenesis by Myc and C/EBP 
alpha, Science, 1992, 256, 379-382. 
 
Friedman, A. D., Landschulz, W. H. and McKnight, S. L., CCAAT/enhancer binding protein 
activates the promoter of the serum albumin gene in cultured hepatoma cells, Genes Dev., 
1989, 3, 1314-1322. 
 
Friedman, A. D. and McKnight, S. L., Identification of two polypeptide segments of 
CCAAT/enhancer-binding protein required for transcriptional activation of the serum albumin 
gene, Genes Dev., 1990, 4, 1416-1426. 
 
Gachon, F., Gaudray, G., Thebault, S., Basbous, J., Koffi, J. A., Devaux, C. and Mesnard, J., 
The cAMP response element binding protein-2 (CREB-2) can interact with the C/EBP-
homologous protein (CHOP), FEBS Lett., 2001, 502, 57-62. 
 
Galea, E., Feinstein, D. L. and Reis, D. J., Induction of calcium-independent nitric oxide 
synthase activity in primary rat glial cultures, Proc. Natl. Acad. Sci. USA, 1992, 89, 10945-
10949. 
 
Geller, D. A., Di Silvio, M., Billiar, T. R. and Hatakeyama, K., GTP cyclohydrolase I is 
coinduced in hepatocytes stimulated to produce nitric oxide, Biochem. Biophys. Res. 
Commun., 2000, 276, 633-641. 
 
Gerber, H. P., Georgiv, O., Harshman, K. and Schaffner, W., In vitro transcription 
complementation assay with mini extracts of transiently transfected COS-1 cell, Nucleic Acid 
Res., 1992, 20, 5855-5856. 
 REFERENCES  
 150 
Gius, D., Cao, X., Rauscher III, F. J., Cohen, D. R., Curran, T. and Sukhatme, V. P., 
Transcriptional activation and repression by Fos are independent functions: the C terminus 
represses immediate-early gene expression via CArG elements, Mol. Cell. Biol., 1990, 10, 
4243-4255. 
 
Golderer, G., Werner, E. R., Heufler, C., Strohmaier, W., Gröbner, P. and Werner-Felmayer, 
G., GTP cyclohydrolase I mRNA: novel splice variants in the slime mould Physarum 
polycephalum and in human monocytes (THP-1) indicate conservation of mRNA processing, 
Biochem J., 2001, 355, 499-507. 
 
Gonzalez, G. A., Yamamoto, K. K., Fischer, W. H., Karr, D., Menzel, P., Biggs, W. W. W., 
Vale, W. W. and Montminy, M. R., A cluster of phosphorylation sites on the cyclic AMP-
regulated nuclear factor CREB predicted by its sequence, Nature, 1989, 337, 749-752. 
 
Grayson, D. R., Costa, R. H., Xanthopoulos, K. G. and Darnell, J. E., One factor recognizes 
the liver-specific enhancers in alpha 1-antitrypsin and transthyretin genes, Science, 1988, 239, 
786-788. 
 
Greco, A., Gong, S. S., Ittmann, M. and Basilico, C., Organization and expression of the cell 
cycle gene, ts11, that encodes asparagine synthetase, Mol. Cell. Biol., 1989, 9, 2350-2359. 
 
Greenwel, P., Tanaka, S., Penkov, D., Zhang, W., Olive, M., Moll, J., Vinson, C., Di Liberto, 
M. and Ramirez, F., Tumor necrosis factor alpha inhibits type I collagen synthesis through 
repressive CCAAT/enhancer-binding proteins, Mol. Cell. Biol., 2000, 20, 912-918. 
 
Grewal, S. S., Fass, D. M., Yao, H., Ellig, C. L., Goodman, R. H. and Stork, P. J. S., Calcium 
and cAMP signals differentially regulate cAMP-responsive element-binding protein function 
via a Rap1 extracellular signal-regulated kinase pathway, J. Biol. Chem., 2000, 275, 34433-
34441. 
 
Groot, M., Boxer, L. M. and Thiel, G., Nerve growth factor- and epidermal growth factor-
regulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells, Eur. J. 
Cell Biol., 2000, 79, 924-935. 
 
 REFERENCES  
 151 
Gross, S. S., Jones, C. L., Hattori, Y. and Raman, C. S., Tetrahydrobiopterin: An essential 
cofactor of nitric oxide synthase with an elusive role, In: Lancaster JR, editor. Nitric oxide. 
Orlando: Academic Press., 2000, pp 167-185. 
 
Guan, Z., Baier, L. D. and Morrison, A. R., p38 mitogen-activated protein kinase 
downregulates nitric oxide and upregulates prostaglandin E2 biosynthesis stimulated by 
interleukin-1β, J. Biol. Chem., 1997, 272, 8083-8089. 
 
Guerrini, L., Gong, S. S., Mangasarian, K. And Basilico, C., Cis- and trans-acting elements 
involved in amino acid regulation of asparagine sythetase gene expression, Mol. Cell. Biol., 
1993, 13, 3202-3212. 
 
Gupta, S., Campbell, D., Derijard, B. and Davis, R. J., Transcription factor ATF2 regulation 
by the JNK signal transduction pathway, Science, 1995, 267, 389-393. 
 
Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Derijard, B. and Davis, R. 
J., Selective interaction of JNK protein kinase isoforms with transcription factors, EMBO J., 
1996, 15, 2760-2770. 
 
Guyton, K. Z., Xu, Q. and Holbrook, N. J., Induction of the mammalian stress response gene 
GADD153 by oxidative stress: role of AP-1 element, Biochem J., 1996, 314, 547-554. 
 
Hai, T. and Curran, T., Cross-family dimerization of transcription factors fos/jun and 
ATF/CREB alters DNA binding specificity, Proc. Natl. Acad. Sci. USA, 1991, 88, 3720-3724. 
 
Ham, J., Babij, C., Whitfield, J., Pfarr, C. M., Lallemand, D., Yaniv, M. and Rubin, L. L., A 
c-jun dominant negative mutant protects sympathetic neurons against programmed cell death, 
Neuron, 1995, 14, 927-939. 
 
Han, J., Lee, J.-D., Jiang, Y., Li, Z., Feng, L. and Ulevitch, R. J., Characterization of the 
structure and function of a novel MAP kinase kinase (MKK6), J. Biol. Chem., 1996, 271, 
2886-2891.  
 
 REFERENCES  
 152 
Hansen, M. B., Mitchelmore, C., Kjaerulff, K. M., Rasmussen, T. E., Pedersen, K. M. and 
Jensen, N. A., Mouse Atf5: Molecular cloning and two novel mRNAs, genomic organization, 
and odorant sensory neuron localization, Genomics, 2002, 80, 344-350. 
 
Hardy, S. and Shenk, T., Adenoviral control regions activated by E1A and the cAMP 
response element bind to the same factor, Proc. Natl. Acad. Sci. USA, 1988, 85, 4171-4175. 
 
Harootunian, A. T., Adams, S. R., Wen, W., Meinkoth, J. L., Taylor, S. S. and Tsien, R. Y., 
Movement of the free catalytic subunit of cAMP-dependent protein kinase into and out of the 
nucleus can be explained by diffusion, Mol. Biol. Cell., 1993, 4, 993-1002. 
 
Hatakeyama, K., Harada, T., Suzuki, S., Watanabe, Y. and Kagamiyama, H., Purification and 
characterization of rat liver GTP cyclohydrolase I. Cooperative binding of GTP to the 
enzyme, J. Biol. Chem., 1989, 264, 21660-21664. 
 
Hatakeyama, K., Inoue, Y., Harada, T. and Kagamiyama, H., Cloning and sequencing of 
cDNA encoding rat GTP cyclohydrolase I. The first enzyme of the tetrahydrobiopterin 
biosynthetic pathway, J. Biol. Chem., 1991, 266, 765-769. 
 
He, C. H., Gong, P., Hu, B., Stewart, D., Choi, M. E., Choi, A. M. K. and Alam, J., 
Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. 
Implication for heme oxygenase-1 gene regulation, J. Biol. Chem., 2001, 276, 20858-20865. 
 
Hendricks-Taylor, L. R. and Darlington, G. J., Inhibition of cell proliferation by C/EBP 
occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by 
large T-antigen, Nucleic Acids Res., 1995, 23, 4726-4733. 
 
Hettmann, T., Barton, K. and Leiden, J. M., Microphthalmia due to p53-mediated apoptosis of 
anterior lens epithelial cells in mice lacking the CREB-2 transcription factor, Dev Biol., 2000, 
222, 110-123. 
 
Hilberg, F., Aguzzi, A., Howells, N. and Wagner, E. F., c-jun is essential for normal mouse 
development and hepatogenesis, Nature, 1993, 365, 179-181. 
 
 REFERENCES  
 153 
Hill, C. S. and Treisman, R., Transcriptional regulation by extracellular signals: mechanisms 
and specificity, Cell, 1995, 80, 199-211. 
 
Hirai, S. and Yaniv, M., Jun DNA-binding is modulated by mutations between the leucines or 
by direct interaction of fos with TGACTCA sequence, New Biol., 1989, 1, 181-191. 
 
Hirayama, K., Shimooji, M., Swick, L., Meyer, A. and Kapatos, G., Characterization of GTP 
cyclohydrolase I gene expression in the human neuroblastoma SKN-BE(2)M17: enhanced 
transcription in response to cAMP is conferred by the proximal promoter, J Neurochem., 
2001, 79, 576-587. 
 
Hoffmeyer, A., Grosse-Wilde, A., Flory, E., Neufeld, B., Kunz, M., Rapp, U. R. and Ludwig, 
S., Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor 
necrosis factor α gene expression in T lymphocytes, J. Biol. Chem., 1999, 274, 4319-4327. 
 
Holt, J. T., Gopal, T. V., Moulton, A. D. and Nienhuis, A. W., Inducible production of c-fos 
antisense RNA inhibits 3T3 cell proliferation, Proc. Natl. Acad. Sci. USA, 1986, 83, 4794-
4798. 
 
Horn, F., Bilezikjian, L. M., Perrin, M. H., Bosma, M. M., Windle, J. J., Huber, K. S., Blount, 
A. L., Hille, B., Vale, W. and Mellon, P. L., Intracellular responses to gonadotropin-releasing 
hormone in a clonal cell line of the gonadotrope lineage, Mol. Endocrinol., 1991, 5, 347-355. 
 
Hornbuckle, L. A., Edgerton, D. S., Ayala, J. E., Svitek, C. A., Oeser, J. K., Neal, D. W., 
Cardin, S., Cherrington, A. D. and O’Brien, R. M., Selective tonic inhibition of G-6-Pase 
catalytic subunit, but not G-6-P transporter, gene expression by insulin in vivo, Am. J. 
Physiol. Endocrinol. Metab., 2001, 281, E713-E725. 
 
Hu, B. R., Fux, C. M., Martone, M. E., Zivin, J. A. and Ellisman, M. H., Persistent 
phosphorylation of cyclic AMP responsive element-binding protein and activating 
transcription factor-2 transcription factors following transient cerebral ischemia in rat brain, 
Neuroscience, 1999, 89, 437-452. 
 
 REFERENCES  
 154 
Hu, S. X., Sheng, W. S., Peterson, P. K. and Chao, C. C., Differential regulation by cytokines 
of human astrocyte nitric oxide production, Glia, 1995, 15, 491-494. 
 
Hua, L. L., Zhao, M. L., Cosenza, M., Kim, M. O., Huang, H., Tanowitz, H. B., Brosnan, C. 
F. and Lee, S. C., Role of mitogen-activated protein kinases in inducible nitric oxide synthase 
and TNFalpha expression in human fetal astocytes, J Neuroimmunol., 2002, 126, 180-189. 
 
Huang, Z. M., Thewke, D., Gong, Q. Q., Schlichter, D. and Wicks, W. D., Functional 
recognition of the neuronal tyrosine hydroxylase cAMP regulatory element in different cell 
types, Brain Res Mol Brain Res., 1991, 11, 309-319. 
 
Huckle, W. R. and Conn, P. M., Molecular mechanism of gonadotropin releasing hormone 
action. II. The effector system, Endocrine Rev., 1988, 9, 387-395. 
 
Hurst, H. C. and Jones, N. C., Identification of factors that interact with the E1A-inducible 
adenovirus E3 promoter, Genes Dev., 1987, 1, 1132-1146. 
 
Hurt, H. C., Transcription factors 1: bZIP proteins, Protein profile., 1995, 2, 101-168. 
 
Hutson, R. G., Kitoh, T., Amador, D. A. M., Cosic, S., Schuster, S. M. and Kilberg, M. S., 
Amino acid control of asparagine synthetase gene: relation to asparaginase resistance in 
human leukemia cells, Am. J. Physiol. Cell Physiol., 1997, 272, C1691-C1699. 
 
Huttner, W. B. and Natori, S., Helper proteins for neuroendocrine secretion, Curr. Biol., 1995, 
5, 242-245. 
 
Imai, T., Hirata, Y., Kanno, K. and Marumo, F., Induction of nitric oxide synthase by cyclic 
AMP in rat vascular smooth muscle cells, J Clin Invest., 1994, 93, 543-549. 
 
Ionescu, A. M., Schwarz, E. M., Vinson, C., Puzas, J. E., Rosier, R., Reynolds, P. R. and 
O’Keefe, R. J., PTHrP modulates chondrocyte differentiation through AP-1 and CREB 
signaling, J. Biol. Chem., 2001, 276, 11639-11647. 
 
 REFERENCES  
 155 
Ishizuka, T., Terada, N., Gerwins, P., Hamelmann, E., Oshiba, A., Fanger, G. R., Johnson, 
J. L. and Gelfand, E. W., Mast cell tumor necrosis α production is regulated by MEK 
kinases, Proc. Natl. Acad. Sci, USA, 1997, 94, 6358-6363. 
 
Jean, D. and Bar-Eli, M., Regulation of tumor growth and metastasis of human melanoma 
by the CREB transcription factor family, Mol. Cell. Biochem., 2000, 212, 19-28. 
 
Jean, D. and Bar-Eli, M., Targeting of ATF-1/CREB transcription factors by signaling chain 
Fv fragment in human melanoma: potential modality for cancer therapy, Crit. Rev. 
Immunol., 2001, 21, 275-286. 
 
Jiang, Y., Chen, C., Li, Z., Guo, W., Gegner, J. A., Lin, S. and Han, J., Characterization of 
the structure and function of a new mitogen-activated protein kinase (p38b), J. Biol. Chem., 
1996, 271, 17920-17926. 
 
Johnson, P. F., Landschulz, W. H., Graves, B. J. and McKnight, S. L., Identification of a rat 
liver nuclear protein that binds to the enhancer core element of three animal viruses, Genes 
Dev., 1987, 1, 133-146. 
 
Johnson, R. S., Spiegelman, B. M. and Papaioaannou, V., Pleiotropic effects of a null 
mutation in the c-fos proto-oncogene, Cell, 1992, 71, 577-586. 
 
Johnson, R. S., Van Lingen, B., Papaioannou, V. E. and Spiegelmann, B. M., A null mutation 
at the c-jun locus causes embryonic lethality and retarded cell growth in culture, Genes Dev., 
1993, 7, 1309-1317. 
 
Jones, R. H. and Jones, N. C., Mammalian cAMP-responsive element can activate 
transcription in yeast and binds a yeast factor(s) that resembles the mammalian transcription 
factor ANF, Proc. Natl. Acad. Sci. USA, 1989, 86, 2176-2180. 
 
Jooss, K. U., Funk, M. and Muller, R., An autonomous N-terminal transactivation domain in 
Fos protein plays a crucial role in transformation, EMBO J., 1994, 13, 1467-1475. 
 
 REFERENCES  
 156 
Jousse, C., Bruhat, A., Ferrara, M. and Fafournoux, P., Evidence of multiple signaling 
pathways in the regulation of gene expression by amino acids in human cell lines, J Nutr., 
2000, 130, 1555-1560. 
 
Jung, D. Y., Lee, H., Jung, B.-Y., Ock, J., Lee, M.-S., Lee, W.-H. and Suk, K., TLR4, but not 
TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-β as a 
decision marker, J Immunol., 2005, 174, 6467-6476. 
 
Jüngling, S., Cibelli, G., Czardybon, M., Gerdes, H. H. and Thiel, G., Differential regulation 
of chromogranin B and synapsin I gene promoter activity by cyclic AMP and cyclic AMP-
dependent protein kinase, Eur. J. Biochem., 1994, 226, 925-935. 
 
Kapatos, G., Stegenga, S. L. and Hirayama, K., Identification and characterization of basal 
and cyclic AMP response elements in the promoter of the rat GTP cyclohydrolase I gene, J. 
Biol. Chem., 2000, 275, 5947-5957. 
 
Karin, M., The regulation of AP-1 activity by mitogen-activated protein kinases, J. Biol. 
Chem., 1995, 270, 16483-16486. 
 
Karin, M. and Hunter, T., Transcriptional control by protein phosphorylation: signal 
transmission from the cell surface to the nucleus, Curr Biol., 1995, 5, 747-757. 
 
Karpinski, B. A., Morle, G. D., Huggenvik, J., Uhler, M. D. and Leiden, J. M., Molecular 
cloning of human CREB-2: An ATF/CREB transcription factor that can negatively regulate 
transcription from the cAMP response element, Proc. Natl. Acad. Sci. USA, 1992, 89, 4820-
4824. 
 
Kaufmann, K., Bach, K. and Thiel, G., Extracellular signal-regulated protein kinases 
Erk1/Erk2 stimulate expression and biological activity of the transcriptional regulator Egr-1, 
Biol. Chem., 2001, 382, 1077-1081. 
 
Kawai, T., Matsumoto, M., Takeda, K., Sanjo, H. and Arika, S., ZIP kinase, a novel 
serine/threonine kinase which mediates apoptosis, Mol. Cell. Biol., 1998, 18, 1642-1651. 
 
 REFERENCES  
 157 
Kawasaki, H., Springett, G. M., Mochizuki, N., Toki, S., Nakaya, M., Matsuda, M., 
Housman, D. E. and Graybiel, A. M., A family of cAMP-binding proteins that directly 
activate Rap1, Science, 1998, 282, 2275-2279. 
 
Keinanen, R., Vartiainen, N. and Koistinaho, J., Molecular cloning and characterization of the 
rat inducible nitric oxide synthase (iNOS) gene, Gene, 1999, 234, 297-305. 
 
Kilberg, M. S. and Barbosa-Tessmann, I. P., Genomic sequences necessary for transcriptional 
activation by amino acid deprivation of mammalian cells, J. Nutr., 2002, 132, 1801-1804. 
 
Klar, J., Sandner, P., Müller, M. W. H. and Kurtz, A., Cyclic AMP stimulates renin gene 
transcription in juxtaglomerular cell, Pflügers Arch Eur J Physiol, 2002, 444, 335-344. 
 
Koide, M., Kawahara, Y., Nakayama, I., Tsuda, T. and Yokoyama, M., Cyclic AMP-elevating 
agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle 
cells, J. Biol. Chem., 1993, 268, 24959-24966. 
 
Kreutzberg, G. W., Microglia: a sensor for pathological events in the CNS, Trends Neurosci., 
1996, 19, 312-318. 
 
Kwok, R. P. S., Lundbald, J. R., Chrivia, J. C., Richards, J. P., Bachinger, H. P., Brennan, R. 
G., Roberts, S. G. E., Creen, M. R. and Goodman, R. H., Nuclear protein CBP is a coactivator 
for the transcription factor CREB, Nature, 1994, 370, 223-226. 
 
Kyriakis, J. M. and Avruch, J., Mammalian mitogen-activated protein kinase signal 
transduction pathways activated by stress and inflammation, Physiol Rev., 2001, 81, 807-869. 
 
Lahti, A., Jalonen, U., Kankaanranta, H. and Moilanen, E., c-Jun NH2-terminal kinase 
inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression 
by destabilizing mRNA in activated macrophages, Mol Pharmacol., 2003, 64, 308-315. 
 
Lamph, W. W., Wamsley, P., Sassone-Corsi, P. and Verma, I. M., Induction of proto-
oncogene Jun/AP-1 by serum and TPA, Nature (Lond.), 1988, 334, 629-631. 
 
 REFERENCES  
 158 
Landschulz, W. H., Johnson, P. F. and McKnight, S. L., The leucine zipper: a hypothetical 
structure common to a new class of DNA binding proteins, Science, 1988, 240-1759-1764. 
 
Langlois, W. J., Sasaoka, T., Saltiel, A. R. and Olefsky, J. M., Negative feedback regulation 
and desensitization of insulin- and epidermal growth factor-stimulated p21ras activation, J. 
Biol. Chem., 1995, 270, 25320-25323. 
 
Lazaroff, M., Patankur, S., Yoon, S. O. and Chikaraishi, D. M., The cyclic AMP response 
element directs tyrosine hydroxylase expression in catecholaminergic central and peripheral 
nervous system cell lines from transgenic mice, J. Biol. Chem., 1997, 270, 21579-21589. 
 
Lee, H. J., Mignacca, R. C. and Sakamoto, K. M., Transcriptional activation of egr-1 by 
granulocyte-macrophage colony-stimulating factor but not interleukin 3 requires 
phosphorylation of cAMP response element-binding protein (CREB) on serine 133, J. Biol. 
Chem., 1995, 270, 15979-15983. 
 
Lee, R. J., Albanese, C., Stenger, R. J., Watanabe, G., Inghirami, G., Haines, G. K., Webster, 
M., Muller, W. J., Brugge J. S., Davis, R. J. and Pestell, R. G., pp60(v-src) induction of cyclin 
D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, 
and JNK kinase pathways. A role for cAMP response element-binding protein and activating 
transcription factor-2 in pp60(v-src) signaling in breast cancer cells, J. Biol. Chem., 1999, 
274, 7341-7350. 
 
Leitman, D, C., Ribeiro, R. C. J., Mackow, E. R., Baxter, J. D. and West, B. L., Identification 
of a tumor necrosis factor-responsive element in the tumor necrosis factor alpha gene, J. Biol. 
Chem., 1991, 266, 9343-9346. 
 
Lekstrom-Himes, J. and Xanthopoulos, K. J., Biological role of the CCAAT/enhancer-binding 
protein family of transcription factors, J. Biol. Chem., 1998, 273, 28545-28548. 
 
Levi, N. L., Hanoch, T., Benard, O., Rozenblat, M., Harris, D., Reiss, N., Naor, Z. and Seger, 
R., Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in 
pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42, Mol. 
Endocrinol., 1998, 12, 815-824. 
 REFERENCES  
 159 
Li, X.-Y. and Green, M. R., Intramolecular inhibition of activating transcription factor-2 
function by its DNA-binding domain, Genes Dev., 1996, 10, 517-527. 
 
Li, Y. and Van de Werve, G., Distinct hormone stimulation and counteraction by insulin of 
the expression of the two components of glucose 6-phosphatase in HepG2 cells, Biochem. 
Biophys. Res. Commun., 2000, 272, 41-44. 
 
Liang, G. and Hai, T., Characterization of human activating transcription factor-4, a 
transcriptional activator that interacts with multiple domains of cAMP-responsive element-
binding protein (CREB)-binding protein (CBP), J. Biol. Chem., 1997, 272, 24088-24095. 
 
Lim, J., Yang, C., Hong, S. J. and Kim, K.-S., Regulation of tyrosine hydroxylase gene 
transcription by the cAMP-signaling pathway: Involvement of multiple transcription factors. 
Mol. Cell. Biochem., 2000, 212, 51-60. 
 
Lin, A., Minden, A., Martinetto, H., Claret, F. X., Lange-Carter, C., Mercurio, F., Johnson, G. 
L. and Karin, M., Identification of a dual specificity kinase that activates the jun kinases and 
p38-Mpk2, Science, 1995, 268, 286-290. 
 
Lin, B., Morris, D. W. and Chou, J. Y., The role of HNF1alpha, HNF3gamma, and cyclic 
AMP in glucose-6-phosphatase gene activation, Biochemistry, 1997, 36, 14096-14106. 
 
Lin, L. L., Wartmann, M., Lin, A. Y., Knopf, J. L., Seth, A. and Davis, R. J., cPLA2 is 
phosphorylated and activated by MAP kinase, Cell, 1993, 72, 269-278. 
 
Lin, Y. S. and Green, M. R., Interaction of a common transcription factor, ATF, with 
regulatory elements in both E1a- and cyclic AMP-inducible promoters, Proc. Natl. Acad. Sci. 
USA, 1988, 85, 3396-3400. 
 
Liu, Y., Gorospe, M., Yang, C. and Holbrook, N. J., Role of mitogen-activated protein 
tyrosine phosphatase during the cellular response to genotoxic stress, J. Biol. Chem., 1995, 
270, 8377-8380. 
 
 REFERENCES  
 160 
Livingstone, C., Patel, G. and Jones, N., ATF-2 contains a phosphorylation-dependent 
transcriptional activation domain, EMBO J., 1995, 14, 1785-1797. 
 
Long, F., Schipani, E., Asahara, H., Kronenberg, H. and Montminy, M., The CREB family of 
activators is required for endochondral bone development, Development (Camb.), 2001, 128, 
541-550. 
 
Lonze, B. E. and Ginty, D. D., Function and regulation of CREB family transcription factors 
in the nervous system, Neuron, 2002, 35, 605-623. 
 
Lowenstein, C. J., Glatt, C. S., Bredt, D. S. and Snyder, S. H., Cloned and expressed 
macrophage nitric oxide synthase contrasts with the brain enzyme, Proc. Natl. Acad. Sci. 
USA, 1992, 89, 6711-6715. 
 
Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W. and 
Murphy, W. J., Macrophage nitric oxide synthase gene: two upstream regions mediate 
induction by interferon gamma and lipopolysaccharide, Proc. Natl. Acad. Sci. USA, 1993, 90, 
9730-9734. 
 
Luo, S., Baumeister, P., Yang, S., Abcouwer, S. F. and Lee, A. S., Induction of grp68/BiP by 
translational block. Activation of the Grp78 promoter by ATF4 through an upstream 
ATF/CRE site independent of the endoplasmic reticulum stress elements, J Biol Chem., 2003, 
278, 37375-37385. 
 
Luthman, H. and Magnusson, G. M., High efficiency polyoma DNA transfection of 
chloroquine treated cells, Nucleic Acids Res., 1983, 11, 1295-1308. 
 
Mabuchi, T., Kitagawa, K., Kuwabara, K., Takasawa, K., Ohtsuki, T., Xia, Z., Storm, D., 
Yanagihara, T., Hori, M. and Matsumoto, M., Phosphorylation of cAMP response element-
binding protein in hippocampal neurons as a protective response after exposure to glutamate 
in vitro and ischemia in vivo, J. Neurosci., 2001, 21, 9204-9213. 
 
MacDougald, O. A. and Lane, M. D., Transcriptional regulation of gene expression during 
adipocyte differentiation, Annu. Rev. Biochem., 1995, 64, 345-373. 
 REFERENCES  
 161 
Maekawa, T., Sakura, H., Kanei-Ishii, C., Sudo, T., Yoshimura, T., Fujisawa, J.-I., Yoshida, 
M. and Ishii, S., Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP 
response element in the brain, EMBO J., 1989, 8, 2023-2028. 
 
Maekawa, T., Bernier, F., Sato, M., Nomura, S., Singh, M., Inoue, Y., Tokunaga, T., Imai, H., 
Yokoyama, M., Reimold, A., Glimcher, L. H. and Ishii, S., Mouse ATF-2 null mutants 
display features of a severe type of meconium aspiration syndrome, J. Biol. Chem., 1999, 274, 
17813-17819. 
 
Mai, F. C., Qiao, J., Tsygankova, O. M., Meinkoth, J. L., Quilliam, L. A. and Cheng, X., 
Differential signaling by cyclic AMP. Opposing effects of exchange protein directly activated 
by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation, J. Biol. 
Chem., 2002, 277, 11497-11504. 
 
Mayr, B. and Montminy, M. R., Transcriptional regulation by the phosphorylation-dependent 
factor CREB, Nature Rev. Mol. Cell. Biol., 2001, 2, 599-609. 
 
McArdle, C. A., Forrest-Owen, W., Davidson, J. S., Fowkes, R., Bunting, R., Mason, W. T., 
Poch, A. and Kratzmeier, M., Ca2+ entry in gonadotrophs and alpha T3-1 cells: does store-
dependent Ca2+ influx mediate gonadotrophin-releasing hormone action?, J. Endocrinol., 
1996, 149, 155-169. 
 
McBride, K. and Nemer, M., The C-terminal domain of c-fos is required for activation of an 
AP-1 site specific for jun-fos heterodimers, Mol. Cell. Biol., 1998, 18, 5073-5081. 
 
Mellon, P. L., Clegg, C. H., Correll, L. A. and McKnight, G. S., Regulation of transcription 
by cyclic AMP-dependent protein kinase, Proc. Natl. Acad. Sci. USA, 1989, 86, 4887-4892. 
 
Menard, C., Hein, P., Paquin, A., Savelson, A., Yang, X. M., Lederfein, D., Barnabe-Heider, 
F., Mir, A. A., Sterneck, E., Peterson, A. C., Johnson, P. F., Vinson, C. and Miller, F. D., An 
essential role for a MEKC/EBP pathway during growth factor-regulated cortical 
neurogenesis, Neuron, 2002, 36, 597-610. 
 
 REFERENCES  
 162 
Mendelson, K. G., Contois, L.-R., Tevosian, S. G., Davis, R. J. and Paulson, K. E., 
Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative 
stress in the liver, Proc. Natl. Acad. Sci. USA, 1996, 93, 12908-12913. 
 
Merrill, J. E. and Benveniste, E. N., Cytokines in inflammatory brain lesions: helpful and 
harmful, Trends Neurosci., 1996, 19, 331-338. 
 
Metz, R., Bannister, A. J., Sutherland, J. A., Hagemeier, C., O’Rourke, E. C., Cook, A., 
Bravo, R. and Kouzarides, T., c-Fos-induced activation of a TATA-box-containing promoter 
involves direct contact with TATA-box-binding protein, Mol. Cell. Biol., 1994, 14, 6021-
6029. 
 
Mielnicki, L. M., Hughes, R. G., Chevray, P. M. and Pruitt, S. C., Mutated Atf4 suppresses c-
Ha-ras oncogene transcript levels and cellular transformation in NIH3T3 fibroblasts, 
Biochem. Biophys. Res. Commun., 1996, 228, 586-595. 
 
Miller, M., Shuman, J. D., Sebastian, T., Dauter, Z. and Johnson, P. F., Structural basis for 
DNA recognition by the basic region leucine zipper transcription factor CCAAT/enhancer 
binding protein α, J. Biol. Chem., 2003, 278, 15178-15184. 
 
Minamino, T., Yujiri, T., Papst, P. J., Chan, E. D., Johnson, G. L. and Terada, N., MEKK1 
suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac 
myocytes, Proc. Natl. Acad. Sci. USA, 1999, 96, 15127-15132. 
 
Minden, A., Lin, A., McMahon, M., Lange-Carter, C., Dérijard, B., Davis, R. J., Johnson, G. 
L. and Karin, M., Differential activation of ERK and JNK mitogen-activated protein kinases 
by Raf-1 and MEKK, Science, 1994, 266, 1719-1794. 
 
Minghetti, L. Nicolini, A., Polazzi, E., Creminon, C., Maclouf, J. and Levi, G., Inducible 
nitric oxide synthase expression in activated rat microglial cultures is downregulated by 
exogenous prostaglandin E2 and by cyclooxygenase inhibitors, Glia, 1997, 19, 152-160. 
 
Mitchell, R., Sim, P. J., Leslie, T., Jojnson, M. S. and Thomson, F. J., Activation of MAP 
kinase associated with the priming effect of LHRH, J. Endocrinol., 1994, 140, R15-R18. 
 REFERENCES  
 163 
Mithieux, G., New knowledge regarding glucose-6-phosphatase gene and protein and their 
roles in the regulation of glucose metabolism, Eur J Endocrinol., 1997, 136, 137-145. 
 
Montminy, M. R., Low, M. J., Tapia-Arancibia, L., Reichlin, S., Mandel, G. and Goodman, 
R. H., Cyclic AMP regulates somatostatin mRNA accumulation in primary diencephalic 
cultures and in transfected fibroblast cells, J Neurosci., 1986, 6, 1171-1176. 
 
Montminy, M. R. and Bilezikjian, L. M., Binding of a nuclear protein to the cyclic-AMP 
response element of the somatostatin gene, Nature, 1987, 328, 175-178. 
 
Morgan, J. I. and Curran, T., Stimulus-transcription coupling in the nervous system: 
involvement of the inducible proto-oncogenes fos and jun, Annu Rev Neurosci., 1991, 14, 
421-451. 
 
Morooka, H., Bonventre, J. V., Pombo, C. M., Kyriakis, J. M. and Force, T., Ischemia and 
reperfusion enhance ATF-2 and c-Jun binding to cAMP response elements and to an AP-1 
binding site from the c-jun promoter, J. Biol. Chem., 1995, 270, 30084-30092. 
 
Muller, R. and Wagner, E. F., Differentiation of F9 teratocarcinoma stem cells after transfer 
of c-fos proto-oncogenes, Nature, 1984, 311, 438-442. 
 
Mulvaney, J. M. and Roberson, M. S., Divergent signaling pathways requiring discrete 
calcium signals mediate concurrent activation of two mitogen activated protein kinases by 
gonadotropin-releasing hormone, J. Biol. Chem., 2000, 275, 14182-14189. 
 
Murphy, S., Simmons, M. L., Agullo, L., Garcia, A., Feinstein, D. L., Galea, E., Reis, D. J., 
Minc-Golomb, D. and Schwartz, J. P., Synthesis of nitric oxide in CNS glial cells, Trends 
Neurosci., 1993, 16, 323-328. 
 
Mustafa, S. B. and Olson, M. S., Expression of nitric-oxide synthase in rat kupffer cells is 
regulated by cAMP, J. Biol. Chem., 1998, 273, 5073-5080. 
 
 REFERENCES  
 164 
Naor, Z., Capponi, A. M., Rossier, M. F., Ayalon, D. and Limore, R., Gonadotropin-releasing 
hormone-induced rise in cytosolic free Ca2+ levels: mobilization of cellular and extracellular 
Ca2+ pools and relationship to gonadotropin secretion, Mol. Endocrinol., 1988, 2, 512-520. 
 
Nelson, D. L. and Cox, M. M., Lehninger Principles of Biochemistry, 2000, Worth publishers. 
 
Newman, J. R. S. and Keating, A. E., Comprehensive identification of human bZIP 
interactions with coiled-coil arrays, Science, 2003, 300, 2097-2101. 
 
Nishikura, K. and Murray, J. M., Antisense RNA of proto-oncogene c-fos blocks renewed 
growth of quiescent 3T3 cells, Mol. Cell. Biol., 1987, 7, 639-649 
 
Nomura, N., Zu, Y.-L., Maekawa, T., Tabata, S., Akiyama, T. and Ishii, S., Isolation and 
characterization of a novel member of the gene family encoding the cAMP response element-
binding protein CRE-BP1, J. Biol. Chem., 1993, 268, 4259-4266. 
 
North, M. J., A practical approach, In: Proteolytic Enzymes. IRL press Oxford, 1969, pp. 117-
119. 
 
Ofir, R., Dwarki, V. J., Rashid, D. and Verma, I. M., Phosphorylation of the C terminus of fos 
protein is required for transcriptional transrepression of the c-fos promoter. Nature, 1990, 
348, 80-82. 
 
Pahan, K., Namboodiri, A. M. S., Sheikh, F. G., Smith, B. T. and Singh, I., Increasing cAMP 
attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes, J. Biol. 
Chem., 1997a, 272, 7786-7791. 
 
Pahan, K., Sheikh, F. G., Namboodiri, A. M. S. and Singh, I., Lovastatin and phenylacetate 
inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, 
microglia, and macrophages, J. Clin. Invest., 1997b, 100, 2671-2679. 
 
Pahan, K., Sheikh, F. G., Namboodiri, A. M. S. and Singh, I., N-acetyl cysteine inhibits 
induction of no production by endotoxin or cytokine stimulated rat peritoneal macrophages, 
C6 glial cells and astrocytes, Free Radic. Biol. Med., 1998, 24, 39-48. 
 REFERENCES  
 165 
Pang, L., Sawada, T., Decker, S. J. and Saltiel A. R., Inhibition of MAP kinase kinase blocks 
the differentiation of PC-12 cells induced by nerve growth factor, J. Biol. Chem., 1995, 270, 
13585-13588. 
 
Parker, D., Ferreri, K., Nakajima, T., LaMorte, V. J., Evans, R., Koerber, S. C., Hoeger, C. 
and Montminy, M. R., Phosphorylation of CREB at Ser-133 induces complex formation with 
CREB-binding protein via a direct mechanism, Mol. Cell. Biol., 1996, 16, 694-703. 
 
Pati, D., Meistrich, M. L. and Plon, S. E., Human Cdc34 and Rad6B ubiquitin-conjugating 
enzymes target repressors of cyclic AMP-induced transcription for proteolysis, Mol. Cell. 
Biol., 1999, 19, 5001-5013. 
 
Patterson, M. K. Jr., and Maxwell, M. D., Effects of L-asparagine deprivation on the cell 
cycle of the Jensen sarcoma, Cancer Res., 1970, 30, 1064-1067. 
 
Pawson, T., Protein modules and signaling networks, Nature, 1995, 373, 573-580. 
 
Perry, V. H., Andersson, P. B. and Gordon, S., Macrophages and inflammation in the central 
nervous system, Trends Neurosci., 1993, 16, 268-273. 
 
Persengiev, S. P., Devireddy, L. R. and Green, M. R., Inhibition of apoptosis by ATFx: a 
novel role for a member of the ATF/CREB family of mammalian bZIP transcription factors, 
Genes Dev., 2002, 16, 1806-1814. 
 
Peters, C. S., Liang, X., Li, S., Kannan, S., Peng, Y., Taub, R. and Diamond, R. H., ATF-7, a 
novel bZIP protein, interacts with the PRL-1 protein-tyrosine phosphatase, J. Biol. Chem., 
2001, 276, 13718-13726. 
 
Petrij, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C., Masuno, M., 
Tommerup, N., Van Ommen, G. J., Goodman, R. H., Peters, D. J. M. and Breuning, M. H., 
Rubinstein-Taybi syndrome caused by mutations in the transcriptional coactivator CBP, 
Nature, 1995, 376, 348-351. 
 
 REFERENCES  
 166 
Pinter, J. H., Janovick, J. A. and Conn, P. M., Gonadotropin-releasing hormone receptor 
concentration differentially regulates intracellular signaling pathways in GGH3 cells, 
Pituitary, 1999, 2, 181-190. 
 
Plüss, C., Werner, E. R., Blau, N., Wachter, H. and Pfeilschifter, J., Interleukin 1β and cAMP 
trigger the expression of GTP cyclohydrolase I in rat renal mesangial cells, Biochem J., 1996, 
318, 665-671. 
 
Plüss, C., Werner, E. R., Wachter, H. and Pfeilschifter, J., Differential effect of 
dexamethasone on interleukin 1β- and cyclic AMP-triggered expression on GTP 
cyclohydrolase I in rat renal mesanglial cells, Brit. J. Pharmacol., 1997, 122, 534-538. 
 
Pugh, P. C. and Margiotta, J. F., Nicotinic acetylcholine receptor agonists promote survival 
and reduce apoptosis of chick ciliary ganglion neurons, Mol Cell Neurosci., 2000, 15, 113-
122. 
 
Pulverer, B. J., Kyriakis, J. M., Avruch, J., Nikolakaki, E. and Woodgett, J. R., 
Phosphorylation of c-jun mediated by MAP kinases, Nature, 1991, 353, 670-674. 
 
Quinn, P. G., Distinct activation domains within cAMP response element-binding protein 
(CREB) mediate basal and cAMP-stimulated transcription, J. Biol. Chem., 1993, 268, 16999-
17009. 
 
Radhakrishnan, I., Perez-Alvarado, G. C., Parker, D., Dyson, H. J., Montminy, M. R. and 
Wright, P. E., Solution structure of the KIX domain of CBP bound to the transactivation 
domain of CREB: a model for activator:coactivator interactions, Cell, 1997, 91, 741-752. 
 
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J. and Davis, R. J., 
Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein 
kinase activation by dual phosphorylation on tyrosine and threonine, J. Biol. Chem., 1995, 
270, 7420-7426. 
 
Ramji, D. P. and Foka, P., CCAAT/enhancer-binding proteins: structure, function and 
regulation, Biochem J., 2002, 365, 561-575. 
 REFERENCES  
 167 
Rauscher, F. J., Sambucetti, L. C., Curran, T., Distel, R. J. and Spiegelman, B. M., Common 
DNA-binding site for Fos protein complexes and transcription factor AP-1, Cell, 1988, 52, 
471-480. 
 
Reimold, A. M., Grusby, M. J., Kosarars, B., Fries, J. W. U., Mori, R., Maniwa, S., Clauss, I. 
M., Collins, T., Sidman, R. L., Glimcher, M. J. and Glimcher, L. H., Chondrodysplasia and 
neurological abnormalities in ATF-2-deficient mice, Nature, 1996, 379, 262-265. 
 
Reinhart, J., Mertz, L. M. and Catt, K. J., Molecular cloning and expression of cDNA 
encoding the murine gonadotropin-releasing hormone receptors, J. Biol. Chem., 1992, 267, 
21281-21284. 
 
Reiss, N., Llevi, L. N., Shacham, S., Harris, D., Seger, R. and Naor, Z., Mechanism of 
mitogen-activated protein kinase activation by gonadotropin-releasing hormone in the 
pituitary of alphaT3-1 cell line: differential roles of calcium and protein kinase C, 
Endocrinology, 1997, 138, 1673-1682. 
 
Rhoades, K. L., Golub, S. H. and Economou, J. S., The regulation of the human tumor 
necrosis factor α promoter region in macrophages, T cell, and B cell lines, J. Biol. Chem., 
1992, 267, 22102-22107. 
 
Riabowol, K. T., Fink, J. S., Gilman, M. Z., Walsh, D. A., Goodman, R. H. and Feramisco, J. 
R., The catalytic subunit of cAMP-dependent protein kinase induces expression of genes 
containing cAMP-responsive enhancer elements, Nature, 1988, 336, 83-86. 
 
Riccio, A., Ahn, S., Davenprot, C. M., Blendy, J. A. and Ginty, D. D., Mediation by a CREB 
family transcription factor of NGF-dependent survival of sympathetic neurons, Science, 1999, 
286, 2358-2361. 
 
Roberson, M. S., Misra-Press, A., Laurance, M. E., Stork, P. J. S. and Maurer, R. A., A role 
for mitogen-activated protein kinase in mediating activation of the glycoprotein hormone α-
subunit promoter by gonadotropin-releasing hormone, Mol. Cell. Biol., 1995, 15, 3531-3539. 
 
Roberson, M. S., Zhang, T., Li, H. and Mulvaney, J. M., Activation of the p38 mitogen-
 REFERENCES  
 168 
activated protein kinase pathway by gonadotropin-releasing hormone, Endocrinology, 1999, 
140, 1310-1318. 
 
Roesler, W. J., Vandenbark, G. R. and Hansen, R. W., Cyclic AMP and the induction of 
eukaryotic gene transcription, J. Biol. Chem., 1988, 263, 9063-9066. 
 
Rolli, M., Kotlyarov, A., Sakamoto, K. M., Gaestel, M. and Neininger, A., Stress-induced 
stimulation of early growth gene-1 by p38/stress-activated protein kinase 2 is mediated by a 
cAMP-responsive promoter element in a MAPKAP kinase-2 independent manner, J. Biol. 
Chem., 1999, 274, 19559-19564. 
 
Ron, D. and Habener, J. F., CHOP, a novel developmentally regulated nuclear protein that 
dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative 
inhibitor of gene transcription, Genes Dev., 1992, 6, 439-453. 
 
Rosa, P. and Gerdes, H. H., The granin protein family: Markers for neuroendocrine cells and 
tools for the diagnosis of neuroendocrine tumors, J. Endocrinol. Invest., 1994, 17, 207-225. 
 
Rosenberg, D., Groussin, L., Bertagna, X. and Bertherat, J., cAMP pathway alterations from 
the cell surface to nucleus in adrenocortical tumors, Endocri. Res., 2002a, 28, 765-775. 
 
Rosenberg, D., Groussin, L., Julian, E., Perlemoine, K., Bertagna, X. and Bertherat, J., Role 
of the PKA-regulated transcription factor CREB in development and tumorigenesis of 
endocrine tissues, Ann. N. Y. Acad. Sci., 2002b, 968, 65-74. 
 
Rudolph, D., Tafuri, A., Gass, P., Hammerling, G. J., Arnold, B. and Schutz, G., Impaired 
fetal T cell development and perinatal lethality in mice lacking the cAMP response element 
binding protein, Proc. Natl. Acad. Sci. USA, 1998, 95, 4481-4486. 
 
Ruther, U., Garber, C., Komitowski, D., Muller, R. and Wagner, E. F., Deregulated c-fos 
expression interferes with normal bone development in transgenic mice, Nature, 1987, 325, 
412-416. 
 
 REFERENCES  
 169 
Ryseck, R. P. and Bravo, R., c-JUN, JUN B, JUN D differ in their binding affinities to AP-1 
and CRE consensus sequences: effect of FOS proteins, Oncogene, 1991, 6, 533-542. 
 
Sadowski, I., Bell, B., Broad, P. and Hollis, M., GAL4 fusion vectors for expression in yeast 
or mammalian cells, Gene, 1992, 118, 137-141. 
 
Saklatvala, J., Rawlinson, L., Waller, R. J., Sarsfield, S., Lee, J. C., Morton, L. F., Barnes, M. 
J. and Farndale, R. W., Role for p38 mitogen-activated protein kinase in platelet aggregation 
caused by collagen or a thromboxane analogue, J. Biol Chem., 1996, 271, 6586-6589. 
 
Sassone-Corsi, P., Coupling gene expression to cAMP signaling: role of CREB and CREM, 
Int. J. Biochem. Cell Biol., 1988, 30, 27,38. 
 
Sassone-Corsi, P., Sisson, J. C. and Verma, I. M., Transcriptional autoregulation of the proto-
oncogene fos, Nature, 1988a, 334, 314-319. 
 
Sassone-Corsi, P., Visvader, J., Ferland, L., Mellon, P. L. and Verma, I. M., Induction of 
proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a 
cAMP-responsive element, Genes Dev., 1988b, 2, 1529-1538. 
 
Sassone-Corsi, P., Ransone, L. J. and Verma, I. M., Cross-talk in signal transduction: TPA-
inducible factor Jun/AP-1 activates cAMP-responsive enhancer elements, Oncogene, 1990, 5, 
427-431. 
 
Scammell, J. G., Granins- Marker of the regulated secretory pathway, Trends Endocrinol. 
Metabil., 1993, 4, 14-18. 
 
Schlingensiepen, K.-H., Schlingensiepen, R., Kunst, M., Klinger, I., Gerdes, W., Seifert, W. 
and Brysch, W., Opposite functions of jun-B and c-jun in growth regulation and neuronal 
differentiation, Dev. Genet., 1993, 14, 305-312. 
 
Schmoll, D., Allan, B. B. and Burchell, A., Cloning and sequencing of the 5´ region of the 
human glucose-6-phosphatase gene: transcriptional regulation by cAMP, insulin and 
glucocorticoids in H4IIE hepatoma cells, FEBS Lett., 1996, 383, 63-66. 
 REFERENCES  
 170 
Schmoll, D., Wasner, C., Hinds, C. J., Allan, B. B., Walther, R. and Burchell, A., 
Identification of a cAMP response element within the glucose-6-phosphatase hydrolytic 
subunit gene promoter which is involved in the transcriptional regulation by cAMP and 
glucocorticoids in H4IIE hepatoma cells, Biochem J., 1999, 338, 457-463. 
 
Schoch, S., Cibelli, G., Magin, A., Steinmüller, L. and Thiel, G., Modular structure of cAMP 
response element binding protein 2 (CREB2), Neurochem. Int., 2001, 38, 601-608. 
 
Schorpp-Kistner, M., Wang, Z. Q., Angel, P. and Wagner, E. F., JunB is essential for 
mammalian placentation, EMBO J., 1999, 18, 934-948. 
 
Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Möhle-Steinlein, U., Tian, J., Karin, M., 
Angel, P. and Wagner, E. F., Control of cell cycle progression by c-Jun is p53-dependent, 
Genes Dev., 1999, 13, 607-619. 
 
Silva, A. J., Kogan, J. H., Frankland, P. W. and Kida, S., CREB and memory, Annu. Rev. 
Neurosci., 1998, 21, 127-148. 
 
Siu, F., Chen, C., Zhong, C. and Kilberg, M. S., CCAAT/enhancer-binding protein-beta is a 
mediator of the nutrient-sensing response pathway that activates the human asparagine 
synthetase gene, J. Biol. Chem., 2001, 276, 48100-48107. 
 
Siu, F., Bain, P. J., LeBlanc-Chaffin, R., Chen, H. and Kilberg, M. S., ATF4 is a mediator of 
the nutrient-sensing response pathway that activates the human asparagine synthetase gene, J. 
Biol. Chem., 2002, 277, 24120-24127. 
 
Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M. and Karin, M., Oncogenic and 
transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 
73, Nature, 1991, 354, 494-496. 
 
Smeyne, R. J., Schilling, K., Oberdick, J., Robertson, L., Luk, D., Curran, T. and Morgan, J. 
I., A fos-lac Z transgenic mouse that can be used for neuroanatomic mapping, Adv Neurol., 
1993, 59, 285-291. 
 
 REFERENCES  
 171 
Smith, F. S., Ceppi, E. D. and Titheradge, M. A., Inhibition of cytokine-induced nitric oxide 
synthase expression by glucagon and cAMPin cultured hepatocytes, Biochem J., 1997, 326, 
187-192. 
 
Sommer, C., Gass, P. and Kiessling, M., Selective c-JUN expression in CA1 neurons of the 
gerbil hippocampus during and after acquisition of an ischemia-tolerant state, Brain Pathol., 
1995, 5, 135-144. 
 
Steinmüller, L. and Thiel, G., Regulation of gene transcription by a constitutively active 
mutant of activating transcription factor 2 (ATF2), Biol. Chem., 2003, 384, 667-672. 
 
Stojilkovic, S. S., Reinhart, J. and Catt, K. J., Gonadotropin-releasing hormone receptors: 
structure and signal transduction pathways, Endocri Rev., 1994, 15, 462-499. 
 
Story, M. D., Voehringer, D. W., Stephens, L. C. and Meyn, R. E., L-asparaginase kills 
lymphoma cells by apoptosis, Cancer Chemother Pharmacol., 1993, 32, 129-133. 
 
Streeper, R. S., Svitek, C. A., Goldman, J. K. and O’Brien, R. M., Differential role of 
hepatocyte nuclear factor-1 in the regulation of glucose-6-phosphatase catalytic subunit gene 
transcription by cAMP in liver- and kidney-derived cell lines, J. Biol. Chem., 2000, 275, 
12108-12118. 
 
Streeper, R. S., Hornbuckle, L. A., Svitek, C. A., Goldman, J. K., Oeser, J. K. and O’Brien, R. 
M., Protein kinase A phosphorylates hepatocyte nuclear factor-6 and stimulates glucose-6- 
phosphatase catalytic subunit gene transcription, J. Biol. Chem., 2001, 276, 19111-19118. 
 
Sun, H., Charles, C. H., Lau, L. F. and Tonks, N. K., MKP-1 (3CH134), an immediate early 
gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo, 
Cell, 1993, 75, 487-493. 
 
Sun, H., Tonks, N. K. and Bar-Sagi, D., Inhibition of Ras-induced DNA synthesis by 
expression of the phosphatase MKP-1, Science, 1994, 266, 285-288. 
 
Sun, P., Enslen, H., Myung, P. S. and Maurer, R. A., Differential activation of CREB by 
 REFERENCES  
 172 
Ca2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a 
site that negatively regulates activity, Genes Dev., 1994, 8, 2527-2539. 
 
Sundaresan, S., Colin, I. M., Pestell, R. G. and Jameson, J. L., Stimulation of mitogen-
activated protein kinase by gonadotropin-releasing hormone: evidence for the involvement of 
protein kinase C, Endocrinology, 1996, 137, 304-311. 
 
Sutherland, J. A., Cook, A., Bannister, A. J. and Kouzarides, T., Conserved motifs in Fos and 
Jun define a new class of activation domain, Genes Dev., 1992, 6, 1810-1819. 
 
Suzuki, T., Yamakuni, T., Hagiwara, M. and Ichinose, H., Identification of ATF-2 as a 
transcriptional regulator for the tyrosine hydroxlase gene, J. Biol. Chem., 2002, 277, 40768-
40774. 
 
Takeda, J., Maekawa, T., Sudo, T., Seino, Y., Imura, H., Seito, N., Tanaka, C. and Ishii, S., 
Expression of the CRE-BP1 transcriptional regulator binding to the cyclic AMP response 
element in central nervous system, regenerating liver and human tumors, Oncogene, 1991, 6, 
1009-1014. 
 
Tanaka, K., Nogawa, S., Nagata, E., Ito, D., Suzuki, S., Dembo, T., Kosakai, A. and 
Fukuuchi, Y., Persistent CREB phosphorylation with protection of hippocampal CA1 
pyramidal neurons following temporary occlusion of the middle cerebral artery in the rat, 
Exp. Neurol., 2000, 161, 462-471. 
 
Tanaka, T., Tsujimura, T., Takeda, K., Sugihara, A., Maekawa, A., Terada, N., Yoshida, N. 
and Akira, S., Targeted disruption of ATF4 discloses its essential role in the formation of eye 
lens fibres, Genes Cells, 1998, 3, 801-810. 
 
Taylor, B. S. and Geller, D. A., Molecular regulation of the human inducible nitric oxide 
synthase (iNOS) gene, Shock, 2000, 13, 413-424. 
 
Thiel, G. and Cibelli, G., Corticotropin-releasing factor and vasoactive intestinal polypeptide 
activate gene transcription through the cAMP signaling pathway in a catecholaminergic 
immortalized neuron, Neurochem. Int., 1999, 34, 183-191. 
 REFERENCES  
 173 
Thiel, G., Kaufmann, K., Magin, A., Lietz, M., Bach, K. and Cramer, M., The human 
transcriptional repressor protein NAB1: expression and biological activity, Biochim Biophys 
Acta., 2000, 1493, 289-301. 
 
Thomas, D. M., Francescutti-Verbeem, D. M. and Kuhn, D. M., Gene expression profile of 
activated microglia under conditions associated with dopamine neuronal damage, FASEB J., 
2005, 20, 515-517. 
 
Thompson, M. E., Zimmer, W. E., Wear, L. B., MacMillan, L. A., Thompson, W. J., Huttner, 
W. B., Hidaka, H. and Scammell, J. G., Differential regulation of chromogranin 
B/secretogranin I and secretogranin II by forskolin in PC12 cells, Mol. Brain Res., 1992, 12, 
195-202. 
 
Thompson, M. E., Valentine, D. L., Strada, S. J., Wagner, J. A. and Scammell, J. G., 
Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat 
pheochromocytoma cell line, Mol. Pharmacol., 1994, 46, 880-889. 
 
Timchenko, N. A., Wilde, M., Nakanishi, M., Smith, J. R. and Darlington, G. J., 
CCAAT/enhancer binding protein (C/EBP) inhibits cell proliferation through p21 (WAF-
/CIP-1/SDI-1) protein, Genes Dev., 1996, 10, 804-815. 
 
Tinti, C., Yang, C., Seo, H., Conti, B., Kim, C., Joh, T. H. and Kim, K.-S., Structure/function 
relationship of the cAMP response element in tyrosine hydroxylase gene transcription, J. Biol. 
Chem., 1997, 272, 19158-19164. 
 
Togari, A., Ishinose, H., Matsumoto, S., Fijita, K. and Nagatsu, T., Multiple mRNA forms of 
human GTP cyclohydrolase I, Biochem. Biophys. Res. Commun., 1992, 187, 359-365. 
 
Tokumitsu, H., Chijiwa, T., Hagiwara, M., Mizutani, A., Terasawa, M. and Hidaka, H., KN-
62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine, a specific 
inhibitor of Ca2+/calmodulin-dependent protein kinase II, J. Biol. Chem., 1990, 265, 4315-
4320. 
 
 REFERENCES  
 174 
Trejo, J. and Brown, J. H., c-fos and c-jun are induced by muscarinic receptor activation of 
protein kinase C but are differentially regulated by intracellular calcium, J. Biol. Chem., 1991, 
266, 7876-7882. 
 
Tsai, E. Y., Jain, J., Pesavento, P. A., Rao, A. and Goldfeld, A. E., Tumor necrosis factor 
alpha gene regulation in activated T cells involves ATF2/Jun and NFATp, Mol. Cell. Biol., 
1996, 16, 459-467. 
 
Tsai-Morris, C.-H., Cao, X. and Sukhatme, V. P., 5` flanking sequence and genomic 
structure of Egr-1, a murine mitogen inducible zinc finger encoding gene, Nucleic Acid 
Res., 1988, 16, 8835-8846. 
 
Tsien, R. Y., New calcium indicators and buffers with high selectivity against magnesium and 
protons: design, synthesis, and properties of prototype structures, Biochemisty, 1980, 19, 
2396-2404. 
 
Tsien, R. Y., A non-disruptive technique for loading calcium buffers and indicators into cells, 
Nature, 1981, 290, 527-528. 
 
Tsutsumi, M., Zhou, W., Millar, R. P., Mellon, P. L., Roberts, J. L., Flanagan, C. A., Dong, 
K., Gillo, B. and Sealfon, S. C., Cloning and functional expression of a mouse gonadotropin-
releasing hormone receptor, Mol. Endocrinol., 1992, 6, 1163-1169. 
 
Uhler, M. D. and McKnight, G. S., Expression of cDNAs from two isoforms of the catalytic 
subunit of cAMP-dependent protein kinase, J. Biol. Chem., 1987, 262, 15202-15207. 
 
Ubeda, M., Wang, X.-Z., Zinszner, H., Wu, I., Habener, J. and Ron, D., Stress-induced 
binding of the transcription factor CHOP to a novel DNA control element, Mol. Cell. Biol., 
1996, 16, 1479-1489. 
 
Ullrich, A. and Schlessinger, J., Signal transduction by receptors with tyrosine kinase activity, 
Cell, 1990, 61, 203-212. 
 
 REFERENCES  
 175 
Umek, R. M., Friedman, A. D. and McKnight, S. L., CCAAT-enhancer binding protein: a 
component of a differentiation switch, Science, 1991, 251, 288-292. 
 
Vallejo, M., Ron, D., Miller, C. P. and Habener, J. F., C/ATF, a member of the activating 
transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding 
proteins and directs their binding to camp response elements, Proc. Natl. Acad. Sci. USA, 
1993, 90, 4679-4683. 
 
Van Dam, H., Duyndam, M., Rottier, R., Bosch, A., De Vries-Smits, L., Herrlich, P., 
Zantema, A., Angel, P. and Van der Eb, A. J., Heterodimer formation of cJun and ATF-2 is 
responsible for induction of c-jun by the 243 amino acid adenovirus protein, EMBO J., 1993, 
12, 479-487. 
 
Van de Werve, G., Lange, A., Newgard, C., Mechin, M. C., Li, Y. and Berteloot, A., New 
lessons in the regulation of glucose metabolism taught by the glucose-6-phosphatse system, 
Eur J Biochem., 2000, 267, 1533-1549. 
 
Vann, L. R., Twitty, S., Spiegel, S. and Milstien, S., Divergence in regulation of nitric-oxide 
synthase and its cofactor tetrahydrobiopterin by tumor necrosis factor-alpha. Ceramide 
potentiates nitric oxide synthesis without affecting GTP cyclohydrolase I activity, J. Biol. 
Chem., 2000, 275, 13275-13281. 
 
Van Schaftingen, E. and Gerin, I., The glucose-6-phosphatase system, Biochem. J., 2002, 362, 
513–532. 
 
Verma, I. M. and Graham, W. R., The fos oncogene, Adv Cancer Res., 1987, 49, 29-52. 
 
Vinson, C. R., Sigler, P. B. and McKnight, S. L., Scissors-grip model for DNA recognition by 
a family of leucine zipper proteins, Science, 1989, 246, 911-916. 
 
Vinson, C., Myakishev, M., Acharya, A., Mir, A. A., Moll, J. R. and Bonovich, M., 
Classification of human B-ZIP proteins based on dimerization properties, Mol. Cell. Biol., 
2002, 22, 6321-6335. 
 
 REFERENCES  
 176 
Walton, M. W., Rehfuss, R. P., Chrivia, J. C., Lochner, J. E. and Goodman, R. H., A 
dominant repressor of cyclic adenosine 3´, 5´-Monophosphate (cAMP)-regulated enhancer-
binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter 
in vivo, Mol Endocrinol., 1992, 6, 647-655. 
 
Walton, M., MacGibbon, G., Young, D., Sirimanne, E., Williams, C., Gluckman, P. and 
Dragunow, M., Do c-Jun, c-Fos and amyloid precursor protein play a role in neuronal death 
or survival?, J. Neurosci. Res., 1998, 53, 330-342. 
 
Walton, M., Connor, B., Lawlor, P., Young, D., Sirimanne, E., Gluckman, P., Cole, G. and 
Dragunow, M., Neuronal death and survival in two models of hypoxic-ischemic brain 
damage, Brain Res. Brain. Res. Rev., 1999, 29, 137-168. 
 
Wang, X. Z. and Ron, D., Stress-induced phosphorylation and activation of the transcription 
factor CHOP (GADD153) by p38 MAP kinase, Science, 1996, 272, 1347-1349. 
 
Wang, X. Z., Kuroda, M., Sok, J., Batchvarova, N., Kimmel, R., Chung, P., Zinszner, H. and 
Ron, D., Identification of novel stress-induced genes downsream of chop, EMBO J., 1998, 17, 
3619-3630. 
 
Wang, Z. Q., Ovitt, C., Grigoriadis, A. E., Mohle-Steinlein, U., Ruther, U. and Wagner, E. F., 
Bone and haematopoietic defects in mice lacking c-fos, Nature, 1992, 360, 741-745. 
 
Watters, J. J., Sommer, J. A., Pfeiffer, Z. A., Prabhu, U., Guerra, A. N. and Bertics, P. J., A 
differential role for the mitogen-activated protein kinase in lipopolysaccharide signaling, J. 
Biol. Chem., 2002, 227, 9077-9087. 
 
Weck, J., Fallest, P. C., Pitt, L. K. and Shupnik, M. A., Differential gonadotropin-releasing 
hormone stimulation of rat luteinizing hormone subunit gene transcription by calcium influx 
and mitogen-activated protein kinase-signaling pathways, Mol. Endocrinol., 1998, 12, 451-
457. 
 
Whitworth, J. A., Studies on the mechanisms of glucocorticoid hypertension in humans, 
Blood Pressure, 1994, 3, 24-32. 
 REFERENCES  
 177 
Wiggin, G. R., Soloaga, A., Foster, J. M., Murray-Tait, V., Cohen, P. and Arthur, J. S., MSK1 
and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and 
ATF1 in fibroblasts, Mol. Cell. Biol., 2002, 22, 2871-2881. 
 
Wilhelm, D., Van Dam, H., Herr, I., Baumann, B., Herrlich, P. and Angel, P., Both ATF-2 
and c-Jun are phosphorylated by stress-activated protein kinases in response to UV 
irradiation, Immunobiol., 1995, 193, 143-148. 
 
Williams, S. C., Cantwell, C. A. and Johnson, P. F., A family of C/EBP related proteins 
capable of forming covalently linked leucine zipper dimers in vitro, Genes Dev., 1991, 5, 
1553-1567. 
 
Wisdom, R. and Verma, I. M., Transformation by Fos proteins requires a C-terminal 
transactivation domain, Mol. Cell. Biol., 1993, 13, 7429-7438. 
 
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J. and Mathison, J. C., CD14, a 
receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein, Science, 1990, 
249, 1431-1433. 
 
Xie, Q. W., Whisnant, R. and Nathan, C., Promoter of the mouse gene encoding calcium-
independent nitric oxide synthase confers inducibility by interferon gamma and bacterial 
lipopolysaccharide, J Exp Med., 1993, 177, 1779-1784. 
 
Xie, Q. W., Kashiwabara, Y. and Nathan, C., Role of transcription factor NF-kappa B/Rel in 
induction of nitric oxide synthase, J. Biol. Chem., 1994, 269, 4705-4708. 
 
Xing, L., Gopal, V. K. and Quinn, P. G., cAMP response element-binding protein (CREB) 
interacts with transcription factors IIB and IID, J. Biol. Chem., 1995, 270, 17488-17493. 
 
Xu, L., Lavinsky, R. M., Dasen, J. S., Flynn, S. E., McInerney, E. M., Mullen, T. M., Heinzel, 
T., Szeto, D., Korzus, E., Kurokawa, R., Aggarwal, A. K., Rose, D. W., Glass, C. K. and 
Rosenfeld, M, G., Signal specific co-activator domain requirements for Pit-1 activation, 
Nature, 1998, 395, 301-306. 
 
 REFERENCES  
 178 
Yamada, T., Murayama, T. and Nomura, Y., Muscarinic acetylcholine receptors on rat 
thymocytes: their possible involvement in DNA fragmentation, Jpn J Pharmacol., 1997a, 73, 
311-316. 
 
Yamada, T., Yoshiyama, Y. and Kawaguchi, N., Expression of activating transcription factor-
2 (ATF-2), one of the cyclic AMP response element (CRE) binding proteins, in Alzheimer 
disease and non-neurological brain tissues, Brain Res., 1997b, 749, 329-334. 
 
Yamamoto, K. K., Gonzalez, G. A., Biggs, W. H. and Montminy, M. R., Phosphorylation-
induced binding and transcriptional efficacy of nuclear factor CREB, Nature, 1988, 334, 494-
498. 
 
Yang, X. and Karsenty, G., ATF4, the osteoblast accumulation of which is determined post-
translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells, J. 
Biol. Chem., 2004, 279, 47109-47114. 
 
Yarden, Y. and Ullrich, A., Growth factor receptor tyrosine kinases, Annual Reviews in 
Biochemistry, 1988, 57, 443-468. 
 
Zanger, K., Cohen, L. E., Hashimoto, K., Radovick, S. and Wondisford, F. E., A novel 
mechanism for cyclic adenosine 3',5'-monophosphate regulation of gene expression by CREB 
binding protein, Mol. Endocrinol., 1999, 13, 268-275. 
 
Zhan, Q., Liebermann, D. A., Alamo, I., Hollander, M. C. and Ron, D., The gadd and MyD 
genes define a novel set of mammalian genes encoding acidic proteins that cooperatively 
suppress cell growth, Mol. Cell. Biol., 1994, 14, 2361-2371. 
 
Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Lightfoot, R. T., Remotti, H., Stevens, 
J. L. and Ron, D., CHOP is implicated in programmed cell death in response to impaired 
function of the endoplasmic reticulum, Genes Dev., 1998, 12, 982-995. 
 
 
 
 
 ZUSAMMENFASSUNG  
 179 
 
G. Zusammenfassung 
 
„Basic Region Leucin Zipper“ (bZIP) Transkriptionsfaktoren sind Proteine, die an spezifische 
Sequenzen im Promotor binden und dadurch die Transkription dieser Gene entweder 
aktivieren oder hemmen. Das bekannteste Mitglied der bZIP-Familie ist das „cAMP 
responsive element“ (CRE)-bindende Protein CREB, welches an die CRE-Consensussequenz 
5’-TGACGTCA-3’ bindet. Um die Gen-Regulation durch bZIP-Transkriptionsfaktoren zu 
untersuchen, wurden konstitutiv-aktive und dominant-negative bZIP-Mutanten verwendet. 
Die Ergebnisse zeigen, dass die GTP-Cyclohydrolase I, Sekretogranin II, Tumornekrosefaktor 
α und Egr-1 kodierende Gene durch CREB und ATF2 via CRE-Bindungsmotive oder 
ähnliche Sequenzen reguliert werden. CREB und ATF2 bilden keine Heterodimere, sondern 
konkurrieren um dieselbe DNA-Bindungsstelle. Im Gegensatz dazu bilden die bZIP-Proteine 
CREB2/ATF4, ATF5 und C/EBP zwar untereinander Heterodimere, jedoch dimerisieren sie 
nicht mit CREB oder ATF2. CREB2/ATF4, ATF5 und C/EBP haben keinen oder nur 
geringen Einfluss auf CRE-regulierte Gene. CREB2/ATF4, ATF5 und C/EBP transaktivieren 
das Asparaginsynthetasegen und regulieren dessen Transkription nach Entzug von 
Aminosäuren im Kulturmedium. 
In einer zweiten Studie wurde die Regulation der induzierbaren Stickstoffmonoxidsynthase 
(iNOS) untersucht. Die Transkription des iNOS-Gens wird nach Stimulation des „toll-like“ 
Rezeptors 4 aktiviert. Die Ergebnisse zeigen, dass stressaktivierte Proteinkinasen und die 
bZIP Proteine ATF2 und/oder c-Jun die Aktivierung der iNOS-Gentranskription vermitteln.  
Schließlich wurde die Regulation von c-Jun und c-Fos kodierenden Genen in pituitary cells 
untersucht. Die Stimulation des „Gonadotropin-Releasing Hormon Rezeptors“ (GnRHR) oder 
des muskarinischen-Acetylcholin-Rezeptors Typ III führte zur Aktivierung des c-Jun und des 
cFos-Gens. Dies zeigt, dass die Biosynthese der bZIP-Proteine c-Jun und cFos durch 
extrazelluläre Stimuli kontrolliert wird. 
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